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Anxiety is the most prevalent adolescent behavioral health condition. Impairments caused by 
anxiety negatively impact educational performance, and social and emotional functioning. 
Moreover, future consequences of undetected and untreated anxiety include increased risk for 
other behavioral health conditions, obesity, and smoking. Despite the high prevalence of anxiety 
and the chronic nature of untreated anxiety, only about one third of youth with anxiety disorders 
receive treatment, constituting a public health problem.  
No national guidelines exist for primary care providers regarding the identification and 
treatment of adolescent anxiety. Moreover, anxiety-specific research in pediatric primary care is 
limited. As such, this qualitative interview study sought to understand what factors, at the 
provider, organizational-, and policy-level, influence primary care providers decisions and 
capacity to identify and treat adolescent anxiety.  
Of the 22 providers interviewed, nearly all perceived identification of adolescent anxiety 
as part of their professional role. Providers were divided on how anxiety should be identified. 
Half of providers believed a short, systematic screening tool would be beneficial for initial 
identification. Others perceived it was necessary to utilize anxiety screening tools only after the 
potential concern was identified. While a majority of providers had prescribed medications for 
adolescents with anxiety, not all providers viewed it as their role to prescribe and/or manage 
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medication treatments. Several providers viewed their role as initiating treatment until the 
adolescent was able to see a specialist, while other providers commented on treatment roles as 
being strictly referral based. Barriers including lack of time, experience, training, and comfort, 
fear of medication side effects, and not having an embedded behavioral health provider were 
discussed as limiting factors on primary care providers’ capacity to treat anxiety.  
Future research should focus on how both the identified factors influencing primary care 
providers’ capacity to treat anxiety and their treatment role perceptions impact decisions to 
routinely screen for anxiety. Efforts to standardize primary care providers’ capacity for anxiety 
treatment and identification may decrease treatment gaps; the development of evidence-based 
national guidelines and expectations may facilitate increased primary care providers’ confidence 
with implementing treatment plans and may support increased resources, training, and education 
from an organizational standpoint.   
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1.0  INTRODUCTION 
The first chapter presents literature specific to the treatment of adolescent anxiety in primary 
care, focusing on why the under-treatment and under-recognition of adolescent anxiety is a 
public health concern. Next, primary care practices are introduced as a viable setting for the 
identification and treatment of adolescent anxiety disorders. Screening tools and two types 
anxiety treatment are introduced followed by a discussion of general barriers faced by primary 
care providers (PCPs) in the identification and treatment of adolescent mental health conditions. 
Clinical care guidelines are subsequently outlined to highlight discrepancies in treatment support 
PCPs may receive for specific conditions (e.g., ADHD, depression, and anxiety). Consequently, 
literature focused on PCP role perceptions and levels of confidence in identifying and treating 
mental health conditions is discussed.  
This chapter concludes with an outline of the primary aims of the study. As a way to 
organize the above evidence and identify significant gaps, the disease screening framework 
created by Wilson and Junger in conjunction with tenants of Social Cognitive Theory are 
explained as a conceptual framework to explore how primary care providers’ awareness, skills, 
comfort level, and the environment in which they operate influence the identification and treatment of 
adolescent anxiety. 
Several things are important to note about chapter 1: (1) Throughout the discussion of the 
major areas reviewed, literature specific to adolescent anxiety in primary care is often sparse. As 
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such, supporting and contrasting literature specific to other conditions, namely ADHD and 
depression, are referenced. (2) Many key factors discussed in chapter 1 were identified based on 
the social ecological framework. The figure below serves as a reference. (3) Adolescents are 
defined as being 13 to 18 years of age. The word youth is used in reference to samples that 
include persons anywhere from 3 to 18 years of age. 
 
 
Figure 1. Ecological Factors from Non-Anxiety Focused Literature 
 
Chapter 2 presents the methodology of this exploratory qualitative research study to 
understand the totality and interplay of factors that may influence a primary care provider's 
decision to identify and treat adolescent anxiety in primary care. Participant selection, data 
collection, data analysis, and the inclusion of expert interviews are presented. Chapter 3 provides 
the results of the study. Quotations are displayed throughout this section.  Chapter 4 provides an 
interpretation of study results including interpretation based on existing evidence in the literature 
and the perspectives of three expert interviewees. The final chapter provides concluding remarks 
and presents possible avenues for future research.  
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1.1 BACKGROUND 
In any given year, 13 to 20% of American youth (ages 3 to 17) have a diagnosable mental 
disorder.1,2 Youth can experience mental health conditions across the spectrum from attention 
deficit hyperactivity disorder (ADHD), to anxiety disorders and depression, to serious mental 
illnesses such as schizophrenia.3 Literature states that among child and adolescent psychiatric 
disorders the most common are anxiety disorders, with prevalence of  anxiety (26.6%)4 being 
higher than depression/dysthymia (11.7%),4 substance use disorders (11.4%),4 and ADHD 
(8.7%)4 for  adolescents. Even when considering how the above disorders co-occur with anxiety, 
anxiety is still the most common.5,6 For example, depression and anxiety co-occur:6 anywhere 
from 25 to 50% of youth experiencing depression experience anxiety. Interestingly of youth 
experiencing anxiety, 10 to 15% experience depression.7 Adolescent anxiety disorders focused 
on in this dissertation include generalized anxiety, phobias, separation anxiety, and panic 
disorders.8 High adolescent anxiety prevalence rates are one major reason researchers and 
practitioners must endeavor to develop national guidelines for primary care providers regarding 
the identification and treatment of adolescent anxiety. 
1.1.1 Prevalence of anxiety in youth 
A variety of estimates exist regarding prevalence of anxiety in youth. Prevalence estimates of 
anxiety disorders for American youth range from 2.6 to 20% (before the year 2009).9,10 A more 
recent lifetime prevalence estimate of anxiety disorders for U.S. adolescents (ages 13 to 18 years 
old) is 26.6%, excluding post-traumatic stress disorder.4 This estimate comes from a landmark 
2010 nationally-representative study utilizing data from the National Comorbidity Survey-
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Adolescent Supplement (NCS-A) (n=10,123).4 International studies estimate a point prevalence 
ranging from 3.1 to 17.5% of youth anxiety disorders.11 Some international studies report even 
higher rates. For example, a German study of students ages 12 to 17 years old found a cross-
sectional anxiety prevalence rate of 18.6% using a diagnostic interview tool.12 Prevalence rates 
appear to vary based on age of the population, mechanism for diagnosis (self-report vs diagnostic 
interview), Diagnostic and Statistical Manual of Mental Disorders (DSM) version/anxiety 
confirmation criteria, and current versus lifetime diagnosis. See table 1 for other prevalence rates 
presented in the literature. 
Table 1. Anxiety Prevalence Evidence 
Population Prevalence Evidence Study Considerations 
n=776 
1983 (age 9-18) 
    At least 1 Dx  
    Any Dx 
1986 (age11-20) 
    At least 1 Dx  
    Any Dx 







Gurley D, Cohen P, Pine DS, 
Brook J. Discriminating depression 
and anxiety in youth: a role for 
diagnostic criteria. J Affect Disord. 
1996;39(3):191-200.13 
Rates for at least 1 anxiety diagnosis 
and for any anxiety disorder; 
community sample in NY state; 
parent/child interview assessment; 
assessment questions changed at 
second time-point; DSM-III-R  
n=210 
ages 8, 12, 17 
    At least 1 Dx  




Kashani JH, Orvaschel H. A 
community study of anxiety in 
children and adolescents. The 
American journal of psychiatry. 
1990;147(3):313-318.14 
Rates for at least 1 anxiety diagnosis 
and for any anxiety disorder; 
community sample in Missouri; 
Child Assessment Schedule; DSM-
III 
Ages 14-24 years 
old (majority of 






Costello EJ, Egger HL, Angold A. 
Developmental epidemiology 
of anxiety disorders.In: Ollendick 
TH, March JS, editors. Phobic and 
anxiety disorders in children and 
adolescents. New York: Oxford 
University Press;2004.p. 334–80.15 
Review of epidemiologic literature; 
any anxiety disorder; n ranging from 
172 to 3,021; DSM III-R; DSM IV; 









Ruth Perou RHB, Stephen J. 
Blumberg, Patricia Pastor, et al. 
Mental Health Surveillance Among 
Children — United States, 2005–
2011. Centers for Disease Control 
and Prevention 2013.16,17 
Current diagnosis; parent-self report 
data National Health Interview 
Survey and National Survey of 
Children's Health data in 2007 
Dx: Diagnosis  
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1.1.2 Potential causes of anxiety disorders 
Several factors have been implicated in the development of anxiety disorders including genetic, 
biological and environmental factors.  For instance, there is evidence that individuals who have a 
parent(s) with anxiety have a higher likelihood of having an anxiety disorder;18 a result of 
genetic and environmental factors.19,20 Factors associated with anxiety disorder incidence 
include: parenting styles/behaviors,20,21 life circumstances/stressors,20,22 negative 
emotionality/temperament,20,22 and dysfunction with biochemical/“neural-circuitry”.20,22,23 
1.1.3 Anxiety, depression, and ADHD impairments 
Hallmark characterizations of anxiety disorders include fears24,25 (e.g., daily life routines25; social 
situations24,25), being separated from home or a “loved one”,25 presenting with somatic 
symptoms,24 worrying/negative thoughts,24,26 and having difficulty sleeping.25 Moreover, there is 
a correlation between anxiety severity and the detrimental effects of somatic symptoms.5 In 
addition to this physical suffering1 caused by anxiety in adolescents, scholastic performance,1,5 
grades,5 missed days at school,5,9 concentration,27 and familial and peer relationships1,28,29 are 
negatively affected. 
Depression in adolescents is associated with feelings of sadness; behavioral pattern 
changes regarding eating, sleeping, and energy; as well as difficulties with attention, school, and 
relationships.30 When depression is severe, symptoms can lead to self-harm, including suicide.30 
Attention deficit hyperactivity disorder (ADHD) in adolescents is also associated with negative 
outcomes related to scholastic work, relationships, and daily functioning.31 Depression and 
ADHD have been highly researched as these diagnoses cause great impairment to youth 
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specifically regarding academics and relationships. A six-year longitudinal study of youth ages 9 
to 13 (n=1,420) by Ezpeleta et al., showed anxiety disorders are associated with the same level of 
impairment in academic and relational domains.24,32 As impairments caused by anxiety are 
similar to impairments caused by depression and ADHD, equal prioritization in screening and 
treatment research is ethically motivated. 
1.1.4 Economic costs of childhood mental health conditions 
Mental health disorders in children cost approximately 247 billion dollars annually (2007) in 
mental health services, health, productivity, and crime.1,33,34 Moreover, child mental health 
disorders are predictive of adult mental illness; 50% of all adult lifetime cases of mental health 
issues began in adolescence (age 14) with mental disorders/symptom onset.3,11,35,36 In any given 
year, 18% of adults experience anxiety disorders in the U.S. (approximately 40 million 
people).37,38 National health care cost estimates for adults with anxiety disorders is 42 to 46.6 
billion dollars a year in both indirect costs (e.g. morbidity such as percent of lost income or 
productivity due to anxiety and mortality39)  and direct costs (e.g. services at mental health 
institutions, physician office visits, hospitalizations, nursing home care, and support costs such as 
physician training39) (1990).39-42  
A major reason why youth with mental health issues, including anxiety disorders, are 
initially seen in primary care settings (75% of youth with mental health issues) 2 is these 
disorders typically present with somatic symptoms.5,9 Somatic symptoms are presenting physical 
symptoms that may stem from behavioral health issues and or are medically unexplainable. 
Somatic symptoms include headaches,27,28,43 gastrointestinal issues,27,44 chest pain,5,45 
tachycardia,5 dizziness,5 nausea,5 vomiting,5 breathing difficulties,5 and insomnia.27 Under-
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recognition of anxiety disorders41 combined with the presentation of somatic symptoms may lead 
primary care providers (PCP) to order expensive, unnecessary diagnostic tests.5,38,41 This 
etiological uncertainty regarding physical presentations of anxiety may also result in an excess 
number of and needless medical visits that may not provide treatment necessary for symptom 
alleviation.5 
1.1.5 Public health significance 
If anxiety goes undetected and untreated, research shows the disorder course is typically 
chronic.5 Untreated anxiety disorders in adolescents negatively impact educational 
performance,6,8,24 and social and emotional functioning.24 Having an anxiety disorder as an 
adolescent increases future risk of depression,8,24,46,47 eating disorders,24 substance use,8,24,46,47 
obesity,28,48 and smoking.28,49 As adolescent anxiety disorders have both negative acute and 
future consequences, preventative measures such as identification (i.e., screening) and 
subsequent treatment may lead to a decrease in associated consequences of the disorder.6,35 
Moreover, anxiety disorders occur earlier than other mental health disorders. For example, 
anxiety disorder onset is 5 to 10 years before the onset of depression -- early onset provides the 
medical community the opportunity to intervene earlier and potentially reduce future risk of 
depression and substance use.18 High prevalence of anxiety in the U.S. adolescent population 
paired with negative individual and social costs constitutes a significant public health problem 
and highlights the need for proper treatment.  
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1.2 DISPARITIES IN PEDIATRIC ANXIETY TREATMENT  
Analysis of the National Health and Nutrition Examination Survey (NHANES 2001 to 2004) 
found only 50.6% (+/- standard error 3.4) of youth with any mental disorder and 32.2% (+/- 
standard error 14.3) of youth with anxiety disorders received treatment.50,51 In a 2018 report from 
a national non-profit, Child Mind Institute, they stated that 80% of children and adolescents 
“never get help” but do not reference where the original data is from. Treatment gaps are 
pronounced for youth with mental disorders,52 and perhaps more pronounced for anxiety 
disorders.  
1.2.1 Treatment gaps 
Chavira et al., conducted a study to assess prevalence of specific mental health disorders and 
associated treatments in a sample of youth ages 8 to 17 years old who had seen a PCP in the past 
year.53 Findings show that the most prevalent mental health issue was anxiety followed by 
ADHD and depression.53 Most importantly, this study provides evidence that significant 
treatment disparities exist for youth anxiety; only 9% of youth with anxiety had ever been treated 
with medication compared to the 20% of depressed youth and 79% of youth with ADHD.53 
Twenty-eight% of youth with anxiety had ever received counseling for their disorder compared 
to the 40% of youth with depression and 33% of youth with ADHD.53 This study highlights a 
treatment gap for anxiety compared to treatment for ADHD and depression. It is important to 
note that level of severity for either anxiety or depression plays a role in a provider’s treatment 
type decision (i.e., therapy, medication, or both).54,55  
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Merikangas et al. conducted a cross-sectional study using a subsample of adolescents 13 
to 18 years old who were interviewed in the national NCS-A survey and whose parents also 
filled out a self-administered questionnaire regarding their children.52 Results showed only 
17.8% of adolescents with anxiety received disorder-specific treatment compared to disorder-
specific treatment rates for ADHD (59.8%) and mood disorders (37.7%).52 Results from Chavira 
and Merikangas mirror each other in their findings that ADHD is treated more frequently than 
other disorders, especially anxiety disorders. Not linked to either above the above discussed 
studies, there may be several reasons for ADHD being treated more frequently compared to other 
mental health conditions including FDA approval of drug treatment,56 recommendation 
guidelines,57 diagnostic comfort,2 and the external nature of symptoms.  
Kataoka et al., (2002), analyzed data from three national surveys (e.g. National Survey of 
American Families, National Health Interview Survey, and Community Tracking Survey) to 
examine the “unmet” mental health service (e.g., doctor, mental health counselor, therapist) 
needs of youth.58 Analysis revealed that of youth who needed services, 88% of Hispanic youth 
and 76% of white youth did not receive care in a 12-month period.58 They also found that 87% of 
uninsured youth and 73% of publicly insured youth did not receive care.58 Results from this 
study provide evidence of disparities in the reception of youth mental health care by ethnicity 
and insurance type.  
1.2.2 Low identification: a factor in treatment disparities 
A study of an integrated health care system (e.g. all providers can see the same electronic 
medical record; care providers, locations, and insurance coverage are integrated)59 using parental 
and adolescent structured interviews found the detection of both depression and anxiety was low 
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in youth (11 to 17 years of age).29 Specifically only 22% of the 51 participants (with 
depression/anxiety) were recognized by this health care system for these disorders.29 Early 
identification is the necessary first step in providing adequate treatment to mitigate the increased 
risks adolescents face regarding “substance abuse, depression, and suicidality”, as well as 
increased behavioral and physical risks over time.60 
1.2.3 Summary 
Over the past twenty years, the need for identification of behavioral health conditions in primary 
care settings has become a discernable and important conversation among researchers and 
practitioners. Between 12% and 22% of youth in primary care offices have a mental health 
disorder.61 Specifically, screening and treatment in primary care offices for certain behavioral 
health conditions (e.g., ADHD and depression) have been increasingly well received by 
providers.62,63 However, the same is not true for anxiety disorders, as anxiety disorders 
frequently go undetected and without detection, untreated.10,24,52 The detrimental effects of 
untreated anxiety as well as the future health risks underscore the necessity for early 
identification and subsequent treatment of anxiety in adolescents.  
1.3 PRIMARY CARE SETTINGS 
Primary care is an ideal setting for identification and treatment (including referrals to treatment) 
of adolescent anxiety disorders.64 Primary care providers (PCPs) are likely to be the first point of 
routine contact with the health care system a youth will have. According to the National Health 
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Interview Survey (2017) 96.1% of persons under the age of 18 were reported to have a “usual 
place of health care”; with usual care locations most often being doctors’ offices (74%) and 
clinics (24.5%).65 Thirty-three percent of youth have family medicine physicians as their usual 
source of care.66,67  Moreover, pediatric primary care providers are used by 90% of youth for 
health care needs.68 For youth six to 18 years of age, in primary care settings, the lifetime 
prevalence of anxiety disorders ranges from 6.6 to 17%.69,70 The data supports primary care is 
used by a majority of youth and youth in these settings have behavioral health needs specific to 
anxiety disorders. 
 Typically, the process of identification and treatment for children who do receive services 
related to their mental health occurs solely in the primary care setting.71,72 Historically, rates of 
identification of behavioral health issues in youth have been increasing for PCPs (e.g., 
pediatricians and family medicine physicians). A study of community-based pediatricians and 
family practitioners (n=425) found an increase in psychosocial issue identification (6.8 to 18.7%) 
for youth ages 4 to 15 years old from 1979 to 1996.56,73 In summary, there are three substantial 
reasons as to why primary care practice settings are ideal for the identification and treatment of 
adolescent anxiety disorders: (1) adolescents have generally high levels of access to primary care 
offices70; (2) adolescents who have anxiety disorders (recognized or not) are overwhelmingly 
seen in primary care offices 24,57; and (3) there is an increasing trend of providers in primary care 
offices identifying specific behavioral health issues. 
In a position paper put forth by the American Academy of Pediatrics and the American 
Academy of Child and Adolescent Psychiatry (2009) there was a strong push to acknowledge 
primary care clinicians have the ability and the responsibility to initiate mental health 
identification and treatment for youth with ADHD, depression, anxiety, and substance use 
 12 
concerns.35 Several reasons have been proposed for why primary care practice is the most 
suitable location for the identification and care of pediatric mental health issues35 that are 
specific to the primary care provider and settings in which they practice (see table 2). 
Table 2. Unique Characteristics in Pediatric Primary Care 
Provider Setting 
Rapport building skills35, including trust36 Conversations in a setting associated with little to no  
mental health stigma35 
Longitudinal aspect of developmental care36,68 
Lifestyle promotion36 
Reinforcement of child/family strengths36  
Recognition of adverse events/stressors36 
Appointments   
Orientation towards family35 74 
Routine well-child visits; Holistic care 
Acute need appointments  
Communication with variety of specialists36  Co-location of mental health providers possible35 
 
Specific to the setting of primary care, there is some consensus in the literature that receiving 
mental health treatment from PCPs/primary care settings versus receiving treatment from mental 
health specialists/mental health specific settings may be perceived as less stigmatizing.2,56,75,76 
Stigma can be reduced merely from not having to go to a mental health clinic70 and instead going 
to a primary care location. Primary care is often not thought of as a usual place of care for mental 
health problems by the general public. Primary care providers also tend to see adolescents as 
well as their families in visits over the course of the child’s development, which can foster a 
trusting relationship which is a factor in mediating stigma and levels of comfort.70 
Youth, as well as adults,77 experiencing emotional distress due to anxiety are more likely 
to go to a general care provider as opposed to a mental health specialist for treatment, with one 
reason being the somatic nature of symptoms.5,77 Contradictory evidence exists according to the 
National Survey on Drug Use and Health (2015) 13.3% of adolescents’ ages 12 to 17 years 
obtained emotional/behavioral care at both inpatient or outpatient mental health settings (i.e. 
specialty mental health settings) and only 2.7% of these adolescents were obtaining emotional/ 
behavioral care from predications or family physicians.78 
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Much literature exists on barriers to receiving mental health services. While there are 
many barriers to mental health services such as insurance/financial barriers35 and waiting times 
for appointments56 the following two barriers will be discussed in turn as they relate to the 
potential need for identification/treatment capabilities in primary care: (1) lack of pediatric 
mental health specialists,2,71 and (2) presentation of somatic symptoms leading to visits with 
primary care.5  
1.3.1 Lack of pediatric mental health providers 
Currently in the United States there are approximately 8,300 practicing child and adolescent 
psychiatrists (2016) who have a potential clientele of over 15 million.79 Comparatively there are 
58,726 general pediatricians, 4,703 internal medicine-pediatric trained physicians (2011)80 and 
87,650 family practice physicians (2010)81 who provide care for up to 33% of all youth.66 There 
is a need for increases in child and adolescent-specific psychiatry, as mental health services 
reach only 20% of the youth in need of such services (2013).79 Moreover evaluation/treatment 
conducted by age-appropriate mental health specialists occurs for “only a small fraction of 
[youth]” as reported by the US Bureau of Health Professions.79 Shortages in this profession stem 
from factors such as a reduction in “child and adolescent psychiatry residency training 
programs”,82 cost of specialized training83 paired with declining funds for graduate medical 
education,84 managed care/health plan payments83,84 and “a devalued image of the profession”.84 
Not only is there a relatively limited supply of psychiatrists specifically trained to work 
with youth, rural geographic regions and areas with low socioeconomic status (SES) in the US 
experience limited or no access to age-appropriate mental health services and/or a 
maldistribution of child psychiatrists.79,85,76 Locations that are both urban and academic centers 
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have reported that access to child psychiatrists is not a severe burden.85 In Pennsylvania (PA), 
every county has been designated by the Health Resources and Services Administration (2017) 
as having too few mental health providers and services.86 This designation is substantiated by the 
American Academy of Child and Adolescent Psychiatry (AACAP) who report PA as having a 
“severe shortage” of practicing child and adolescent psychiatrists (2015), with 33 counties not 
having at least one practicing child and adolescent psychiatrist.79 
One way the Pennsylvania Department of Humans Services is attempting to remedy the 
shortage of mental health specialists is through the Telephonic Psychiatric Consultation Service 
Program (TiPS).87 TiPS provides consultation services for primary care providers (and others) 
who need to or want to consult child psychiatry experts regarding behavioral health concerns 
faced by their patient population.87 While this program is an excellent resource for PCPs as it 
was “designed to increase the availability of child psychiatry consultation teams, regionally and 
by phone, to primary care providers (PCPs)”,88 the program can only be utilized on behalf of 
patients on Medical Assistance.87   
The importance of utilizing PCPs in areas with limited access to age-appropriate mental 
health services is underscored by locational and transportation barriers to the few practicing child 
and adolescent psychiatrists that are available. While telemedicine is a growing mechanism to 
connect patients with mental health providers, it is by no means consistently available.89 It is 
reasonable to look to PCPs for both identification and treatment of non-serious mental illness 
such as adolescent anxiety.82,85  
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1.3.2 Somatic symptoms 
Physical presentations of symptoms may be one reason why appointments are set at primary care 
as opposed to a mental health clinic. As previously noted, physical complaints are common for 
persons with anxiety or depression and these somatic symptoms are one reason why anxiety and 
depression often go undiagnosed.64 Youth frequently go to primary care settings, over the course 
of multiple visits, with concerns regarding “neurologic, pain, autonomic, or gastrointestinal tract 
symptoms” and often these complaints are met with null test results for physical conditions.90  
Abdominal pain, headaches, and chest pain are three symptoms that often present during 
pediatric primary care visits.90 Campo et al., (2003) conducted a case-control study of youth ages 
8 to 15 years old with and without recurrent abdominal pain in primary care practices. Results 
showed that 79% and 31% of youth with recurrent abdominal pain met the clinical criteria for 
anxiety and depression respectively.90,91 While anxiety can be the main diagnosis when a patient 
presents with physical (somatic) symptoms, certain physical health conditions may be associated 
with anxiety in adults such as irritable bowel syndrome, chronic obstructive pulmonary disease 
and heart disease.92 However, as evidenced above, anxiety can often be the primary health 
concern affecting youth and the physical ailments presented are truly somatic of this mental 
health disorder.  
1.4 SCREENING TOOLS: ADOLESCENT ANXIETY IN PRIMARY CARE 
There has been a movement to incorporate mental health screening34,63 into primary care. 
Specific to adolescent anxiety, reliable, effective and feasible screening tools exist. The purpose 
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of this section is to provide an overview of available anxiety-specific screening tools for primary 
care providers, not to determine the “best” option.  
 To note, the following are guidelines to determining if the measures below have good 
psychometric properties: (1) Cronbach's alpha at or above 0.70 demonstrates acceptable levels of  
item inter-relatedness93; (2) intraclass correlation coefficients of .075 to .90  demonstrate good 
test-retest reliability94; and (3) the higher the correlation (i.e. Pearson Correlation) between 
youth-reported measure and parent-reported measure, the more agreement there is between the 
two measures. 
1.4.1 Screen for Child Anxiety and Related Emotional Disorders (SCARED) 
SCARED is a validated parent and child self-report screening tool for anxiety disorders in youth 
ages eight years and older.6,95,96 It was developed at Western Psychiatric Institute and Clinic. 
Three versions of the SCARED tool exist, the original 38-item version, the 41-item version, and 
the 5-item version. All three versions yield a five-factor solution: panic/somatic, generalized 
anxiety, separation anxiety, social phobia, and simple/school phobia.95,97 Factor analysis was 
conducted on an initially developed 85-item scale, which was used to reduce the scale to 38-
items.98  Psychometric properties for this original study used a sample of children (n=341) and 
parents (n=300), with 88 children and 86 parents participating in test-retest reliability five weeks 
post first administration.98  The following are reported psychometric properties for total score 
and each of the five factors found: (1) internal consistency ranged from alpha=0.74 to 0.93; (2) 
test-rest reliability interclass correlation coefficients ranged from 0.70 to 0.90, and (3) parent-
child agreement for all correlations ranged from 0.20 to 0.47, p<0.001.98   
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 In a second study, psychometric properties of the 41-item SCARED was assessed using a 
sample of youth ages nine to 18 (n=190) and their parents (n=166).95 Authors then reduced the 
41-item scale to 5-items “by selecting the single item from each of the 5-factors which loaded the 
highest in the discriminate function analysis”.95,99 They found similar psychometric properties 
compared to the properties of the 41-item scale.95,99 Results from this study are presented in 
Table 3. Results are presented in table format because authors do not explicitly report the 5-item 
scale statistics. The reason, as stated above, is because the 5-item properties are similar to the 
properties of the 41-item scale. The 5-item SCARED is likely to be the most efficient way for 
primary care providers to identify anxiety disorders experienced by youth as the time it takes for 
assessment and scoring are relatively short, thereby posing less of a visit time threat.  
Table 3. 41-item SCARED Psychometric Summary 
Psychometric Properties 41-item SCARED tool 
Internal Consistency  
Remainder coefficients  
Coefficient alphas  
 
0.34-0.67 (all 41 items) 
0.9 (child & parent totals) 
Factor Structure  
Coefficient alphas 
 
0.78-.087 (for each of the 5 factors) 
Parent-Child Correlations 
Total anxiety score 
 
p=0.32, p=0.0001 
Cut-off point of 25 
Child SCARED discriminating 
Anxiety to non-anxiety  
Anxiety to depression 
Anxiety to disruptive  
 
 
sensitivity 71%; specificity 67% 
sensitivity 71%; specificity 61% 
sensitivity 71%; specificity 71% 
1.4.2 Multidimensional Anxiety Scale for Children (MASC) 
MASC6 is a reliable and valid screening tool for anxiety.96,100,101  This 39-item scale includes 
four subscales (e.g., physical symptoms, harm avoidance, social anxiety and separation, 
panic).101 The original scale was developed utilizing an initial sample for factor structure and 
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validity assessment. This scale was subsequently assessed for test-retest reliability and validity at 
two-time points (three weeks and three months) with a new sample.102  
 A more recent study by Wei et., al., (2014) was conducted to test the validity of MASC 
using a sample of youth diagnosed with an anxiety disorder based on a structured diagnostic 
interview with youth and their parents (n=488).101 For internal consistency reliability of youth 
and parent report respectively, Cronbach’s alpha for total MASC was 0.88 and 0.87, with alphas 
ranging from 0.64 to 8.7 for subscales.101 Pearson correlations between youth and parent report 
for youth seven to 12 years old was 0.29 (total MASC) and ranged from 0.16 to 0.47 for 
subscales.101 Pearson correlations between youth and parent report for adolescents 13 to 17 years 
old was 0.35 (total MASC) and ranged from 0.27 to 0.57 for subscales. The Pearson correlations 
mean that there is only weak to moderate agreement between youth and parent reports. While 
MASC is a promising tool for anxiety identification, validation in the adolescent primary care 
population is needed. 
1.4.3 Spence Children’s Anxiety Scale (SCAS) 
SCAS follows DSM-IV anxiety disorder dimensions and assesses anxiety (e.g., generalized 
anxiety, social phobia, separation anxiety, obsessive-compulsive disorder (OCD), and fears of 
injury) symptom severity in youth ages eight to 14 years old.103-105 The developer of the SCAS 
reports 44-item scale takes approximately 10 minutes for an adolescent to complete.104 In total, 
38 of the 44-items are symptom specific to anxiety and these 38 items were selected from 80 
initial items.106,107 Using a sample of adolescents 13 and 14 years old (n=875) a study found: (1) 
internal consistency of total scale having a coefficient alpha of 0.92 and subscale alphas ranging 
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from 0.6 to 0.80 and (2) in a 12 week test-retest (n=362) total score reliability coefficient of 
0.63.105  
1.4.4 The Patient Health Questionnaire for Adolescents (PHQ-A) 
PHQ-A is an instrument that can be used to screen 13 to 18-year-old adolescents for generalized 
anxiety, panic disorders, eating problems, mood problems, and substance abuse.103,108 A study 
conducted by Johnson et, al., assessed the validity of PHQ-A using a sample of adolescents ages 
13 to 18 years old (n=403) who were seen in primary care. Diagnosis of a disorder made by 
PHQ-A was validated through a clinical diagnosis made by a mental health professional. 
Through professional diagnosis, 4.2% of the sample was identified as having an anxiety disorder 
and 5% were identified by PHQ-A.108  
 Reported psychometric properties of PHQ-A are as follows: (1) 75% sensitivity (i.e. 
proportion of persons the scale finds has the condition, who actually do have the condition); (2) 
92% specificity (i.e. proportion of persons the scale finds does not have the condition, who 
actually do not have the condition); (3) 89% accuracy (i.e. cases identified correctly); and (4) 
0.65 diagnostic agreement (i.e. moderate agreement between the scale and a mental health 
professionals assessment –criterion validity).103,108  There are several advantages for the PHQ-A 
as it has been validated in an adolescent population, was developed specifically for primary care 
physicians,109 takes five minutes to score,103 has acceptable levels of sensitivity, specificity and 
accuracy, and screens for mental health issues that may be comorbid with anxiety. The tool, 
however, could be taxing to the adolescent as this self-report measure has 83 items103 and it does 
not screen for as many anxiety disorders as SCARED 5-item tool. 
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1.4.5 Generalized Anxiety Disorder Scale (GAD-7) 
GAD-7 was developed to incorporate criteria from DSM-IV and initially started with 13 items.110 
This 13 item scale was tested on adult patients in 15 difference primary care sites across 12 states 
over two phases to: (1) determine final scale items (n=1654) and (2) determine test-retest 
reliability (n=236).110 Seven items had correlation scores of 0.75 to 0.85 with the total scale. 
Based on these results, the authors found internal consistency of alpha=0.92 and intraclass 
correlation of 0.83 for GAD-7.110 This measure can be self-administered or administered by the 
provider; administration takes approximately two to five.111  
1.5 SYSTEMATIC SCREENING 
The extant literature demonstrates if one can identify a youth experiencing anxiety and treat that 
diagnosis, symptoms and future risks would be greatly reduced.6 Research has found that 
systematic screening by age group may be more feasible than identifying children at high risk.34 
Systematic screening for anxiety may remove a potential barrier of defining “at-risk” youth for 
the disorder – as there is evidence youth experiencing mental health risk factors (i.e., 
disadvantaged families) have low rates of being identified and the provider may not be able to 
connect risk factors (known or unknown) to mental health concerns.112 Moreover occurrence of 
systematic screening does not preclude identification of children at-risk for mental health 
conditions.112 
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1.5.1 Evidence for and against systematic screening 
Zuckerbrot et al., conducted a feasibility and acceptability study in three pediatric primary care 
offices regarding implementation of a “2-stage adolescent identification” depression screening 
protocol.63 Overall results indicated providers accepted the paper screener and limited time was 
needed for the screener (4.6 minutes), suggesting screening feasibility. Providers in the study 
were able to screen approximately 79% of their patients. The other 21% of patients were not 
screened for a variety of reasons including refusal (2.9%), eligibility status, and other 
administrative reasons.63 
  Hacker et al., conducted a study using a sample of pediatricians who had been mandated 
to conduct behavioral health screenings.113 Results of the study are mixed. Providers were 
receptive to and used screening tools. Many felt that mental health discussions were 
“normalized” due to the universality of screening. However, providers also reported not 
uniformly trusting the screening scores as they felt (1) literacy levels influenced parents’ 
responses, and (2) question comprehension was often difficult.113  
 Berger-Jenkins et al., (2011) conducted a study to assess the feasibility of screening 
youth (five to 12 years old) in low-resource primary care settings whose patient population was 
“primarily African American and Hispanic”.114 This study compared outcomes before 
implementation of a routine mental health screener and after implementation.114 While results 
did not show a significant increase in youth screened over the two-time points, concerns about 
mental health issues were voiced significantly more often by parents after implementation.114   
 Within the literature reviewed, there have been no reviews of how screening for anxiety 
impacts clinical outcomes.34,44 Results from a literature review conducted by American Academy 
of Pediatrics Task Force on Mental Health found that using a validated mental health screener 
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was “useful” in various visit types such as maintenance, acute, and risk appointments.34 
However, this Task Force paper only presented evidence regarding screening tools validated in 
youth populations for depression, drugs, maternal depression, and domestic violence. As such, 
screening tool usefulness specific to anxiety disorders is left to be determined. 
1.5.2 Other sources of information used for identification 
Often providers rely on their own or parental observations/descriptions of youth behavior and 
functioning to identify a mental health concern.75 Relying on parental concerns is an important 
part of building a trusting relationship with patient’s family and provides key insight into issues 
that may help PCPs identify health and behavioral health issues.  
 However, it has been reported that not even half of parents who have concerns regarding 
their child’s behavioral/mental health will mention them, let alone discuss concerns with their 
children’s physicians.66 Parents may not bring such concerns up to PCP’s due to (1) feelings of 
doubt regarding PCP’s ability to treat mental health conditions; (2) prioritizing physical health 
aliments; (3) treatment being administered by a different health care provider;66 (4) parental 
feelings of wanting to be viewed as competent by provider, which is compounded by feelings of 
embarrassment and/or guilt, or (5) parents may not know what the adolescent is experiencing. If 
providers are not using validated identification tools and are relying on parents to express 
concerns in order to help them identify behavioral health concerns, there may be a risk of a youth 
with a diagnosable mental illness not being identified and subsequently not being treated. 
Systematic screening, as evidenced by Berger-Jenkins (2001), may prove as a technique to 
increase parental disclosures of mental health concerns to primary care providers. 
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1.5.3 Specific research is needed 
It can be hypothesized having reliable and valid screening tools may improve PCPs in 
recognizing adolescent anxiety if they trust, feel equipped to use, and have time to utilize the 
tool. Evidence for this hypothesis has yet to be fully developed, and counter-evidence does exist 
in the literature. As outlined in the latter section, validated screening tools for anxiety for 
primary care settings are available to PCPs. Despite the existence of these tools and other sources 
of information, the problem of under-recognition of anxiety persists.44 Research specific to PCPs 
who see adolescent patients is needed to understand unique aspects of anxiety identification in 
their practice settings and if systematic screening is a potential solution to under-identification. 
1.6 TREATMENT: ADOLESCENT ANXIETY IN PRIMARY CARE 
While there are various treatment methods for adolescent anxiety (i.e., attention bias medication, 
exposure therapy, family therapy, parental education22), this review will focus on cognitive 
behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) as these are 
commonly compared and recommended in the literature as first line treatments.115,116 The most 
common efficacious non-pharmacologic therapy is CBT.96 While CBT provides youth with 
education, management, and coping skills, it is not always conducive to the treatment of youth 
with moderate or severe anxiety.96 Also, it is not a therapeutic technique commonly used in 
primary care settings.117 Moreover, as mental health specialists are most likely to provide CBT, 
“access to this specialized treatment” is a major barrier to receiving it.118 While cutting-edge 
technological advances are beginning to allow for computer and web-based care delivery, not all 
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geographic areas with limited access to mental health services have been reconfigured for such 
novel solutions118 and future research is needed to assess the reliability and effectiveness of these 
methods as well as telehealth solutions. 
Medication treatment (e.g., SSRIs) for adolescent anxiety disorders can be used in a 
multimodal approach with CBT or sometimes as a stand-alone intervention; both of which have 
been shown to be effective treatments.116,118 A randomized comparative treatment study called 
Child/Adolescent Anxiety Multimodal Study (CAM) compared CBT, sertraline (a SSRI), the 
combination of CBT and sertraline, and a placebo medication in the treatment of youth ages 
seven to 17 years old who had three common pediatric disorders (generalized anxiety, social 
phobia, and separation anxiety).119 Overall, results of CAM study provide evidence that the 
combination of CBT and sertraline produce higher response rates compared to the other 
treatment conditions but that there was no significant difference between response rates for CBT 
versus sertraline.118,120 Remission rates followed a similar trend to response rates, with 
combination treatment remission rates being 46 to 68% compared to just sertraline (34 to 46%), 
just CBT (20 to 46%), or placebo (15 to 27%).112,115  
Recently, a meta-analysis (2017) of 115 studies was conducted with the purpose of 
comparing CBT and various medication treatments for effectiveness in treating anxiety disorders 
in youth.121 Generally, this report found that CBT is an effective treatment for improving anxiety 
symptoms based on study designs of treatment vs. no treatment and wait-list comparison.121 The 
report also found SSRIs reduced more anxiety symptoms compared to placebo medications.121 
However, this review was not able to produce results comparing CBT to SSRIs as too few 
studies comparing the two exist.   
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There are no US Food and Drug Administration (FDA) approved medications for youth 
experiencing anxiety disorders other than OCD.116 Specifically, SSRIs have been shown to be a 
more effective treatment for pediatric anxiety disorders compared to placebos through seven 
different randomized medication trials.116,122 Moreover, SSRIs are currently the “medication of 
choice” for treatment, 96,116 despite an FDA (2004) announcement regarding risk of suicidality 
and SSRIs.123 In terms of treating anxiety, there has been a reported increase in SSRI 
prescriptions from primary care providers.85,124,125 
1.7 IDENTIFICATION AND TREATMENT BARRIERS: PRIMARY CARE 
Evidence presented thus far showcases that the identification and treatment of adolescent anxiety 
are appropriate for providers in a primary care setting (i.e., high prevalence, appointment 
frequency, available screening tools and treatments, familial relationships). Unfortunately, in 
primary care settings, less than one in three youth who have mental health issues are identified as 
such.34 It has been consistently presented in the literature that only 20 to 30% of youth are 
identified as having anxiety and or depression,28 with the rest being undiagnosed or 
misdiagnosed. Key barriers to the identification and treatment of adolescent mental health 
conditions by primary care providers are presented below.  
1.7.1 Lack of training/education 
A barrier to identification of emotional disorders for primary care physicians is lack of training 
and education (i.e., knowledge and skills) regarding specific disorders and subsequent 
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treatments.2,36,71,75 Since 1990, residency programs for pediatricians have undergone continuous 
changes to accreditation requirements regarding childhood mental health conditions.126 In 2000, 
the Accreditation Council for Graduate Medication Education (ACGME) required specific 
mental health curricular content for residency training program (e.g. one month “experience in 
behavioral and developmental aspects of pediatrics” and screening, counseling, and referral 
experiences), but has since moved to mandating these programs to employ a certified faculty “in 
development and behavioral pediatrics” and a similar one month experience mentioned 
previously.126 For pediatric nurse practitioners, developing skills to assess and treat mental health 
conditions is possible through passing the “Pediatric Primary Care Mental Health Specialist 
Exam”.127,128 
In order to support training of residents, in 2002, the American Board of Pediatrics 
developed a certification for pediatricians that would allow them to have a developmental and 
behavioral subspecialty. To date, 775 pediatricians have been awarded this certification.126,129 
Depending on the state, there is currently only one subspecialist pediatrician for every 59,000 or 
300,000 children.126,129 As with most accreditations for different graduate-level disciplines, 
stipulations from ACGME can be implemented and interpreted numerous ways. Also, even with 
a subspecialty certification now available, the few who do receive this are reported to have 
limited time with residents who could learn from their expertise.126,129 Even though pediatrician 
behavioral health training has been undergoing constructive changes, the literature states there is 
still not “an adequately trained pediatric workforce in the areas of developmental and behavioral 
health.”126  
A study comparing questionnaire responses of pediatricians who were members of the 
AAP in 2004 (n=687) and 2013 (n=510) found 65% of pediatricians in 2004 and 66% of 
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pediatricians in 2013 reported a lack of treatment training for adolescent mental health 
problems.126,130 Further evidence that current training requirements for residency programs are 
not sufficient in closing the gap in the proportion of children who are unrecognized and untreated 
in pediatric primary care settings can be found in a 2014 survey of directors of pediatrics 
residency programs (n=99). Seven programs were reported to have a rotation for residents 
specifically for mental health and all other programs incorporated mental health education into 
“another rotation”.131  
An important set of outcomes in this study came from directors reporting on level of 
resident mental health knowledge (e.g. poor/fair, average, and very good/excellent).131 Regarding 
ADHD treatment, 57% of directors reported they felt their residents’ knowledge was very good/ 
excellent while only approximately 22% of directors and 15% of directors respectively, reported 
feeling their residents knowledge of depression and anxiety treatment as being very 
good/excellent.131 Anecdotally this may be due to the residents’ pediatric preceptor being more 
comfortable in treating ADHD compared to depression and anxiety. Several solutions for 
training improvement have been proposed including new mental health curricula, practice 
assessment of mental health skills, and immersion experiences in primary care practices.126 
1.7.2 Shortage of mental health providers 
The shortage of mental health providers specializing in adolescent populations,126 as previously 
discussed, is a barrier to receiving age-appropriate care in the mental health care system. 
Shortages of these mental health providers also present as a barrier to PCPs who want to identify 
and or treat their adolescent patients for mental health conditions. If the PCP does not feel 
confident or have the educational background and training to administer testing or treatment, 
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they would need to refer the child and family to a mental health specialist. Often physicians 
report that there is a shortage of psychiatrists they can refer to,113  and even if there is a mental 
health specialist they can refer to, having that referral occur in a “timely fashion” is 
variable.71,85,56,75  
Treatment delays due to referrals could negatively harm the adolescent or could 
jeopardize the trust relationship between PCP, the youth, and parents if the youth/parents are 
expecting immediate support but are not seeing that occur. Also, parents may not act on the 
referral due to negative perceptions and stigma of mental health services,71 leaving the youth 
untreated for an identified mental health condition. 
1.7.3 Rural barriers 
There is a paucity of specific research regarding how geography influences identification, 
treatment and future outcomes for adolescents with anxiety. Using evidence from other health 
conditions in regards to how rurality influences treatment may provide insight into similar 
factors influencing anxiety treatment and outcomes. 
For instance, literature points to several barriers to mental health care that may be more 
pronounced for rural communities compared to urban communities such as, “access to 
affordable care”, transportation, and stigma.132 Two qualitative studies (focusing on different 
health topics: management of childhood obesity and reproductive health care) found similar 
barriers to care as reported by rural physicians. The common barriers reported were lack of time 
in appointments, lack of resources, and familial attitudes.133,134 Providers managing childhood 
obesity uniquely mentioned barriers such a limited clinical knowledge, lack of reimbursement, 
lack of specialists, and high prevalence.133 Providers in the reproductive health perception study 
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reported “they had a greater role in providing contraceptive care than did non-rural physicians” 
and that a foremost barrier to pre-contraception care were rural norms.134  
Another study conducted by Colon-Gonzalez et al., (2013) investigated rural providers 
(e.g., family physicians, internists, and OBGYNs) attitudes towards mood disorder care for their 
female patients.135 Specific to rurality, providers reported mental health care barriers including 
low SES and unique pressures of acceptability of having a mental health condition in rural 
society.135 Research focusing on unique barriers to anxiety treatment that rural providers face is 
warranted. Factors reported in studies focused on other health conditions may serve as a starting 
point to determine if such factors apply to adolescent anxiety. 
1.7.4 Other individual, organizational- and system-level barriers 
Barriers occurring within the primary care visit include time constraints,5,71,126 provider concerns 
about embarrassing or stigmatizing their patients2,5 and reaction of their patients’ 
parents/guardians regarding presence or possibility of a mental health condition.5 Other barriers 
persist on the insurance system level56,71 such as “inability to obtain separate reimbursement for 
assessments and well-child care when both are included in a single visit”,46,136  and “inadequate 
levels of reimbursement”.75,126,136 Williams et, al found several factors pediatricians reported as 
to why they would not make a behavioral health diagnosis in general: (1) missing comorbid 
conditions; (2) meeting full criteria of the disorder; (3) discrepancies from presentations and 
child/parental report; (4) negative impact of labeling and parental acceptance; and (5) their own 
personal comfort, experience, and training.2  
Looking internationally, the National Institute for Health and Clinical Excellence (NICE) 
recommends use of a program called Beating the Blues to reduce CBT treatment barriers for 
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primary care providers.137 Beating the Blues is a computerized program that also reduces patient-
level barriers such as transportation and offers patients “anonymity” as they can receive 
treatment from any location they choose (given they have an Internet capable device).137 While 
there are various models of care that integrate mental health and physical health, a comparison of 
such models is outside the scope of this review.76,138 However, as a summary of factors that may 
reduce barriers to mental health care in primary care, the relevant and high-level results from a 
review conducted by the Canadian Collaborative Mental Health Initiative are outlined below.  
The Canadian Collaborative Mental Health Initiative conducted a review of “the impact 
of collaborative mental health care using experimental methodologies in the primary care 
setting” (n=38 studies).139 In this report, there was one relevant review of a collaborative care 
model for youths experiencing mental illness in the United Kingdom. Authors reported details of 
the models components are limited but the overall goal is to “improve management of mental 
health problems within the general practice setting” by the provision of services focused on 
mental health education, training and consultation to and for PCPs.139 The model was compared 
to usual mental health care over the span of a year.139 Results found that patients reported 
“feelings of being less stigmatized” and general practitioners reported “high levels of satisfaction 
with the service”.139 Overall, the entire report found collaborative relationships at the provider- 
and system-level between primary care and mental health require time, supportive structures 
such as co-located services, and treatment guidelines.139  
1.7.5 Summary 
Many of the above-reported barriers are generally presented in the literature regarding mental 
health conditions and are not specific to anxiety. One approach to hypothesizing about anxiety 
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specific identification and treatment barriers is using the extant literature focused on other mental 
health conditions. However new research is needed to confirm or disconfirm these hypotheses 
and generate new data specific to adolescent anxiety in primary care. Looking towards models of 
care developed to improve mental health care in primary care is another avenue to generate 
anxiety specific hypothesis. 
1.8 GUIDELINES: ADHD, DEPRESSION, ANXIETY  
For clinical care processes and decisions to be standardized, clinical practice guidelines are often 
developed to influence medical care providers such as clinicians.140 For pediatricians and family 
practitioners141 to learn about evidence-based practice guidelines and recommendations 
regarding certain physical health and behavioral health conditions they would reference clinical 
practice guidelines put forth by the American Academy of Pediatrics (AAP). The AAP is a large, 
national organization represented across the US (59 chapters) and Canada (7 chapters),142 
dedicated to ensuring youth receive optimal care from providers who are AAP members.143 The 
purpose of the section that follows is to present guidelines and recommendations from various 
organizations, including AAP, as they relate to three most common mental health conditions 
experienced by youth: ADHD, depression, and anxiety. The order in which condition guidelines 
are presented is based on the level of guidance available. As such, anxiety is presented last 
because no guidelines outside of Bright Futures exist for primary care providers for either 
identification or treatment. 
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1.8.1 ADHD guidelines 
In 2000, the AAP recommended pediatricians should evaluate for ADHD144 and in 2001, 
published ADHD treatment recommendations.145 Similar to varying reports of anxiety 
prevalence rates, AAP guidelines for ADHD  mention varying prevalence rates.144 Unlike 
anxiety, the FDA has approved medication treatment (stimulants) of ADHD for youth three years 
and older.56  The guideline also notes that the media and the public have expressed high levels of 
interest in processes that enable identification and treatment of ADHD.144 Treatment guidelines 
for youth ages 12 to 18 year old experiencing ADHD state that approved FDA medications 
“should” be prescribed by the PCP, and behavior therapy (in-school or home) may also be 
prescribed.145 It has been postulated that the attention of the public, the externalizing nature of 
this disorder, along with the AAP recommendations, facilitated a “major campaign” to 
disseminate knowledge and toolkits specific to ADHD broadly.62 
1.8.2 Depression guidelines 
The AAP does not currently have guidelines for identification and treatment of depression 
targeted to pediatricians or family practitioners. The AAP website does provide facts about 
adolescent depression, treatment options, and case vignettes to help providers think through 
different circumstances relating to these disorders.25,146 For depression, AAP provides specific 
pharmacologic treatment options as well as a more nuanced guide for a “good diagnostic 
evaluation” of depression.146  
Specific to primary care, U.S. Preventive Services Task Force (USPSTF) (2009) 
recommended depression should be screened for routinely for adolescents’ ages 12 to 18 years 
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old.34 The recommendation stems from their review of the literature that in primary care settings, 
depression screening tools are accurate in identification of depression in adolescents.34,147 
USPSTF  also stated that while there is a lack of direct evidence regarding the association of 
screening and better health outcomes in this population, they “…found adequate evidence that 
treatment of MDD [major depressive disorder] detected through screening in adolescents is 
associated with moderate benefit (for example, improved depression severity, depression 
symptoms, or global functioning scores).”147 Similar to ADHD, FDA has approved the use of 
medication (i.e., SSRIs) for youth six years and older experiencing depression.56 
Several other governmental entities have focused their attentions on adolescent 
depression. For example, the Healthy People 2020 objective MHMH-11.2 specifically is to 
“increase [by 10%] the proportion of primary care physician office visits where youth aged 12 to 
18 years are screened for depression”.148  This objective arose from evidence citing that from 
2005 to 2007, depression screening for this population occurred in only 2.1% of these visits as 
reported by CDC/NCHS and National Ambulatory Medical Care Survey.148 In 2003, the 
President’s New Freedom Commission (2003) made several policy recommendations regarding 
child and adolescent mental health screenings -- including that screening specific to depression 
and substance use should take place in primary care settings for adolescents that are at high-
risk.34 
1.8.3 Anxiety guidelines 
Similar to depression, the AAP website provides facts about adolescent anxiety, treatment 
options, and case vignettes to help providers think through different circumstances relating to 
these disorders.25,146 However, information specifically relating to diagnoses of anxiety is 
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lacking. The AAP website refers clinicians to DSM-IV or ICD 10 criteria and to use 
“standardized anxiety tools”25; no recommendations or reference links are provided on when and 
how to use the tools. While presenting the above-mentioned information on the official AAP 
website is a step in the right direction, an official guideline specifically focusing on the 
availability of screening tools and treatment in PCP offices is needed to begin standardization of 
clinical care for adolescents with anxiety in pediatric primary care settings.  
Interestingly, AAP does support the provision of guidelines for an initiative called Bright 
Futures. Bright Futures was started in 1990 by the Health Resources and Services 
Administration’s Maternal and Child Health Bureau to promote national health for youth.149 A 
major function of Bright Futures is advocating for states to include Bright Future guides/toolkits 
into Medicaid coverage policies.149 Currently the Medicaid youth benefits called Early and 
Periodic Screening, Diagnostic and Treatment (EPSDT) benefits allows primary care providers 
to bill for behavioral health screening, including anxiety screens (e.g. SCARED).150 However, 
the guidance is vague as screening is recommended when concern is brought up by the provider, 
the parent, the patient, or when risk factors are known.  
 Neither USPSTF, HealthyPeople 2020, the New Freedom Commission, nor the FDA has 
published official guidelines, recommendations, national health objectives or approvals 
regarding the screening and treatment of adolescent anxiety. However, to improve identification 
of behavioral and emotional issues in pediatric primary care settings, American Academy of 
Pediatrics Task Force on Mental Health put forth a recommendation that these primary health 
care settings should implement programs for mental health detection, citing high rates of 
common disorders, including anxiety.34,151   
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1.9 IDENTIFICATION AND TREATMENT PERCEPTIONS: PROVIDERS 
1.9.1 Role and responsibility 
American Academy of Pediatrics conducts a Periodic Survey that is representative of 
“approximately 80% of pediatricians”.62 Results using a random sample of respondents from the 
59th Periodic Survey (2004) showed several notable findings: (1) in respondents’ practice 
settings, 27% thought ADHD was extremely/very prevalent compared to 9% who thought 
depression and 8% who thought anxiety was extremely/very prevalent; (2) 90% of the sample 
felt responsibility for identifying ADHD and eating disorders; (3) 80 to 90% felt responsibility 
for identifying depression, substance abuse, anxiety disorders, and behavioral issues; (4) 70% 
believed it was their role to treat and manage ADHD and (5) “less than one-third thought that it 
was their responsibility to treat or manage any other condition” such as depression, anxiety 
disorders,  behavior problems, learning disabilities, substance use and eating disorders.62  
The first finding of this survey is startling, as there is clear evidence anxiety disorders and 
depression are highly prevalent in the general pediatric patient population. This discrepancy 
between provider beliefs and prevalence data may stem from several factors including a lack of 
mental health awareness, lack of mental health training, or confusion regarding the most recent 
prevalence studies. Regardless, these survey results clearly find pediatricians overwhelmingly 
believe they are responsible for identification of the above-mentioned behavioral health 
conditions (findings 2 and 3), which may be indicative of an attitude that could aid in the 
facilitation of mental health screening uptake. While results show belief in responsibility, results 
also showcase that belief in the pediatricians’ roles to treat anxiety is relevantly low compared 
pediatricians’ belief in their role to treat ADHD.  
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Factors contributing to providers’ role acceptance of screening and treating ADHD in 
their patient population have been already mentioned throughout the introduction chapter. Much 
of provider comfort with recognition and treatment of ADHD is credited to PCP-specific practice 
parameters (i.e., standardized clinical practice guidelines) concerning this disorder, as mentioned 
previously.85 Moreover, ADHD screening tools are relatively straightforward questionnaires.152 
Literature points to another treatment facilitator, which is the fact that medications used for 
ADHD treatment are “relatively safe”,62 and once treatment begins, noticeable behavioral 
improvements can occur in a short timeframe.152 Success in treating adolescent anxiety is said to 
be less immediate and consistent152 and as mentioned before, no FDA medications have been 
approved. This is evidence leading to one hypothesis that not knowing or seeing success/clinical 
effects of anxiety treatment as being a barrier to identification and treatment of anxiety disorders.    
As anxiety is unique from ADHD, future research should explore views about 
identification and treatment from the primary care providers’ perspective specific to anxiety, as 
identification methods for the latter disorders may not prove fruitful for anxiety. Future research 
should assess how providers define their responsibility to identify and treat anxiety disorders, 
what identification and treatment processes entail, what their preferred method for identification 
is, what factors would support their identification method, and if screening guidelines are 
necessary, needed, and helpful.  
1.9.2 Comfort and confidence 
Of the literature reviewed, there is an apparent consensus that PCPs report recognizing certain 
child and adolescent behavioral health concerns (i.e., ADHD, mood, and anxiety disorders) are a 
part of their professional role.85 However, level of comfort and confidence diagnosing and 
 37 
treating behavioral health disorders varies by condition. Lack of training may lead providers not 
to feel comfortable with both the diagnostic/screening process and treatment of pediatric mental 
health conditions.5,136  
While there is limited literature regarding primary care providers’ levels of comfort 
treating anxiety in their pediatric patients, a 2005 survey study conducted by Fremont et. al., 
investigated pediatricians’ and family medicine physicians’ (n=200) treatment comfort levels 
regarding several behavioral health disorders in youth including attention deficit disorder (ADD), 
anxiety, depression, and bipolar.56 One major finding from this study was both pediatricians and 
family medicine physicians were less comfortable diagnosing bipolar affective disorder 
compared to ADHD, anxiety, and depression. Interestingly, authors report anxiety and 
depression as one category (e.g., 56% of pediatricians and 82.4% of family medicine physicians 
reported being comfortable diagnosing anxiety/depression),56 making it impossible to know the 
sample’s comfortability making a diagnosis of anxiety specifically.  
Analysis of the 2005 survey also found of providers who are “comfortable” making a 
behavioral health diagnosis, approximately 52% (pediatricians) and 63% (family medicine 
physicians) reported being comfortable prescribing antidepressant for treatment of 
depression/anxiety with 95.2% (pediatricians) and 98.6% (family medicine physicians) reporting 
actually prescribing these medications.56 This finding is interesting because providers 
overwhelming report prescribing the medication, even though little more than half report feeling 
comfortable prescribing. Overall, this study does attempt to fill the gap in the literature regarding 
“PCPs comfort levels in diagnosing and treating psychotic disorders in children”,56 while also 
clearly highlighting the need for anxiety specific research. 
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Pediatric PCPs overwhelmingly have more confidence in screening and diagnosing and 
are more comfortable treating ADHD compared to both depression and anxiety disorders.85,113 
Results of a study using structured interviews with urban pediatricians (n=47) found 
pediatricians report diagnosing ADHD most frequently (n=45) with less than half diagnosing 
depression and anxiety.2 Moreover, this study found that 94% of physicians used stimulants as 
ADHD treatment, and only 50% treated depression and anxiety with SSRIs.2 A major finding 
was prescription of SSRIs frequency was statistically associated with diagnostic comfort.2  
Prescription of stimulants is an appropriate treatment for ADHD and is formally recommend, 
while medication prescription of depression and anxiety may not always be the most 
“appropriate” treatment. Providers in this study felt properly trained to handle cases of ADHD 
but less so for both anxiety and depression.2  
 Availability of effective and safe treatment medications is a major factor in the ability of 
a PCP to treat anxiety (or any mental health condition). If safe and effective treatments exist, 
primary care providers must know about the medication and guidelines for use in adolescents, 
and must feel empowered, responsible and comfortable prescribing and maintaining the 
medication. 
1.10 PRIMARY AIMS 
Multiple factors involving provider-, organizational-, and policy-levels of the ecological model153 
influence the lack of appropriate screening and treatment for anxiety disorders. This dissertation 
focuses on identification and treatment of adolescent anxiety disorders by primary care 
providers. Anxiety and depression are the most common mental health disorders among youth 
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presenting to primary care settings.40 Patients experiencing emotional distress due to anxiety or 
depression are “more likely to see a medical provider than a mental health specialist”.77 
Moreover, PCPs are often an early point of contact with the healthcare system for many 
adolescents, giving additional weight to those interactions. As primary care offices are used by 
the majority of youth and youth in these settings have anxiety disorders,68-70 these providers are 
in a unique position to recognize the symptoms, screen and treat this population.  
Literature regarding identification and treatment of adolescent anxiety disorders in 
primary care is in a nascent stage. High prevalence of anxiety among youth paired with the 
negative costs to the individual and society constitute a public health problem and highlights the 
need for adequate treatment. As adolescent anxiety disorders have both acute and future negative 
consequences, early identification via screening and subsequent treatment may lead to a decrease 
in associated consequences of the disorder.6,35  
For a patient to receive appropriate treatment, they must be identified and diagnosed. 
Identification of anxiety may increase with screening and subsequently may increase treatment 
rates. Factors presented in the literature affecting treatment and screening rates for adolescent 
mental health disorders such as ADHD and depression include  training/education,2,36,71,75 
shortages of mental health providers,126 visit time constraints,5,71,126 concerns about stigmatizing 
patients,2,5 and reimbursement concerns.75,126,136 These factors may not be the same for anxiety. 
As such, research is needed to explore the unique aspects specific to identification and treatment 
of adolescent anxiety disorders by primary care providers. 
Such research may identify opportunities for intervention in primary care settings that 
will support earlier identification and treatment of adolescent anxiety disorders. The overarching 
research question for this study is: What factors, at the provider-level, organizational-level, and 
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policy-level, influence primary care providers’ decisions and capacity to identify and treat 
adolescent anxiety? To address the research question two primary aims were explored:   
Primary Aim 1: To explore primary care providers’ perceptions of adolescent anxiety 
 disorders, specifically (1) their awareness of the prevalence and symptoms; (2) their 
 perceptions and attitudes regarding identification and treatment; and (3) their beliefs
 about their professional role in identification and treatment.     
 Primary Aim 2: To explore the perceived individual-, organizational-, and system-level 
 barriers and facilitators to identifying and treating adolescent anxiety disorders in 
 primary care settings. 
1.11 CONCEPTUAL FRAMEWORK 
1.11.1 Disease screening framework 
The seminal public health report Principles and Practice of Screening for Disease (1968) was 
produced by James Wilson and Gunner Junger at the behest of the World Health Organization.154 
The rationale for this report stemmed from a fundamental ethical vantage point that there are 
real-world practice challenges relating to early disease detection and subsequent treatment of 
diseases.154 The dilemma lies in being able to properly identify a disease and being able to 
provide adequate and timely treatment, as well as ensuring individuals who should not be treated 
remain unharmed.154,155   
Wilson and Junger’s report provides a set of criteria to be followed to determine which 
diseases merit screening (see Table 4).154 This assessment framework can provide guidance 
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regarding whether (1) screening for a disorder is necessary and (2) that screening is feasible from both 
the point of view of the person conducting the screening and the person screened.155,156  While these 
criteria are still currently viewed as the “gold standard” guidance for screening of diseases as 
well as genetic testing,154,157 modifications and changes have occurred over time.154 
Table 4. Screening Criteria Set by Wilson and Junger 
1 The condition sought should be an important health problem. 
2 There should be an accepted treatment for patients with recognized disease. 
3 Facilities for diagnosis and treatment should be available. 
4 There should be a recognizable latent or early symptomatic stage. 
5 There should be a suitable test or examination. 
6 The test should be acceptable to the population. 
7 The natural history of the condition, including development from latent to declared disease, should be adequately understood. 
8 There should be an agreed policy on whom to treat as patients. 
9 
The cost of case-finding (including diagnosis and treatment of patients diagnosed) 
should be economically balanced in relation to possible expenditure on medical care 
as a whole. 
10 Case-finding should be a continuing process and not a “once and for all” project. 
Application of the original screening criteria in the mental health context does have a 
precedent. Batelaan et al., relied on Wilson and Junger’s criteria to make a case for adult anxiety 
screening which they used as their logic for conducting a study of the “willingness” of adults to be 
screened for anxiety.156 This research appeared to be attempting to provide evidence for the sixth 
criteria in Table 4. While the Batelaan study findings shed light on an adult Swedish population (e.g., 
low patient participation rates in screening),156 some limitations are apparent. Results do reflect patient 
general willingness to be screened for anxiety. However, results do not specifically reflect the patients’ 
willingness to be screened by their primary care providers for two main reasons. First, recruitment into 
the study and the offer to be screened was presented by a member of the study team who was in the 
primary care provider’s office lobby. Second, participants were not screened by their primary care 
149-151
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provider, but instead, screened over the phone by a member of the study team.156 Research is still 
needed to understand patient feelings about the appropriateness of anxiety screening by their PCP. 
 In Wilson and Junger’s original report, they also call attention to mental illness specifically, 
noting that, at the time of their report, “etiological classification of mental disease” was lacking, as well 
as the limited presence of treatments for mental illness.155 They clearly outline the burden of mental 
illness on populations and the state of relevant research – logic that points to the high importance of 
future research in this field to support the accurate identification and safe treatment of mental illness.155 
Further research is needed to understand if adolescent anxiety screening in primary care is 
appropriate, and the guidance set forth in table 4 may serve as an assessment framework for such 
research. Exploration of primary care providers’ views regarding these criteria compared to current 
evidence may lead to novel approaches specific to adolescent anxiety identification and treatment in 
primary care settings.  
1.11.1.1 State of evidence for criteria set by Wilson and Junger 
The screening criteria set by Wilson and Junger (1968) was developed to assist the medical 
community in understanding what factors ought to be known before the screening of a specific 
disease condition is conducted. These criteria can be used as a guide to determine if it is both 
necessary and feasible to screen for adolescent anxiety in primary care based on our 
understanding of the current state of evidence.   
In review of the extent literature, evidence exists for several criteria set by Wilson and 
Junger to support the screening of anxiety in adolescents. However, there are gaps in the 
evidence specific to other criteria set by Wilson and Junger.  Table 5 presents a summary of the 
state of evidence addressing each of the 10 criteria and areas for further research.  
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Table 5. State of Evidence for Criteria Set by Wilson and Junger 
1 The condition sought should be an important health problem. 
Due to the prevalence and illness burden, adolescent anxiety is an 
important health problem. However, based on the literature, it is unclear 
as to whether PCPs view adolescent anxiety as prevalent and burdensome 
and warranting exploratory research.  
2 
There should be an accepted 
treatment for patients with 
recognized disease. 
Effective pharmacological and talk therapies exist for anxiety but PCP in-
depth awareness of and role acceptance for delivering such therapies 
remains an area for future research. 
3 Facilities for diagnosis and treatment should be available. 
Not only do PCPs have the legal professional capability to treat anxiety, 
the primary care office setting is both feasible and appropriate for the 
screening and treatment of adolescent anxiety. 
4 There should be a recognizable latent or early symptomatic stage. 
While there is a strong literature on the symptoms of anxiety, including 
DSM-IV criteria, symptoms can often begin in childhood making it 
difficult to discern an early symptomatic stage in adolescents. As such, it 
is important to ask PCPs at what point should anxiety specific screening 
occur. It is also unclear if PCPs have the awareness or feel professional 
responsibility to recognize common presentations of anxiety symptoms in 
adolescents. 
5 There should be a suitable test or examination. 
Just as there are available treatments PCPs can access, there are also 
accessible and validated screening tools to identify adolescent anxiety. 
Some research shows the PCPs feel it is their responsibility to identify 
anxiety; however, rates of identification are low. Research is needed to 
understand this discrepancy (i.e. provider awareness regarding the tools 
and barriers to using tool).  
6 The test should be acceptable to the population. 
The physical screening of anxiety via adolescent self-report or parental 
report will not cause undue harm to the adolescent. 
7 
The natural history of the 
condition, including development 
from latent to declared disease, 
should be adequately understood. 
Evidence does exist regarding the etiology of anxiety; with causal 
mechanisms including the interaction of genetics and the environment.  
8 There should be an agreed policy on whom to treat as patients. 
It is known that pediatric patients can experience anxiety.  
9 
The cost of case-finding 
(including diagnosis and 
treatment of patients diagnosed) 
should be economically balanced 
in relation to possible expenditure 
on medical care as a whole. 
A potential barrier to PCPs treating anxiety is the cost of identification – 
however the monetary cost of identifying adolescents with anxiety is low 
and may reduce medical expenditures by lowering the frequency of costly 
physical diagnostic testing based on somatic symptoms. 
10 
Case-finding should be a 
continuing process and not a 
“once and for all” project. 
Lastly, identification of anxiety does not have to be on a case-by-case 
basis – systematic screening or professional guidelines could aid in a 
universal pathway to identify adolescent anxiety in primary care settings. 
 
Such gaps provide evidence of the need for exploratory research. This study will begin to 
fill some of those gaps: 
Criteria 1 Gap: What are PCPs views regarding the prevalence and burden of adolescent     
                          anxiety? 
Criteria 2 Gap: What level of awareness do PCPs have of treatment options and what is  
  their perceptions of their role for delivering such therapies? 
Criteria 4 Gap: What are PCPs views on professional responsibility to recognize the  
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   common presentations of anxiety symptoms in adolescents? 
Criteria 5 Gap: What level of awareness do PCPs have regarding screening tools and  
   barriers to use? 
1.11.2 Social Cognitive Theory 
To understand and eventually increase the uptake of the identification and treatment of adolescent 
anxiety by primary care providers, we need to understand factors that hinder and facilitate these 
processes. A robust learning theory is needed to guide exploratory research regarding perspectives of 
primary care providers on identification and treatment of adolescent anxiety disorders. Social Cognitive 
Theory (SCT) is classic learning theory for behavior change commonly used to guide practice focused 
on health behaviors.158 Moreover SCT is an ecological level theory, allowing for use of this theory in 
the exploration of factors that may influence behavior from various levels of the social ecological 
model.159 
SCT has been used to create self-efficacy scales for health care providers. For example, 
Kennedy et al., (2015) used SCT to develop the Nursing Competence Self-Efficacy Scale; a scale 
measuring nursing students efficacy in their ability to be practitioners.160 The rationale for the study 
came from the hypothesis that nurse attrition may be in part due to a lack of confidence in the nurse’s 
ability to practice.160 The purpose of the scale was to allow educators to understand nursing students 
self-efficacy and if more education/skills training is necessary.160 Regarding physical health issues, 
many interventions use SCT constructs. For example Tougas et al., (2015) conducted a systematic 
review of chronic health condition interventions (e.g., arthritis, asthma, chronic pain, diabetes, heart 
disease, and overweight/obesity) whose study foundations draw from SCT.161 Based on the 35 unique 
interventions reviewed, authors report evidence that SCT theory-based interventions can benefit 
individual health outcomes.161  
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Other SCT constructs have guided lifestyle interventions developed for individuals living with 
mental health conditions as evidenced by a 2010 systemic review of lifestyle interventions for 
individuals with mental illness (e.g., schizophrenia, schizoaffective disorder, major depression, bipolar 
disorder, alcohol dependence, and anxiety disorders).162  Each of the 23 interventions reviewed 
incorporated the following components: goal setting, self-monitoring, problem solving, education and 
skill teaching.162 Each of these components maps onto key two key constructs of SCT: self-efficacy 
(e.g., self-monitoring; problem solving; education and skills) and agency (e.g. goal setting; problem 
solving). 
Lastly, there is a precedent for utilizing SCT constructs when developing interventions for 
health care providers. For instance of the 24 studies included in a systematic review of inventions 
targeting the clinical decision making of nurses, the author’s report that these educational interventions 
were largely based on five different theories with one of the five being SCT.163  
In essence, constructs of SCT164 are in constant interplay with each other and this interplay 
occurs and influences an individual’s behavior.158  SCT focuses on human cognition and at the center 
of cognition are two key constructs, personal agency and self-efficacy. Personal agency emits from this 
theory as SCT posits that the environment may serve as a change mechanism for individuals and but at 
the same time, individuals may have agency to modify or change the environments they live in. Self-
efficacy hinges on the individual’s perception that they are capable of performing a task or changing 
their behavior and at the same time, believe they can shape their social environment.165,166  
Personal agency will help to develop a line of questioning to understand what identification and 
treatment processes providers feel they can affect directly and how the environment in which they 
operate interacts with those processes.166 Self-efficacy will allow for the investigation as to providers 
perceptions of their awareness, skills, and level of comfort specific to adolescent anxiety.  
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1.11.2.1 Social Cognitive Theory: influence on aims and data collection tool 
The central tenant of SCT is that both personal and environmental factors influence behavior and that 
personal factors can influence the environment (and vice versa).158 This constant interplay between 
behavior, personal factors, and the environment heavily relies on an individual’s level of personal 
agency.  
Agency hinges on individuals’ belief in their ability to change circumstances.164  This belief 
stems from individuals’ level of self-efficacy and self-confidence in their capacity to act. In this study, 
the concept of personal agency guided the development of both aims. The aims were intended to 
facilitate a better understanding of what identification and treatment processes providers believe 
they can impact directly and how the environment in which they operate interacts with those 
processes. Key constructs from SCT (self-efficacy, outcome expectations, and environmental 
factors) are implicit in the study aims.164  Moreover, the aims address factors at multiple levels of 
the ecological model which is one reason SCT is an appropriate theoretical choice as it is an 
ecological level theory.159 The key constructs utilized as part of the conceptual framework for 
this study are operationalized below and guided the construction of the interview guide. Figure 2 
(adapted from Bandura’s model) displays the pathways by which key constructs from SCT 
influence behavior.167  
Figure 2. Key Construct Pathways Influencing Behavior
162
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 Self-efficacy167 was operationalized as the providers’ perception of their capability to identify 
and treat adolescent anxiety. Self-efficacy, as a construct, helped guide the development of interview 
questions focused on awareness, skills, and comfort level. It is important to note that a provider’s self-
efficacy in screening and treating anxiety may stem from multiple factors at multiple levels of the 
ecological model including organizational and policy level factors.159 For instance, having low self-
efficacy in the ability to adequately identify anxiety in part may stem from a lack of skill mastery.159 
Without the opportunity to learn and practice (i.e. medical program curriculum limitations) a provider 
may not feel equip to identify anxiety and/or may seek out other avenues to develop such skills. 
[Primary Aim 1]  
 Outcome Expectations167 were operationalized as the providers’ expectations of the outcomes 
associated with identification and treatment of adolescent anxiety. These expectations are influenced by 
the providers’ level of self-efficacy. The perceived outcome of screening/treatment may be positive or 
negative. An example of a perceived negative outcome is that a provider may anticipate incorrectly 
identifying an adolescent as experiencing anxiety when in fact the adolescent is experiencing a 
situational event that becomes resolved.  An example of a perceived positive outcome associated with 
treatment is that a provider may anticipate the adolescent will respond well to treatment. The positive or 
negative nature of the expected outcome may stem from (1) provider’s confidence in their ability to 
perform the necessary actions (or not); (2) believed incentives or disincentives that would come from 
identification and treatment; and (3) a providers self-evaluative reactions; defined as “reactions to one’s 
own behavior based on internal personal standards”.159 These personal standards may stem from 
feelings associated with personal compliance expectations to practice policies regarding screening 
procedures or “living up to” perceived professional role responsibilities. [Primary Aim 1 & 2] 
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Environmental Factors167 were operationalized as factors in the providers’ environment that 
both influence and are influenced by the providers’ self-efficacy and outcome expectations. 
Environmental factors at the organizational (i.e., time constraints, training, and referral ability) and 
system level (i.e., specific guidelines, financial reimbursement, and lack of specialists) of the ecological 
framework were a focus of exploration in this study. Moreover, the barriers and opportunities construct 
of SCT focuses on the environment that “makes behaviors harder or easier to perform”.159 For example, 
an opportunity for preforming a behavioral health screen may be an organizational practice policy on 
screening. However, providers might not have the self-efficacy or perceived positive outcome 
expectation to follow through with the policy. [Primary Aim 2] 
Utilizing a disease screening criteria155 created by Wilson and Junger in conjunction with SCT 
provided a framework for exploring how primary care providers perceptions of and attitudes towards 
adolescent anxiety influences their beliefs regarding identification, treatment and clinical decision 
processes. Public health professionals are uniquely qualified to explore factors from a provider 
perspective that may influence identification and treatment of adolescents experiencing anxiety 
disorders. 
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2.0  METHODS 
Exploratory qualitative research was needed to better understand the totality and interplay of 
factors that may influence the identification and treatment of adolescent anxiety in the proposed 
population and setting. As the purpose of this research was to uncover new information 
regarding an important public health topic on which limited evidence exists, semi-structured 
interviews were conducted with primary care providers, who see adolescent patients, in 
Southwestern Pennsylvania.  
As the overall goal of this research study is to collect in-depth information specific to 
both primary aims, the qualitative principle of saturation guided sample size. Saturation is the 
idea that data is collected until no new/novel content emerges. Based on the literature, 
approximately 12 to 20 interviews are often sufficient to attain saturation.168 As such, the goal of 
this study was to attain approximately 20 to 25 interviews. Content analysis was used as the 
methodological orientation for this study.  
2.1 PARTICIPANT SELECTION 
A non-probabilistic sampling technique was used as this exploratory research study was not 
designed to offer generalizability of results as is often sought in quantitative research.169 A 
purposeful sample was drawn, consisting of non-mutually exclusive categories of up to five rural 
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and urban providers, respectively, and up to five providers whose offices have embedded 
behavioral health provider(s), and up to five providers whose offices do not have onsite 
behavioral health provider(s). 
All participants were recruited through Pediatric PittNet, a network of over 230 providers 
in 13 Southwestern PA counties, all of whom provide care to pediatric patients with either 
private or public insurance.170 Pediatric PittNet facilitates recruitment of patients and providers 
into studies focusing on “pediatric behavioral and physical health concerns”.170  
To be eligible for this study, participants must have, 1) been a primary care provider; 2) 
practiced in the state of Pennsylvania; 3) practiced at least 50% of the time in a primary care 
setting; 4) completed their medical training, and 5) have authority to prescribe and dispense 
drugs171-173 in Pennsylvania.   
Pediatric PittNet sent up to five online invitations to 189 eligible providers within their 
network between June 19, 2018 and July 5, 2018. Interested providers (n=25) were connected, 
via email, to the study PI for interview scheduling. A total of 22 providers participated in the 
study, with three providers being unreachable for scheduling.   
2.2 DATA COLLECTION 
The semi-structured interview guide was designed to address the primary aims, utilizing existing 
literature and the conceptual framework outlined above. SCT constructs (e.g., self-efficacy, 
outcome expectations, and organizational and system level environmental factors) were 
incorporated into question construction to ensure the gathering of data specific to providers’ 
awareness, perceptions, attitudes, and beliefs.  
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The study PI engaged two stakeholders to (1) review the content of the interview guide, 
(2) recommend modifications or script additions, and (3) review the connotation of the questions 
for provider blame.174 It was essential to ensure that the interview questions asked were not 
framed in a manner that may have been perceived as blaming the provider for not being aware of 
certain information (example: presentation of somatic symptoms) or for not treating adolescent 
anxiety. The first stakeholder engaged had similar characteristics to the population under study, a 
Doctor of Osteopathic Medicine who provides care to adolescents. This stakeholder also had 
expertise in pediatric psychiatry through an academic lens. The second stakeholder, a Doctor of 
Philosophy, provided a developmental psychology perspective to the interview guide. 
After stakeholder input was incorporated, the interview guide was shared with Pediatric 
PittNet for final review and approval, and was finalized by the study PI. The study PI conducted 
all semi-structured interviews via telephone.175 Participants were assigned an unique study 
identification code and verbally consented to participate in the research study. Interviews were 
audio recorded, with interview duration ranging between 30 and 45 minutes. Each interviewee 
was mailed a $20 gift card as compensation for their time. This study was approved by the 
University of Pittsburgh’s Institutional Review Board (PRO17100074). 
2.3 DATA ANALYSIS 
All audio-recordings were transcribed by a professional transcriptionist. The study PI ensured 
transcript reliability by conducting cross-checks. Inductive conventional content analysis was 
conducted to (1) understand provider awareness, role perceptions, attitudes, and beliefs about 
identification and treatment of anxiety disorders, and (2) explore barriers and facilitators at the 
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provider-, organizational- and system-levels influencing identification and treatment 
decisions/behaviors.  
All provider transcripts were read by the PI to gain a contextual understanding of the 
data.176 The study PI conduced open coding on six transcripts to allow for initial categorization 
of relevant themes/concepts. Codes were further created and defined through an iterative process 
of reviewing seven additional transcripts177, thereby formulating the final question-specific 
codebook (e.g., coding frame).176,178 Dedoose coding software was utilized for analysis.  
To test the codebook, the study PI and an experienced and independent coder applied 
codes to three transcripts. Both coders met to review and adjudicate inconsistencies in code 
application. Minor changes to code definitions occurred. Using the revised codebook, the two 
independent coders co-coded 12 transcripts. Based on co-coded transcripts, an unweighted 
Cohen’s Kappa statistic was calculated for each code.179 As it is impossible to discern which 
code application disagreements are more severe than others, a weighted Kappa statistic was not 
used.180 For each question, an average Kappa score was also calculated. Remaining transcripts 
were coded by the study PI.  
2.3.1 Expert interviews  
Expert interviews are often used in exploratory research and can offer “practical insider 
knowledge”.181 For this study, three expert interviews were conducted to provide descriptive 
context to key content from provider interviews and to guide a deeper interpretation of provider 
interview results. “Insider knowledge” gathered provided contextual information from three 
perspectives.  
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As provider interviews were being collected and analyzed, the study PI engaged in 
notetaking to support preliminary theme generation. Throughout codebook development 
processes, along with an iterative reading of interview notes, the PI identified three perspectives 
for which thematic interpretation would greatly benefit from: a public health professional, a 
behavioral health provider, and an organizational expert. Experts were identified based on the 
literature, word of mouth from other experts in the field adolescent medicine, and for their 
knowledge of the area where the sample was drawn. 
 Expert interview guides were specifically tailored for each interviewee based on their 
prior work as well as relevant content from provider interviews. Each expert was asked a series 
of questions focused on their perspective of content shared by interviewees, context clarification 
for theme interpretation, and their expert opinions regarding identification and/or treatment of 
adolescent anxiety in primary care settings. These expert interviews were not intended to reach 
thematic saturation but rather to provide a broader contextual perspective on the factors 
illuminated through the PCP interviews. Perspectives and information shared during expert 
interviews are highlighted throughout the discussion chapter.  
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3.0  RESULTS 
Primary care provider (PCP) participants (N=22) were primarily female (72.2%; n=16), with a 
mean age of 41.2 years. The majority of interviewees were Doctors of Medicine (77%; n=17), 
with 18% (n=4) being Nurse Practitioners, and one being a Physician Assistant. On average, 
providers had been practicing medicine for 11.3 years.  
 In terms of practice location, 36.4% (n=8) of the sample identified their practice setting 
as urban, 36.8% (n=8) identified their practice setting as suburban, 22.7% (n=5) identified their 
practice setting as rural, with one provider identifying practicing in both rural and suburban 
settings. Provider self-report of practice location differs from labels provided by Pediatric PittNet 
research network. For example, Pediatric PittNet categorizes six providers as practicing in rural 
settings compared to the five providers who self-reported rural locals.   
The majority of providers reported having at least one part-time behavioral health 
provider, on-site, at their primary care practice (54.6%; n=12), with 22.7% (n=5) providers 
stating no on-site behavioral health provider. 22.7% (n=5) of the sample had missing self-report 
data for onsite behavioral health providers. According to Pediatric PittNet, 77.3% (n=17) of the 
study sample had an on-site behavioral health provider, with 22.7% (n=5) of the sample not 
having an on-site behavioral health provider (3 matching with provider self-report, and 2 
providers with missing self-report data). Interestingly, Pediatric PittNet categorized 2 providers 
has having on-site behavioral health providers, when those two providers self-categorized the 
opposite. Of the providers without an embedded behavioral health provider, three were classified 
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as rural, one as urban, and one as suburban. See table 6 for full details of available provider 
characteristics.  
Based on the question specific codebook (see appendix A), total kappa statistics were calculated 
for each question and each code. See table 7 for total kappa scores by question and appendix B 
for individual code kappa statistics. 
Table 6. Participant Characteristics 
Characteristic N % Mean; Range 
Age  22 100 41.2; 27-59 
Under 30 3 13.6 -- 
30-40 9 40.9 -- 
41-50 4 18.2 -- 
51+ 6 27.3 -- 
Sex 22 100 -- 
Female 16 72.7 -- 
Male 6 27.3 -- 
Provider Type 22 100 -- 
MD 17 77 -- 
NP 4 18 -- 
PA 1 5 -- 
Years in Practice 22 100 11.3; .83-30 
1 Year or less 3 13.6 -- 
2-5 years 5 22.7 -- 
6-9 years 4 18.2 -- 
10-13 years 3 13.6 -- 
14-17 years 1 4.6 -- 
18+ years 6 27.3 -- 
Self-Report Geography 22 100 -- 
Rural 5 22.7 -- 
Urban 8 36.4 -- 
Suburban 8 36.4 -- 
Rural/ & Suburban 1 4.5 -- 
Recruitment Geography 22 100 -- 
Rural 6 27.3 -- 
Urban 3 13.6 -- 
Suburban 8 36.4 -- 
Urban & Suburban 5 22.7 -- 
Self-Report On-site 
Behavioral Health Provider 17 77 
-- 
Yes 12 54.6 -- 
No 5 22.7 -- 
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Table 6 Continued 
Missing Data 5 22.7 -- 
Recruitment On-site 
Behavioral Health Provider 22 100 
-- 
Yes 17 77.3 -- 
No 5 22.7 -- 
 





Question 1  0.855 
Question 2   0.921 
Question 3  0.906 
Question 4  0.736 
Question 5  0.941 
Question 6   0.918 
Question 7  0.921 
Question 8  0.961 
Question 9  0.972 
Question 10  1.000 
 
Key themes that emerged from provider interviews are described below along with 
illustrative quotations. Indications of differences in responses by geography and having on-site 
(embedded) behavioral health providers are specified as appropriate.  
3.1 ROUTINE MEDICAL VISITS: DETECTING BEHAVIORAL HEALTH 
CONCERNS  
During a well child visit, providers overwhelmingly reported having 15 to 30 minutes per 
adolescent patient, with about half reporting less than 20 minutes. The format of a well child visit 
was generally described in the same manner by participants, with more or less detail being 
shared on certain visit aspects. Overall, layout of well child visits were discussed as such: (1) 
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adolescent fills out a depression and substance use questionnaire, on a tablet, in the waiting 
room; (2) parents and adolescents go to exam room and providers talk to both parties about 
health concerns they might have “from the medicines, allergies, problem with hospitalizations, 
emergency room visits, anything like that (220 Rural; Yes BH)”, paperwork to be completed, and 
general social questions; (3) providers conduct physical health exam, almost exclusively without 
parents, asking adolescents questions regarding depression and substance use questionnaire 
responses, sexual history, social life, and other confidential questions; and (4) after exam is 
completed, providers bring parents back into the room to discuss next steps. A representative 
quote of a well child visit is as follows,  
So, in our office we have a tablet that we give the kids before they even come into the 
room that have the questionnaire in regard to depression and drug use. And it’s private. 
The parents are not given that access to that information. Then when I’m able to open up 
a chart electronically, then all of that populates into that chart. So, I have access to their 
answers privately without going through any middlemen…Once the visit has started, I 
usually do it without the parent. Sometimes I start with the parents in the room initially to 
find out what concerns they have, and then ask the parents to leave. Then speaking with 
the patient about medical issues, emotional issues, social issues, family dynamics, etc. 
And then examine the patient. Once we have discussed all of that patient’s concerns, and 
we determine what things can, and should be discussed with the parents -- then we have 
the parents come in and go over any information they have as long as it’s okay with the 
adolescent (118 Urban; Yes BH). 
The routine behavioral health questionnaires were discussed as a tool supporting 
providers in detecting behavioral health concerns. Within the context of a visit, providers had 
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varied responses regarding how helpful routine screening for depression and substance use were. 
Often, providers felt screeners were helpful in providing them with extra patient information,  
So, those screens are helpful. Sometimes they allow you to kind of get a little bit of info, 
and then ask them more pertinent questions…if the screens kind of light up, and that’s a 
way to kind of get into that a little bit more (119 Urban; Yes BH).  
Similarly, providers discussed how responses to the questionnaires provide them with a jumping 
off point for behavioral health discussions,  
I find it extremely helpful because what I can do is I can set the adolescent at saying, 
‘well, thank you for filling out this questionnaire. I really appreciate you doing that. On 
this questionnaire it sounds like things are x, y, or z. Based on what you’ve told me 
already about how hard it is to fall asleep, it sounds like maybe there’s more going on’ 
(101 Suburban; Yes BH).  
However, providers also commented on not always being able to rely on adolescent 
questionnaire responses for reasons of honesty,  
Their parents are near them and they’re not honest on those. So, you’ll see negative 
screens, and then when you talk to them face-to-face, one-on-one without the parent in 
the room their stories are different. So, we do not rely on any paperwork or tablet 
screenings because even though they’re good, we might pick up some; we don’t feel that 
they’re replacement of face-to-face (104 Suburban; No BH).  
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3.1.1 Impacts of parental presence on information gathered 
Parental involvement during visits was described as an asset to learning about adolescent 
behavioral health concerns. In general, many providers discussed that parents provided helpful 
information about the adolescent’s behavioral health,  
I think it’s usually very helpful...I find that in our population a lot of the kids are open 
with their parents and sometimes…the child might not be aware of their own declining 
mental health or concerns where the parent might bring up, ‘I noticed that Sally hasn’t 
been eating as much or sleep has changed or she hasn’t wanted to go out with friends as 
much.’ And, the patient may or may not be aware and may not bring those concerns up. 
So, I think it’s definitely helpful to touch base with parents (221 Suburban; Yes BH).  
Another provider shared,  
Well, it’s very helpful if they have insight. If they have concerns, and sometimes the 
family will come in and say, ‘I’m really worried about my child – they’re sad, they seem 
worried.’ If their child has shared with them or they can pick up on that, that’s really 
helpful (116 Urban; Yes BH). 
At the same time, providers discussed the importance of discussing behavioral health 
without the presence of the parent as a tactic to create an open space for adolescents to disclose 
personal concerns,  
So, a lot of the times, if anxiety or depression is an issue and the parent is aware- 
because we will get that a lot at wellness checks or even just people come in for anxiety 
or depression. A lot of the times the parent is very helpful. They give some more insights, 
but they’re not helping as much in the room when we talk to the patient because the 
patient won’t want to disclose as much a lot of the time (108 Rural; No BH).  
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The majority of providers mentioned that each adolescent-parent dyad experience 
different levels of comfort during discussions of discussing behavioral health symptoms or 
concerns,  
I think sometimes behavioral health with parents in the room it can kind of go both ways. 
Some kids will feel very comfortable talking in front of their parents. Other kids don’t feel 
as comfortable. They want to be able to have a little bit of privacy. Whether or not it’s 
because the parent is involved in the situation or not involved. Or, if it’s social – some 
kids would prefer their parents to be there and so it’s kind of helpful. Parents can chime 
in and say, “Oh, yeah, well last week, she only slept six hours (112 Rural; No BH). 
During discussions about what information is collected with or without the presence of a parent, 
several providers spoke about the important of transparency between all parties,  
I do find that adolescents, obviously, they're going to be much more truthful when their 
parents are not in the room with rare exceptions. But, I find that having them in the room 
fosters open communication at the outset. If there's a mental health concern, I like to 
start off with both people to get a sense of their individual dynamics that's involved and 
then I try and talk to each of them individually as well and then come together at the end 
and figure out a plan going forward. I think there's value to having a together 
conversation as well as an individual conversation. If anything, just to kind of see how 
the family interacts with each other and it gives me clues as to any problems that might 
be going on in the family (109 Suburban; Yes BH). 
Another parent related challenge providers’ face is dismissiveness of potential behavioral 
health concerns. While this was only mentioned by a few providers (rural, urban, and suburban), 
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with four of the six rural providers discussed this challenge. For example, one provider 
described,  
I think it is sometimes challenging, despite my best attempts to explain that while some 
anxiety is helpful and keeps us functioning, keeps us from getting hit by cars, or by bears, 
or what have you -- that a lot tends to be dysfunctional. There’s a line where it starts to 
cause us physical or emotional concerns. I think unless that is glaringly obvious, it is 
sometimes hard for patients or their parents to make that connection, or because it’s -- 
I’m assuming they’re uncomfortable with the stigma or because they themselves 
[referring to parents] have just never sought treatment and don’t necessarily view it as a 
problem because they’ve made it to 30, or 40, or 50. And, so and done fine (220 Rural; 
Yes BH). 
Another provider described how they view their role in working with dismissive parents,  
I would just say that like sometimes it’s a challenge with the patient, the teenager says, ‘I 
feel down, or anxious, and feel this way, that way’, and the parent just dismisses it, or 
downplays it, or just tells them to- usually not entirely helpful feedback. I mean they 
might think it’s helpful from their perspective, but it’s kind of like not what they’re asking 
for. And so, our role we would be kind of like to advocate for them, and kind of say listen, 
‘This is what I’m hearing, and have you thought of it this way, that way?’ And, sometimes 
it can be hard to- you just want the parents to be onboard with what you’re doing, and 
sometimes it takes a bit of talking to win them over, whatever, to get them to see it your 
way (114 Urban; Yes BH).  
The time it takes to support parents and adolescents with understanding and believing the 
provider concerning behavioral health issues was echoed by other interviewees.  
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Overall, providers used multiple sources to gather information about potential behavioral 
health concerns including routine screeners, patient history, parents and patients, lines of 
questioning focused on adolescent’s habits, social/scholastic life, and observing parent child 
interactions within the visit. Information disclosed during face-to-face adolescent and parent 
encounters appear to play a major role in how providers detect potential behavioral health 
concerns.  
3.2 SIGNS AND SYMPTOMS OF ANXIETY  
In order to recognize anxiety and collect the information necessary for diagnosis during well 
visits, providers have to be aware of certain signs and symptoms. Recognizing signs and 
symptoms of anxiety also may impact perceived prevalence and morbidity of the disorder. 
Providers discussed what signs and symptoms they believe indicate anxiety in their adolescent 
patient population, including physical health symptoms, mental health symptoms, and overall 
ability to function in day to day life. Signs and symptoms will be discussed first, followed by 
how providers attain additional information that may indicate an adolescent patient is 
experiencing anxiety.   
Providers reported using both physical health and mental health symptoms to recognize 
adolescent anxiety. Approximately three fourths of providers discussed several physical health 
symptoms/somatic complaints (reported by patients or parents) as red flags for anxiety, including 
headaches, chest pain, stomach aches, trouble sleeping, dizziness, and constipation. As one 
provider stated, “frequent headaches, frequent chest pains, frequent abdominal pain – that kind 
of stuff. A lot of the somatic stuff, I think, go along with anxiety, too (113 Rural; Yes BH)”. 
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Several providers spoke about using physical health complaints, along with information learned 
about the patient’s life, as clues that physical symptoms may be due to anxiety, “so, same thing 
with chest pain and same thing with bellyaches. If they’re associated with something that is 
causing anxiety or if their parents got separated and they’re going through a divorce and that’s 
giving the children a lot of anxiety, or depression (108 Rural; No BH)”. 
Only a few providers shared that reoccurring physical complaints, that yield no positive 
results on physical health tests, as a sign of anxiety,  
I mean, I think for the family sometimes it’s really hard when their child has had physical 
complaints for a while. I see a lot of kids with abdominal pain or chest pain and we’ve 
done work-ups and really hasn’t been revealing anything. Sometimes it’s hard to accept 
that there may be a mental health component. And, I mean, similar for me as well. 
Sometimes understanding really how strong that can be towards the physical as far as 
when kids are struggling with anxiety (221 Suburban; Yes BH). 
Almost all providers described using mental symptoms as indicators of adolescent 
anxiety, including anxious feelings, panic attacks, worry, and stress. For example, many 
providers shared similar symptoms associated with adolescent anxiety, “so, signs and symptoms 
that I use are children’s irritability. Sometimes having actual panic attacks, feeling very anxious, 
not being able to fall asleep at night. Being excessively worried about things that the average 
person wouldn’t be worried about (105 Urban; Yes BH)”.  
These types of symptoms were closely linked to lifestyle behaviors, such as poor 
hygiene, and social and scholastic functioning. All providers discussed asking adolescents a 
series of questions pertaining to daily living, such as,  
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’How are we doing in school? Are the headaches associated with anything specific? So, 
is it in four out of four in school, or only in school? Are we dealing with a certain issue in 
school? Are we being bullied in school? How do we feel generally about school?’ (108 
Rural; No BH).  
As with physical health symptoms, providers discussed making connections between mental 
health symptoms (i.e., panic, worry, stress) and aspects of daily living. As providers gave 
examples of lifestyle questions, the concept of assessing patients as either high and low 
functioning, as an indicator of anxiety, arose. Almost half of providers described adolescents 
highly engaged in scholastic studies and extracurriculars, as a potential sign for being at-risk for 
anxiety. For instance, one provider shared, 
I think it seems like- maybe this as a stereotype, like, kids who are, maybe, higher 
functioning coming from more intact families of the ones that we see higher expectations 
for excellence and achievement. I think those kids are harder on themselves. It seems like 
they feel more anxiety there. Parents are more anxious (116 Urban; Yes BH).  
However, more than half of the providers stated the opposite; that adolescents who are 
preforming less well in school, and are less interested in extracurriculars are at-risk for anxiety. 
For example,  
I find the patients with anxiety tend to be little bit more closed-off and may not have the 
same kind of level interest – although that's not universal I can tease it out from many 
different clues. But I find that just like depression, kids just tend to be faltering and may 
not be doing quite as well in school as they could be doing (109 Suburban; Yes BH). 
Another provider explained,  
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…it really seems like it’s interfering with sleep, and relationships, or kids aren’t being as 
engaging socially, or not as interested in activities, or kind of more isolation, or if it’s 
really interfering with day to day activities -- then that’s something that would be a 
concern. And, sometimes the kids recognize it and some kids sometimes -- they don’t 
really recognize it (119 Urban; Yes BH). 
Along with adolescent reported symptoms, or signs gleaned from patient-provider 
conversations, providers discussed obtaining information from parents as a way to recognize 
anxiety. Several providers stated parents often express concerns of anxiety directly, either before 
the visit, or during the visit. For instance,  
…mostly the parents. I think most parents feel more comfortable coming to the primary 
care doctor first to kind of confirm their suspicions that their child has anxiety. And so, 
it’s usually how it starts, or even by questions, and then towards the end discussion about 
when should they call me if they think the anxiety is getting out of hand (118 Urban; Yes 
BH). 
Another provider shared that while parents may directly express concerns about anxiety, 
the time of information sharing may not be optimal,  
They’re hesitant to tell the schedulers…I saw someone last Friday who was on my 
schedule for belly pain and part way through I’m like, ‘There’s more nerves in your belly 
than there are in your head. Is there any chance that – has there been bigger worries, or 
stresses, or changes? Is there any chance that either you think this could be anxiety 
related, or sadness, or depression related?’ And, the mom’s like, ‘Oh, I thought she’s had 
anxiety for six months.’ But, yet it took me 25 minutes of her visit, or 20 minutes into the 
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visit before she volunteered that information. So, I don’t know why people are so hesitant 
to just spit it out or get it out on the table early (220 Rural; Yes BH).  
Other providers shared that while a parent may not expressly state concerns of anxiety, 
they might share key signs or symptoms, “he or she is so worried, she’s worried all the time. It’s 
affecting appetite, sleep, social interactions.’ So, I find most often it’s them who is saying the 
chief complaint (106 Urban; Yes BH)”. 
Lastly, providers commented on in-visit behaviors of adolescents, as information that 
might contribute to learning if the patient is anxious or not. In-visit cues specific to anxiety 
include, affect, nervousness, being withdrawn or engaged, interactions with parents, and body 
language. For example, one provider discussed cues for anxiety they notice without even asking 
a question, 
I mean, I think first is what’s going on in the room. Are they engaged or are they 
withdrawn? What’s their relationship like if the parent is in the room? Is there tension? 
Do they have an open relationship? So, I think you can get a lot of clues just before you 
even ask anything (221 Suburban; Yes BH).  
Another provider described how adolescents makes themselves feel as a cue for anxiety, “when 
they make me feel nervous, you know, basically that kind of tense body language…That closed 
off kind of tense body language. And try and – a lot of head nodding, and agreeing, and all of 
that (101 Suburban; Yes BH)”. Another provider spoke about signs in the visit of some patients 
who might not self-recognize they have anxiety “if they start fidgeting, they start losing eye 
contact – those are some of the ones that we pick up on that [they?] don’t recognize it (114 
Urban; Yes BH)”. 
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Providers look out for many different signs and symptoms, experienced by adolescents, 
that may be attributed to anxiety. Symptoms can be both physical (i.e., headaches, stomachaches) 
and mental (i.e., worry, panic), and providers gather this information from both parents and 
adolescents. Moreover, providers look to how the adolescent is behaving in their day to day life, 
and if any of their physical or mental health symptoms connect to those behaviors (i.e., not 
wanting to go to school due to social dynamic stress). Several providers also draw on more 
subtle signs of anxiety within the context of the visit, including non-verbal cues, engagement 
level in the visit, and affect. Knowing what signs and symptoms to look out for, and where this 
information comes from is the foundation of being able to identify anxiety.  
3.3 IDENTIFYING ANXIETY: PRIMARY CARE PROVIDER ROLES 
All providers discussed their role in identifying anxiety. Overwhelmingly, providers believed 
identification of anxiety is part of their professional role, albeit the rationale for why varies. 
Many providers spoke to why it was specifically their role to identify anxiety, citing three major 
reasons, (1) high prevalence rates of anxiety; (2) symptom severity of anxiety; and (3) being the 
first point of contact an adolescent might have with the medical system, including potentially 
being the only provider whom an adolescent can talk with. However, during these discussions, 
several providers noted it was their role to identify behavioral health conditions in general. 
Providers whom felt it was their role to identify behavioral health conditions, in general, varied 
on if it was their role to make the diagnosis or to refer adolescents to another provider type for 
diagnostic identification. Below are detailed descriptions of how providers view their role in 
identifying anxiety, along with representative quotations.  
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High prevalence rates of anxiety were a key reason providers’ believed identification of 
anxiety was an important part of their role. For instance,  
I think anxiety is so common that we have to be the people to help identify it. Since we’re 
getting an audience with adolescents, at least, through what I told you when they need 
something like a driver’s exam, sports exam, and so forth. So, we have an opportunity 
and we know the questions to ask and that kind of stuff. So, we have an obligation to 
identify it because it affects so much of their lives (113 Rural; Yes BH). 
Another provider stated, “one of the reasons why I did this survey is because I think it’s so 
important. As I’ve been in practice for over 20 years and I have never seen more anxiety in 
children than I have now…. (118 Urban; Yes BH)”. One provider felt that while anxiety was 
common, and therefore was part of their role, they faced challenges, stating  
We have a very small office. So, it's just me and another physician at work right now. I 
think he's kind of in the same boat as me as far as we know that it's something very 
common and we need to do more -- but, finding the resources and it's something very 
difficult for us to kind of follow because we're not specialized (110 Suburban; Yes BH). 
Symptom severity associated with anxiety was one key factor as to why a few providers 
felt identification of anxiety was an important part of their role as primary care physicians. For 
example,  
So yes, I think it’s an important part of what we do. Anxiety and depression are 
incredibly common -- as common as asthma or other things. So, I think it’s an incredibly 
important thing for us to identify and know that long term, adults who don’t have their 
anxiety identified in their adolescent years, can have decreased levels of function because 
of other persistent symptoms because it’s not ever been identified. And, I think the reality 
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is probably more teens come and get seen by their doctor than young adults or older 
adults, my age. So, I think that’s an important time to identify it. (220 Rural; Yes BH). 
Another provider simply stated,  
My thoughts are, I mean, it's extraordinarily important. I mean, it's so common and it can 
be certainly debilitating for certain people and life-altering, so it's important. Most of 
disease that we deal with as pediatricians is, I think, mental health-derived to some 
degree. So, it's absolutely important to confront it and realize it's there (109 Suburban; 
Yes BH). 
The third key reason a few providers mentioned, as to why it is important to identify 
anxiety, is that primary care providers are often the first point of contact adolescents have with 
the medical system. One representative quote of this factor is as follows  
Oh, I think it’s super important. I mean, I feel like we can actually make a difference. And 
typically, we are the first point of contact for most of our patients. So, if we don’t bring it 
up or if we miss it, we kind of miss the boat because who else are they going to see? (107 
Rural; No BH).  
Other providers believe that while being the first point of contact, they also might be one 
of the only points of contact adolescents have. For example, “I think that it’s good because a lot 
of times we are the first line of people. So, we’re going to be the first ones that see the kid getting 
into pediatric psychiatry is very difficult. There’s not a lot of them (108 Rural; No BH)”. One 
provider described while identification should be their role as frontline providers, that “to just 
throw that on the plate of pediatricians is a little bit unrealistic without any actual formal 
training (115 Suburban; Yes BH)”. 
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Other providers spoke simultaneously about being the first point of contact for 
adolescents, as well as being an approachable provider type. For instance,  
I think it’s super important to do. Just because these kids may- even if it’s not their 
primary concern -- if it is a problem, they’re- obviously if it’s not a primary concern, then 
they’re not going to really be talking to anybody else about it. And, it’s super 
common…So, I don’t know. I feel like we’re the first one ever seeing the kid, so we know 
the kids a lot of the times and hopefully they’re more comfortable with us then they might 
be with some random person or stranger, whatever. So, hopefully we can pick up on it 
and then kind of go from there (103 Urban; Yes BH).  
Another provider described potentially being the only person an adolescent might have to talk to 
about their anxiety,  
I definitely do think that as a primary care provider it is our role to identify it because at 
times, we’re the only provider that is seeing these patients and if the parents aren’t 
addressing it with them then they don’t have anybody else to talk to about it (105 Urban; 
Yes BH). 
Similarly, providers frequently discussed the importance of building rapport, with 
patients and parents, during identification and treatment of anxiety. Specific to identification, 
providers remarked having a good relationship with families supports them seeking care. For 
example,  
I think it's critical for us because if we have a relationship with the family, we're 
probably the most likely people to think about it -- because if this family shows up to the 
ER with a headache or a bellyache, you know, acute care facility is not necessarily 
thinking about it until they rule out all the stuff. So, of course, they're going to do all the 
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tests. So, our role is hopefully to keep them out of the emergency room, screen for it on a 
frequent basis, and prevent it (111 Rural; Yes BH). 
Several providers who believed it was their role to identify anxiety, also believed it was 
their role to identify other behavioral health conditions. For instance,  
I think- my role…is well, it’s kind of two-fold. Like, I think about the medical standpoint. 
I think it’s my job to rule out any physiological cause for any of the symptoms that kids 
may come in with. And then, at the same time, my patient’s well-being as a whole is kind 
of important. So, I need to always have that kind of on the back burner and being able to 
approach the behavioral health side just kind of helps for everything as a whole (112 
Rural; No BH). 
Another provider described  
…the difference is not in identifying. The difference is feeling willing to treat it. We’re 
much more likely to feel comfortable beginning treatment for anxiety than we are for 
pediatric depression. I think depression scares us a little bit more because of the risk of 
suicide. But, yeah, I don’t think there’s any difference in how we- our willingness or 
ability to identify (113 Rural; Yes BH). 
Other providers discussed their role in identification as identifying the adolescent is 
experiencing some behavioral health concerns, and referring the adolescent to a mental health 
professional to determine exact diagnosis. For example,  
I think our role is pretty similar in all these conditions which is the identification that 
something might be wrong even though even though we may not be exactly sure what and 
be able then to guide those patients…which oftentimes is a child therapist who kind of 
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tease everything out. Is it anxiety? Is it depression? Is it both? Is the child bipolar? Has 
this child been abused? (ID: 118 Urban; Yes BH).  
Another provider commented that “the older providers don’t want to be as involved in 
identifying anxiety disorders. Just because I feel like they’d rather just refer just a psychiatrist if 
they sense anything abnormal, mentally (105 Urban; Yes BH).” Moreover, several providers 
discussed their role in terms of being the front-line provider, who connects patients to specialists:  
I think so. I think we identify a lot of things as, like, first line for the people. And then, get 
people to the right specialist and the person with the right amount of training. I think 
that’s how most of us would probably see our role (115 Suburban; Yes BH). 
A few providers shared insights as to why other providers may view their role in 
identification as picking up on a potential concern, and referring patients elsewhere for specific 
condition identification. Specifically, one provider shared while providers who refer to obtain a 
diagnosis are “not really opposed” to identification, they believe “sending them somewhere else 
to meet somebody new is kind of more scary than just approaching it in our office, in that setting 
(112 Rural; No BH)”. Other providers expressed similar sentiments regarding outcomes of 
patients not diagnosed in primary care; for instance,  
I think everyone thinks it’s important. I think it’s more, you know, after identifying what 
happens from there because I think the primary care providers are a lot more 
comfortable in starting talking about it and starting treatment versus someone who will 
just refer out. I feel like a lot of the ones who get referred out don’t always actually seek 
care. They kind of get lost in the system as well (107 Rural; No BH). 
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 Interestingly, the idea that adolescents would either be more comfortable, or actually receive 
care in the primary care office was discussed by four of the five providers without embedded 
behavioral health providers, as well as six providers with embedded behavioral health providers. 
Lastly, providers discussed reasons for why other providers might not feel as strongly or 
are less comfortable having the identification of anxiety as part of the primary care provider role. 
As one provider stated,  
I think it’s less important to some people…I think people who are maybe farther up from 
training or don’t have like the connections that I have don’t feel as comfortable with it. 
And so, therefore, may not address it as much. Whether they think it’s important or not -- 
I don’t know, but I feel like it’s not something that they address as regularly as perhaps I 
do (103 Urban; Yes BH).  
Another provider stated,  
It’s just they're not interested in it. You know, I think it's easy if you're interested to learn 
more about something, but for some practitioners -- that's not a high priority. To get a 
history on these kids takes time and a lot of people don't have the time built into their 
schedule. So, it's not that they're bad doctors -- it's just they work in a system that doesn't 
allow it. It's unfortunate (111 Rural; Yes BH). 
All providers felt they have a role in identification of behavioral health conditions, with 
some providers focusing specially on their role identifying anxiety, and others focusing on 
mental health in general, including anxiety. How providers defined identification varied between 
identification/diagnosis and referring for diagnosis/conditions’ specific identification. Several 
providers also commented on why other providers may not focus on identification of anxiety, 
including interest levels, trainings, and time constraints.  
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3.4 FACILITATORS AND CHALLENGES TO IDENTIFICATION OF ANXIETY IN 
PRIMARY CARE 
During discussions focused on identification of anxiety in primary care, providers shared both 
facilitators and challenges faced in identifying anxiety in primary care. Facilitators are presented 
first, followed by challenges.  
3.4.1 Identification facilitators  
Factors facilitating providers’ ability to identify anxiety in primary care included 
parent/adolescent disclosure of concerns/symptoms, having an embedded behavioral health 
specialist, value within the practice on mental health, being a recipient of anxiety specific 
training, co-learning, and TiPS service.   
3.4.1.1 Parent/adolescent disclosure  
Parental and patient disclosure of symptoms or explicit disclosure of anxiety as a formal concern, 
facilitates providers’ abilities to identify anxiety. Several providers mentioned disclosure of 
symptoms as a facilitator, 
In the sick visits it’s usually centered around what their concern is and again, while some 
people are savvy and come in for a sick visit for mental health concerns because they’re 
identifying difficulty concentrating, or depression, or are usually coming in with other 
physical complaints that are- we figure out are related to behavioral health complaint 
(220 Rural; Yes BH).  
Another provider vaguely stated,  
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So, a lot of the times, if anxiety or depression is an issue and the parent is aware- 
because we will get that a lot at wellness checks or even just people come in for anxiety 
or depression. A lot of the times the parent is very helpful. They give some more insights 
(108 Rural; No BH).” 
With regards to explicit disclosure of anxiety, one provider stated “as far as recognizing 
it, in my experience, it’s usually either the patient or the parent that comes to us and says, ‘Hey, 
I think this might be going on. What do you think?’ And then, we examine it and identify it 
appropriately (117 Suburban; Yes BH).” Other providers specially compare the likelihood of 
parents and patients disclosing anxiety; “most of the time when any concerns about anxiety come 
up it’s kind of brought up at the very beginning by the parent, not always the patient. (102 
Suburban; Yes BH).”  
3.4.1.2 Organizational-level factors  
Organizational-level facilitators were also mentioned as supportive anxiety identification 
processes. Many providers reported having an embedded behavioral health specialist (e.g., on-
site behavioral health provider), made the identification process simpler. For example, providers 
felt an embedded behavioral health specialist made referrals easier; “almost all of our practices 
have a behavioral health person in the office, like a therapist of some type. So, it’s really easy 
then to refer from there (103 Urban; Yes BH)”. Other providers mentioned embedded behavioral 
health providers also supported the identification process due to being able to engage in bi-
directional communication,  
The only exception to that is when I refer them to [Insert Name] in our own office which 
is very nice because I get to talk to her and we collaborate. So, I try to refer into our own 
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as much as possible just because I can have that loop closed myself (109 Suburban; Yes 
BH)”.  
A few providers spoke to how their practice culture (i.e., work-life balance, increased 
visit time), was supportive of identifying behavioral health concerns. For example, one provider 
mentioned their practice makes evaluation a priority as they have hired a therapist to work in 
their office and that “[they] give them an extra 15 minutes so they have a total of 30 minutes 
with the provider (101 Suburban; Yes BH)”. This provider went on to share,  
You know, we value our personal lives very highly in making sure that we have a good 
work life balance, and that was something that our founders’ thought was really 
important. And therefore, I think that translates to how we care for our patients (101 
Suburban; Yes BH)”.  
None of five providers, without on-site behavioral health, discussed practice-level facilitators. 
3.4.1.3 Education and co-learning 
Only a few providers described educational trainings or co-learning as factors that facilitate their 
ability to identify anxiety. With regards to education, one provider described participating in 
training, stating, “I’m perhaps more likely than some of my other colleagues....to use the 
SCARED form…which was outside my comfort zone about a year ago (106 Urban; Yes BH)”. 
Another provider spoke about how co-learning has increased their comfort level talking to 
patients during the identification process:  
I have a lot of good friends who have done triple board training. So, they’ve done 
pediatrics and psychiatry together. And so, just really being friends with them -- I’m 
more comfortable with the topic because also when I have questions, I just talk to them 
about what to do about their patients (103 Urban; Yes BH). 
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Lastly, providers pointed to the TiPS service as an identification facilitator. For example, 
one provider stated  
I think once- what I actually found very helpful is we have the TiPS program and we’ve 
had some lectures through them in terms of identifying anxiety and depression and a 
roadmap. So, I thought that has been extremely helpful for me in knowing what questions 
to ask (107 Rural; No BH).  
Providers also shared details about how TiPS consults support the identification process,  
It does help with identification. So, what we do is and what TiPS does is say we have a 
kid that comes in that we suspect depression or anxiety -- we can call and they will get a 
mental health physician that specialize on the phone and we kind of describe what 
happened at the visit, what they saw, and kind of what they would recommend as far as if 
they would prefer to see them in a quick and kind of get additional screening questions 
done or if they were to recommend starting a medication (110 Suburban; Yes BH). 
3.4.2 Identification challenges  
Many facilitators described by providers dovetailed from discussions surrounding challenges to 
identification of anxiety in primary care. Each of the major challenges to identifying anxiety in 
primary are described below, including patient/parent-provider communication, visit length, and 
provider comfort with what happens after they identify an adolescent has anxiety.  
3.4.2.1 Patient/parent-provider communication 
Several providers expressed the honesty and openness of adolescents as a challenge to 
identifying anxiety,  
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The biggest challenges are the patient being actually truthful and honest with us. So, 
when we’re asking them questions- because sometimes you can sense there’s more going 
on and yet, they still don’t want talk to you about it or admit to the way that they’re 
feeling (105 Urban; Yes BH). 
Other providers described challenges with both the adolescent and parent disclosing a concern,  
I think a lot of it has to do with the patient itself. With whether or not the child is 
comfortable in one, talking to us and being honest with their answers on their 
questionnaire and whether or not they feel, that they’re willing to talk about it, I think is 
huge. And then, again, sometimes, too, even the parents are the opposite. The kid wants 
to talk about it but the parent wants to ignore it. So, that kind of makes things difficult for 
us, too (112 Rural; No BH). 
As noted in the above quote, patient/parent reluctance to disclosing mental health is a 
challenge several providers mentioned. Directly related to this challenge is patient/parent 
reluctance to accepting anxiety as a mental health concern. For instance, one provider shared 
“either one parent thinks its anxiety, the other parent doesn’t, with the reluctance of the teen, 
himself, to think that what they’re experiencing might be related to mental health (117 
Suburban; Yes BH)”. In this situation, the provider continued to share that in these instances, 
discussions related to “anxiety, specifically, take a lot of time. And, many times, we don’t have 
that much time to give either a well child visit or sometimes when it’s just brought up off the cuff 
(117 Suburban; Yes BH)”.  
Three of the five providers without embedded behavioral health providers shared similar 
sentiments as described above by providers with embedded behavioral health providers. For 
example, one shared,  
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The biggest challenge I have is convincing a family potentially or a patient that that’s 
where their symptoms are coming from. You’re trying to get them that trust in you and 
get a second opinion if they don’t believe you. It’s just that denial. But, that’s a small 
proportion. I think once we have someone who comes in currently for the same issues or 
multiple issues all the time, they’re frequent fliers, and you know it’s anxiety but they 
don’t recognize it. It’s being in denial pretty much a lot of times. That’s the biggest thing 
on diagnosis (104 Suburban; No BH). 
Another provider briefly mentioned stigma around mental health concerns, but focused 
mostly on how patients prioritize mental health:  
Yeah, I mean there’s definitely still a stigma about mental health concerns. In the patient 
population that I serve, everyone’s got very busy lives. They’re very highly scheduled, 
which is probably why they have anxiety. So, trying to fit in one more thing with a visit to 
a therapist is often the challenge for them, and not always a priority for them. So, that 
makes it harder. Yeah. I think that’s pretty much it (101 Suburban; Yes BH).  
3.4.2.2 Organizational-level barriers 
Length of time allowed for primary care visits was overwhelmingly mentioned by providers as a 
barrier to identification of anxiety. While providers from different geographies indicated time 
during visits as a barrier to identification, more than half of the rural providers mentioned this 
barrier. Similarly, three of the five providers without embedded behavioral health providers 
noted time as a barrier to identification. Several providers simply stated that short visit times 
limits their ability to see or notice symptoms of anxiety, “it’s a relatively short appointment. I 
think kids are going to put on a good face, especially the anxious ones, that everything is fine. 
And so, sometimes we don’t have insight that they may need some help (116 Urban; Yes BH)”.  
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Time was also seen as a barrier to reviewing all topics within a visit “it does just come at 
the expense of other things. It comes at the expense of either more discussion on diet, or exercise, 
or healthy choices, or friends, or future career plans, things like that. So, time is the currency of 
the visit (117 Suburban; Yes BH).” Moreover, providers shared how much time identification 
can take,  
So, the anxiety discussion like to identify it, and then talk about it may be brief if the 
family is not worried, and you’re not too worried about it. But, it can take a while. The 
SCARED itself sometimes takes kids like five to ten minutes. So, that can be time 
consuming. (103 Urban; Yes BH).  
Overall providers spoke about how short visits, take away “the time that it [anxiety] really 
deserves to have” (108 Rural; No BH).  
For a few providers, the type of visit (well child visit or sick visit) and length of visits 
presented challenges in terms of financial reimbursement. For instance, one provider described 
that for sick visits compared to well visits, they are allowed to  
Bill by time or complexity, so…I can get reimbursed appropriately if my schedule gets 
hijacked in a plus 15-minute belly pain, 15 minute I think they had a stomach bug, and 
really, they’ve had a belly pain for seven months and it’s because they’re anxious...it 
doesn’t make my next patient have to wait less, but at least my time is being valued (220 
Rural; Yes BH). 
One provider, with control over visit structures, described placing priority on ensuring 
there is enough time in a visit to allow full coverage of the adolescents needs. The provider 
continued to say 
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Most practices can't be sustainable like that [with 30 minutes visits]. But I have a very 
high poverty, high ADHD, high foster child care environment and I just can't get through 
all those visits any faster. So, rather than have 35 kids…I see 22 or 25 kids a day and I'm 
able to still make a living, but have the time I need. I don't generate the revenue as 
everybody else does, but, you know, unfortunately or fortunately, that's not my priority 
(111 Rural; Yes BH). 
3.4.2.3 Next step challenges  
Another major barrier to identification or comfort in the identification process, is what happens 
after the primary care provider identifies the adolescent as having anxiety. As one provider 
summarizes “I know that we’re talking about identifying, but I think, you know, if you’re 
uncomfortable about treating or triaging mental health problems, you’re not going to feel 
comfortable with identifying them depending on what you do next (107 Rural; No BH)”. Other 
providers echoed this sentiment, “the biggest challenge is it’s not knowing what to do next – that 
not having enough resources to refer to and roadblocks for that – just getting people to the right 
provider (115 Suburban; Yes BH)”. Challenges to treatment are linked, by interviewees, to 
provider comfortability identifying anxiety. While providers overwhelming feel they have a role 
in identifying anxiety, concerns over what happens next (i.e., treatment) is seen as an 
identification barrier. Treatment challenges discussed by providers are found in section 3.7.2.  
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3.5 SCREENING TOOLS  
Approximately one third of providers shared that they had never used a standardized screen for 
anxiety. Only two of the seven providers who discussed not utilizing standard anxiety screens, 
disclosed they were not aware of any such tools,  
I honestly think it's because we have no screening tool for it and, personally, from a 
provider that doesn't have a lot of experience -- I think a screening tool that if we did 
implement it into our visit, it would help because it is a hard thing I feel like to screen for 
(110 Suburban; Yes BH).  
The remaining providers shared other reasons for not utilizing anxiety screening tools, including 
(1) not having time to use an anxiety screener during visits, “I have not really had the time to do 
that kind of scale with what everything we have to do within the office (118 Urban; Yes BH)”,  
(2) relying on the PHQ9, and (3) relaying on their own “conversational skills (109 Suburban; 
Yes BH)”.  
3.5.1 SCARED screener 
Of providers who have used routine anxiety screens, all used the SCARED tool, with one 
provider also sharing they had used the GAD-7. Providers who used the SCARED tool, 
described when they believed it was most appropriate to give to patients, and sometimes parents. 
Mainly, providers utilized the SCARED when they or the parent has concerns that the adolescent 
is experiencing anxiety or severe anxiety. In these instances, providers described generally 
finding results provide, “a little more direction that makes...[the] visit a little more efficient (220 
Rural; Yes BH)”. Specifically, providers mentioned data from the SCARED allows for them to 
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better track anxiety, “I think it’s objective data that you can follow and you can trend over time. 
So, I think that works well (117 Suburban; Yes BH)”. Another provider shared how objective 
data can be used to overcome parent/patient denial,  
I find it’s really helpful to present something objective to them especially when it’s a 
somatic complaint that, “Hey, your score is 30 and above 25 really might be concerning 
here.” So, it really, I think, brings a lot to light to the family. So, I do like using those 
tools. (221 Suburban; Yes BH). 
Providers overwhelmingly spoke about the negative aspects of the SCARED screening 
tool as is relates to their ability to use it during a primary care visit. One major barrier provider 
shared was manual scoring, “it’s a real pain to add up the scores on the SCARED (103 Urban; 
Yes BH)” and “I think the SCARED itself is also a barrier. Not a hard form to fill out, but really 
hard to score (116 Urban; Yes BH)”. Providers mentioned that if the SCARED could be 
automatically calculated it would be less tedious. 
From a patient and parent perspective, providers noted two major complaints adolescents 
and parents had specific to filling out the SCARED tool: (1) form length, and (2) the repetitious 
nature of the questions. Several providers also noted the irony of having an anxious youth fill out 
a long form,  
And, the problem is, you know, you’re trying to get someone who’s anxious and worried 
about doing things perfectly fill out a form. You know, something like that. If they’re 
worried about doing something right -- they’re going to agonize over ‘Is it a one or a 
two?’ So, just it’s imperative in the condition that it’s going (101 Suburban; Yes BH). 
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3.5.2 Systematic screening for anxiety  
Turning the focus away from the SCARED tool specifically, providers had mixed feelings about 
routinely screening for anxiety. Almost half of providers felt a routine anxiety screener would be 
a helpful change, including three of the five providers without embedded behavioral health 
specialist. One provider mentioned that if the screener “could be included in something that’s 
done prior to the visit, that would be helpful (108 Rural; No BH)”, as during the visit there is not 
enough time for patients to fill out forms. Another provider stated,  
But, like I said, I can honestly say that most of it is for depression and we don't really 
screen for the anxiety aspect. So, it's something I think we need to get better at as an 
office, for sure I think, like I said, more education, getting maybe some kind of tool 
implemented just like we have for the alcohol, tobacco, and marijuana, and the same 
thing for depression. I think adding an anxiety screening tool would really help us to kind 
of get that conversation started while we're in the room (110 Suburban; Yes BH). 
Other providers spoke to how a routine screen would support them in recognizing the 
symptoms of anxiety. For example,  
I think anxiety is a little bit more subtle. You know, so I think some pointed questions can 
be pretty helpful with regards to that. But, would it be a good idea? Yeah, I would say 
that it wouldn’t be a bad idea for sure. Particularly, if there was maybe four or five 
questions (119 Urban; Yes BH).  
The sentiment of a short routine screener was echoed by other providers as well. Providers also 
cited prevalence of anxiety as a rationale for having an anxiety-specific screener be used 
routinely;  
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I think routine. If we’re screening for depression- and I’m sure anxiety is that prevalent – 
why wouldn’t we screen for anxiety? You could argue that that’s even maybe harder to 
pick up. So, yeah. But, I think so. As I said, we definitely going to be, I’m sure, missing 
kids. (116 Urban; Yes BH). 
A few providers discussed the inadequacy of the routine depression screen for picking up 
anxiety as a rationale for having a routine anxiety screen,  
I feel like the PHQ9 is the only screening we use for mental health which I feel like, at 
least to me, the questions seems more geared towards depression rather than anxiety. 
And, I feel like anxiety is very, very prominent in this population and it’s being diagnosed 
more often because it’s being caught more. But, a lot of- the way the screen for is mostly 
just an in-person interview and questions. And, I think it would be beneficial if there was 
some kind of paper screening or something that could be added on to the inpatient 
screening for the providers that don’t want to actually ask those questions (105 Urban; 
Yes BH)”.  
Another provider shared,  
“I just feel like sometimes the depression scales – they kind of hit on the more depressive 
symptoms. So, the hopelessness, the crying, the feeling tired, the lack of interests – that 
kind of thing. I think with anxiety, it can sometimes be a complete opposite. So, even if a 
kid is- I don’t want to say that. If a child is actually just having the anxiety part of things 
when they answer those questionnaires, you know, ‘No, I don’t really feel like I’m losing 
interest it’s just I’m nervous about doing things,’ or, ‘I don’t really feel tired all the time 
even though I’m not sleeping because I’m having nightmares’. Do you know what I 
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mean? Sometimes they might get a little bit confused and not really know how to answer 
the questions (112 Rural; No BH)”. 
About half of the providers discussed reasons for why they do not think there is a need 
for a routine anxiety screener, including barriers to using the SCARED as a routine screening 
tool. Similar to when providers view it is appropriate to provide the SCARED tool, many 
providers noted they are not in favor of a routine anxiety screen as they would prefer to provide 
screens only to patients who indicate the need, “I don't know if I'd integrate it into routine 
screens, but certainly for the patients that I have suspicion for would be helpful. But, I don't 
currently integrate it (109 Suburban; Yes BH)”. 
Providers also discussed form fatigue as a barrier to adding more routine screeners, 
“…Yeah, we have so many forms people fill out (106 Urban; Yes BH)”. Providers noted that 
time spent in waiting rooms before a visit is often not long, which may affect data accuracy, “So, 
having extra screens may or may not be beneficial. I think kids will have a tendency to say no 
problem, no problem, no problem if they feel that they’re rushed (118 Urban; Yes BH). 
Specific to using SCARED as a routine screener, providers noted that the length of 
SCARED form would be a major barrier, “so, I think selectively giving that to the people that 
you’re curious about is more helpful. Because it’s so long, I don’t think that would be a good one 
to give to everybody (115 Suburban; Yes BH)”. Another provider echoed, “I think it’s a great 
tool. It does take a bit of time. I wouldn’t give it to everybody because the time constraints and 
that, yeah. Like they already have enough forms to fill out, I think (114 Urban; Yes BH)”.  
Two providers also shared they do not think the presence of a routine screener for anxiety 
would greatly improve the odds that a case of anxiety is not missed. One provider stated that 
while they have patients fill out the form whom they have “alarm bells going off”, they “don’t 
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think we’re missing kids because we’re not having everybody fill it out.” (114 Urban; Yes BH). 
The other provider stated,  
I think that probably 90% of the time if an adolescent is anxious, we’re going to identify 
it with, or at least suspect it, without the SCARED form. We may be missing some 
adolescents with anxiety, but I think the majority we’re catching – SCARED might help 
us pick up a few more (113 Rural; Yes BH). 
In general, providers are in favor of using anxiety specific screens for adolescents for 
whom they or a parent is concerned about. Adding a routine anxiety screen to the mix of existing 
routine screeners is seen as a mixed bag. Some providers believe adding the screen is important 
and beneficial as it could help start conversations, assist with recognizing symptoms of anxiety, 
and could support not missing adolescents with anxiety. Other providers do not believe adding a 
routine screen would be beneficial due to barriers such as time limitations, form fatigue, and the 
screen may not yield a higher rate of identifying anxiety.  
3.6 TREATING AXNIETY: PRIMARY CARE PROVIDER ROLES 
Providers overwhelming specified identification of anxiety as part of their professional role. In 
terms of treatment, role responsibilities varied, including what aspects of treatment fall under the 
domain of PCPs. Few providers spoke to beliefs that treating anxiety, within primary care, was a 
new aspect of care and a new responsibility. For instance, one provider stated, “well, I think 
there seems to be a push to have pediatricians be willing to do that in the office. The process – I 
think that it’s a totally new knowledgebase that you would need to acquire to be able to do a 
good job at that (115 Suburban; Yes BH).” Another interviewee provided a rational for why 
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treatment is a new addition of care, stating, “I think there are not enough child psychiatrists. I 
think we have too (116 Urban; Yes BH)”. Other providers expressed while they did not prefer 
treatment was a part of their role, it was; “so, I prefer it wasn’t -- but it is and because there’s 
lots of people (220 Rural; Yes BH)”.  
Insights providers shared as to their role in treatment of anxiety fell into four domains: 
initiation of treatment, referral to behavioral health providers, medication approaches and 
therapeutic approaches. Each domain is exemplified below. 
3.6.1 Initiation of treatment  
Many providers discussed that it was both their role to identify anxiety and their responsibility to 
initiate treatment. However, providers defined “initiation of treatment” differently. For some 
providers, initiation of treatment meant starting treatment, and referring out to a behavioral 
health provider as needed.  
I think I play an important role in picking the kids up, starting treatment. If we’re not 
able to manage it, then we can get help from psychiatrists. Any of that’s like – they are 
doing well sometimes psychiatrists have their input and blessing on what we’re doing, 
but yeah, I think we are able to manage it. I think it…falls in our purview and we should 
be doing it (114 Urban; Yes BH). 
Another provider shared that it is important for providers to feel comfortable initiating 
medication treatment, due to wait times for behavioral health providers,  
I think it’s very helpful for primary care providers to be comfortable at least starting 
meds and titrating up. But, you know, I fear- I don’t know. I only know that people aren’t 
super comfortable with it always, but I think it’s easy to start meds. I think it’s easier to 
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go up slowly while they wait to get in with a psychiatrist if you’re not comfortable 
managing long-term (103 Urban; Yes BH).  
This sentiment was shared by other providers, for example,  
I think it’s definitely necessary. And, because we can at least start decisions on treatment 
– whether we can manage it on the long run – that’s a different story. But I know it does 
take a long time to get these patients into seeing psychiatrists and people who have been 
educated specifically on pediatric health issues. So, if we can at least start treatment 
while they are waiting for their referral and to be able to make an appointment with 
someone, with a specialist – I think that’s the best thing we can do (105 Urban; Yes BH). 
For others, initiation of treatment means waiting for a behavioral health provider to ask the PCP 
to initiate medication treatment. For instance,  
Sometimes I am asked by the outside therapist to initiate medication which I usually feel 
comfortable with a few medications, but not others. In other words, as we start treatment 
-- if it looks like certain medications aren’t working we try another medication. It’s not 
working, I feel that they should probably see a psychiatrist (118 Urban; Yes BH).  
3.6.2 Referral to behavioral health providers 
Other providers believe their role in treatment is to refer patients to behavioral health specialists 
once identified. For example, one provider stated,  
Yeah, I think our role ideally is to identify the person that has anxiety – come up with a 
high-level, 30,000-foot treatment plan, which would include, ‘Okay, I would like you to 
see this therapist, and I would like you to see this provider’. And, get them to the most 
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appropriate providers who can either provide cognitive behavioral therapy or 
pharmacotherapy. I think that’s the ideal role of a pediatrician. (117 Suburban; Yes BH) 
 This was echoed by a few providers, including one who stated  
As far as our role, I think it is our role to identify it and not necessarily treat it. But I 
think it is our role to identify it and identify when they need additional help or assistance. 
So, I believe that's my primary role. That's what I take from it (110 Suburban; Yes BH). 
However, more often, providers described while they prefer to refer adolescents to behavioral 
health providers first, they are willing and able to treat with medication,  
Well, I think we try to first refer them to therapy. I don’t medicate first. Very seldom have 
I medicated…before they started therapy because they’ve invested- difficult that you 
can’t even get them to therapy. It kind of takes the edge off, if you will. But, that’s a very, 
very minority of people that do that that I’ve ever done that to (104 Suburban; No BH). 
Another provider stated,  
I usually refer them to– we have three in our office. We have three offices. So, one of 
them spends most of her time at one of our offices and the other two kind of split time. 
And so, I do have the names of the different therapists, and I say, ‘I’d like you to see 
them’.  And, I also talk about medication if it’s someone that I feel is really, really kind of 
in a bad way -- but I usually kind of say, ‘Let’s start with therapy and see how it goes’. 
And, then if we want to consider medication…(101 Suburban; Yes BH). 
3.6.3 Medication treatment approaches 
The majority of providers stated having prescribed medications for anxiety, including providers 
without embedded behavioral health providers. Providers feel comfortable with certain 
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medications, including “Zoloft [SSRI], Lexapro [SSRI], Celexa [SSRI], and Prozac [SSRI]. 
Those are the main ones that I feel comfortable with. The other ones -- I don’t have as much 
experience with and I am very upfront about parents about that (118 Urban; Yes BH)”. One 
provider, who does not have a license from the Drug Enforcement Agency, shared  
I typically, with my kids that have anxiety, I like to stick to low dose things like SSRIs. I 
have tried even Atarax is something that has been used previously for anxiety that tends 
to work. If it’s just very minor stuff, I think, it’s just enough to kind of calm them down. 
And then, I also, in my practice, at least, I feel comfortable doing- using Melatonin and 
things that are natural and essential oils and adding that into practice also. So, I think 
those are the kind of the things I usually start to play with first before doing any of the 
heavy antipsychotics or heavy antidepressants or I don’t feel they need to take anything 
like that (112 Rural; No BH). 
Some providers spoke about side effects as a reason for prescribing or not prescribing certain 
classes of medication. For instance, one provider stated,   
I usually use like the SSRIs or SNRIs [serotonin and norepinephrine reuptake inhibitors]. 
So, Zoloft [SSRI], Prozac [SSRI], Celexa [SSRI], Lexapro [SSRI]. Trying to think what 
else. I don’t think I ever started Effexor [SNRI], but I think I’ve had a patient or two who 
might be on it came to me on it or was hospitalized and put on it, and it worked well. So, I 
continued it. I’m not a big fan of any of the Benzodiazepines just because of the risk of 
tolerance, addiction, and all of that. So, usually, if they were in as-needed medication, I’ll 
give them something like Hydroxyzine [antihistamine] to kind of just make them more 
sleepy and calm them a little bit. I have done like short-acting Propranolol [beta blocker] 
like before public speaking, or things like that. (222 Urban; No BH)”.  
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Other providers shared that they did not prescribe benzodiazepines as well as having less 
familiarity with medications outside of the SSRI family.  
Providers also discussed long term, complex, treatment of adolescents with anxiety. 
While many providers expressed comfort prescribing medications, many commented that if the 
patient was complex or did not respond to treatment, they would have their patient see a 
behavioral health provider,  
I'm very comfortable starting a treatment. Typically, I'll do an anti-depressant like an 
SSRI such as Zoloft or Lexapro, the SSRI's. I mean, that's generally how we start off. I 
usually start off with Zoloft [SSRI] or Lexapro [SSRI], but I'm becoming a little bit more 
comfortable and maybe these other nuances to it. And then, if they're not doing better, if 
they're anxiety is severe or significant, they're not doing well with my initial prescription, 
I'll try to get them into seeing a psychiatrist. with a psychiatrist any time to get a little bit 
more guidance (109 Suburban; Yes BH). 
A similar sentiment was shared by another provider regarding SSRI comfort level,  
I would start an SSRI. That’s pretty much my comfort level. SSRIs or Vistaril 
[hydroxyzine] are generally what we do at our office. So, we generally, I think, we try 
one or two SSRIs and moving on to the second SSRI. At that point, we usually try to get 
them plugged in with a pediatric psychiatrist because we’re saying they probably need a 
little bit more help than what we're able to do (108 Rural; No BH). 
Several providers spoke about how other providers, in their office, are not comfortable 
prescribing medications. One provider’s statement summarizes this point, 
I mean, there’s definitely very black and white line. There’s no grey in our group. I would 
say half of us do prescribe SSRIs … But, the other half of my group definitely does not 
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have that comfort level and only will refer to a psychiatrist for meds (106 Urban; Yes 
BH).  
One provider compared comfort in treating physical health conditions to comfort in 
treating behavioral health conditions, and how that should impact a provider’s treatment 
decision,  
Like I feel really confident with taking care of sports injuries, but my partner does not 
because they have not had a lot of training or experience and haven’t seen a lot of those 
patients. So, if they don’t feel comfortable treating that, then they shouldn’t. They should 
be referring that person to me or to an orthopedist. So, I see it very similarly. Medicine 
unfortunately is not like a perfectly evenly taught throughout every single provider. 
Everyone has their own interests and everyone has their own experiences. And so, if you 
don’t have a lot of experiences or interests in an area -- I don’t think you should be made 
to focus on that area. You have to be able to refer and tell someone where to go or how to 
get help, but I don’t know that you’re necessarily obligated to treat that (101 Suburban; 
Yes BH).  
Providers similarly gave examples of how other providers might behave in certain 
clinical situations. For example, one provider shared  
Four of us of the eight are definitely comfortable starting meds, titrating meds, maybe 
three, maybe four of us are comfortable following on meds long-term like as long as the 
kid is doing well…And, we’re comfortable with it and then there are three other 
providers. Two are very like old school and one is nurse practitioner who just hasn’t 
really had training in it. So, they’re not at all comfortable. They won’t even – I don’t 
know if they’ll do this, but I don’t think so. Like if a kid ran out of the Prozac [SSRI] or 
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something, and couldn’t reach their psychiatrist -- they might provide a refill for a month 
for a stable dose. But, they might not. And, they just don’t know enough about treating 
with meds to be comfortable with this stuff. (103 Urban; Yes BH). 
Another provider shared a detailed scenario of when their comfort level with treatment 
clashed with another provider in the office:  
Well, I had a patient that I was seeing for a well child check for one of my colleagues. 
And, I went over all the screening and the PHQ9 score was 15. So, it was a little bit 
elevated. And, they have already been working with the in-office therapist. And, she had 
told me in the past she had asked the doctor about starting him on medication and the 
provider had said no and didn’t want to do it... I didn’t personally feel comfortable 
starting them on medication because that provider did not want to do it. But, I did have to 
refer them out to a psychiatrist because I do feel like they needed those services. Then I 
did have to talk to the provider after that and explain myself to them and tell them I 
wasn’t trying to go behind their back…They weren’t very happy…But, I think they 
appreciated that I was honest with them and I didn’t just take it upon myself to do the 
treatment because I know in that case they would’ve been very angry (105 Urban; Yes 
BH). 
 The provider continued to share the reason for treatment resistance, 
The only thing that I can think of is they just feel like they’re somewhat responsible if 
something does happen to go wrong especially because of the black box. I think that’s 
what most providers are afraid of when starting on medications…So, if they do happen 
to, unfortunately, commit suicide or try to harm themselves. But they find out that 
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responsibility also falls upon them because they were that person’s primary care 
provider (105 Urban; Yes BH). 
3.6.4 Therapeutic treatment approaches  
Lastly, providers discussed how they viewed talk therapy as part of their role in treating 
adolescent anxiety. For the majority of providers, while an important form of treatment, 
cognitive behavioral therapy was outside of their purview. For example, one provider plainly 
stated “So, I think I’m comfortable with screening. I’m not comfortable with doing cog therapy 
(104 Suburban; No BH)”. Providers spoke about the importance of talk therapy and who would 
be best to provide that type of treatment,  
I think, you know, my big message -- because I mean, I’m there for 15 minutes and I’m 
not going to- I will see them back for med management and anxiety, but I’m not 
necessarily a therapist per say. I mean I can start them off with some ideas about 
managing stress, and anxiety, and relaxation techniques, and kind of, you know, talk with 
them a little bit about that, and giving them some ideas about that. But really, I think 
stressing the importance with the patients and families that, you know, this is something 
that you can really work on. But, you know, seeing someone, and dedicating a certain 
amount of time, seeing a therapist, and kind of developing these strategies, you know, 
would be helpful for you to kind of empower yourself to kind of manage this (119 Urban; 
Yes BH). 
Many providers felt as if they were able to give adolescents some form of advice or 
coping strategies within the context of a visit. For instance, one provider stated  
 96 
Well, I think positive reinforcement for things that you’ve seen that they’re working on or 
encouragement. I think that we can talk with them about breathing techniques and other 
relaxation techniques they used. If they have a positive activity or they like to do like 
outlet and just encouraging that, and getting exercise to help with their stress levels. We 
can address those things (221 Suburban; Yes BH). 
Another provider generally stated that while they can do “basic counseling” and would refer out 
for cognitive behavioral therapy because they cannot see a patient “for an hour each week”, that 
“sometimes people who are resistant to even counseling or addressing their issues since you’re 
able to give them some medicine to take the edge off that they can deal with whatever underlying 
issues (222 Urban; No BH)”. A few providers spoke to the importance of learning non-
medication treatment options, 
I don’t personally feel well prepared to offer a therapeutic approaches myself. I’m trying 
to get better at that with some concrete training on my end to do some basic relaxation 
techniques and mindfulness techniques, and how to explain that to kids and teens…that’s 
a definitely an area of weakness on my end, but something I’d like to get better at 
because it’s hard to convince. You know, not everybody needs medicines. And, even 
everybody who does need a medicine -- it’s sometimes hard to convince them that they 
could benefit from it. So, like to have other techniques (220 Rural; Yes BH). 
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3.7 FACILITATORS AND CHALLENGES TO TREATMENT OF ANXIETY IN 
PRIMARY CARE 
During discussions focused on treatment of anxiety in primary care, providers shared both 
facilitators and challenges they face treating adolescents with anxiety. Facilitators will be 
presented first, followed by challenges.  
3.7.1 Treatment facilitators  
Factors facilitating providers ability to treat anxiety in primary care include having an embedded 
behavioral health provider, co-learning, and the TiPS service.  
3.7.1.1 Embedded behavioral health provider 
For the majority of providers, having an on-site behavioral health provider was a major asset in 
the treatment process for adolescents experiencing anxiety for several reasons, including ease of 
treatment access, bi-directional communication, and learning. In terms of ease of access to 
treatment one quote summarizes several provider perspectives,  
Well, I think we’re really lucky because we have an embedded model with therapists in 
our office. So, I feel like that presents a really great opportunity for families to get rapid 
treatment and it’s convenient for them as well. So, I feel like we have a lot of access for 
them (221 Suburban; Yes BH).  
Providers with embedded behavioral health providers often made comparisons between 
on-site therapists compared to off-site therapists. One common comparison had to do with 
access,  
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Yeah, I think before we had our own, we were just giving people a list of phone numbers 
and letting them call and see who they could make an appointment with. Many people 
had what they felt like was a more urgent concern, and couldn’t be seen for four months 
or six months, and for someone with a behavioral health concern, that’s a really, really 
long time because a lot can happen in that. So, basically, we just increase accessibility – 
someone who is qualified to do counseling for kids who are not very severe. And then, the 
kids that were more severe we could refer out. We still have trouble, I think, with long 
waits with psychiatry right now, but we do our best to get the most urgent kids in. (115 
Suburban; Yes BH). 
Another provider shared reasons for why access to psychiatry is challenging and how an 
embedded behavioral health provider can support overcoming these challenges,  
…There’s only a handful of them [psychiatrists] in certain locations, and sometimes they 
live far away, or it conflicts with their schedule. And, what’s helped with that is having 
like therapists at our office. It’s a huge help to just say look, “We have a therapist here,” 
as you go there for counseling because obviously they can make an appointment to see 
me, they can make it to see the therapist and that. And then, they [embedded behavioral 
health provider] are also helpful in kind of navigating the whole mental health treatment. 
So, those things have helped with that barrier (114 Urban; Yes BH). 
Bi-directional communication and ease of information shared was another major asset 
providers’ with embedded behavioral health providers discussed,  
Oh, it’s so easy. She’s in our office. She’s in one of our- four days a week -- the other one 
day a week. So, I see her usually at least three days a week. And so, I’ll often tell her 
about every kid I refer to her just to give her a heads-up, and what my worries are, what 
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we think needs to be addressed. And then, after she sees the kid -- she’ll send me the note. 
And also, next time she sees me -- we’ll touch base about what she thought, how things 
went. So, it is super helpful. I love when patients see her versus outside therapists 
because I don’t know what’s going on there (103 Urban; Yes BH). 
Another provider shared,  
The communication is much better when there is a therapist, or psychiatrist in the office 
mainly due to the fact that they’re in the office. So, if they think that there’s a child who is 
really high-level anxiety, or high-level depression they’re able to communicate that to us 
so that we can then be a part of that relationship and help the family out if necessary 
(118 Urban; Yes BH).  
3.7.1.2 Co-learning  
Others commented on being able to get advice from their on-site therapist as an advantage,  
Oh, definitely. Because, I mean, our therapist is right in the office, and I can tell her, 
‘Hey, these are my concerns’. And then, she’ll see the kid and she might stop in my office 
and be like, ‘Hey, I’m worried about this’ or ‘this kid is too complicated for me. I’m 
going to refer them to WPIC, or whatever’. But, there’s a lot of feedback (106 Urban; 
Yes BH).  
The concept of co-learning was brought up by providers as a technique used to become 
more confident in creating treatment plans and or following through with treatment options. For 
example, one provider described putting a treatment plan into action,  
I have several patients where I did my homework, I had the dose, I was ready. I talked to 
my favorite child psychiatrist, I was all set. And, it’s only a few cases, but the patients 
were not ready to start medication. They did not want to start meds (116 Urban; Yes BH). 
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Another shared how a fellow provider provided them information that increased their confidence 
in medication prescribing, “One of the doctors that I work with gave me this algorithm on how to 
follow-up properly as far as SSRIs and when to keep it at that same dose versus increasing and 
when would be the appropriate time to continue (105 Urban; Yes BH). 
 Others spoke about shifts in their own or other providers willingness to treat anxiety,  
I think my shift was probably just I was seeing these kids and they couldn’t get in for a 
while so I’d think I just talk to my friends and said, ‘What should I do in the meantime?’ 
So, I think that’s what started me and then -- there was kind of a [organization] wide 
initiative or push to get us to do these things and that’s really kind of what spurred at 
least two of the others. (103 Urban; Yes BH).  
Another example, showcasing the effectiveness of co-learning, is  
I don’t know about medication-wise. I think, again, diagnosis is easy. I have one doctor 
in our practice who is very afraid of putting them on medication. She herself has anxiety 
and that’s what we said to her. This is anxiety, this is why you can’t do this. Then she 
would refer them to one of us who was comfortable. And then, because we have two 
offices, now, she’s getting more comfortable and she’ll call me, or she’ll call one of us 
and say, ‘Look, I have a kid that needs to go on it’, and okay. She just needs that 
confirmation (104 Suburban; No BH). 
3.7.1.3 Telephonic Psychiatric Consultation Service Program (TiPS) 
Similar to co-learning, many providers spoke about a resource called TiPS. Generally, providers 
viewed the TiPS line as helpful when working with complex cases, “we also use I think it’s 
called the TiPS line where we can call and speak to a psychiatrist for a complicated issue where 
we don’t know what to do and they’ll give us advice I think they actually do work pretty well 
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(105 Urban; Yes BH)”. Another provider shared that they use the TiPS line to discuss “complex 
cases with a psychiatrist” citing a specific example, “actually I have a call today that I may have 
to discuss a patient who has anxiety and not doing well on the current medication I prescribed 
(109 Suburban; Yes BH)”. 
Some providers spoke about how the TiPS line supports them with initiating treatment, 
“…they can kind of talk us through that process of implementing some kind of medication…it's 
very nice, especially for me, who's not quite there yet on prescribing those kinds of medications. 
So, that's super-beneficial to me (110 Suburban; Yes BH)”. Another provider shared that TiPS 
helps not only with medication decisions but also referrals and care coordination,  
Let me tell you I have them on speed dial…they’ll take the information and you get a call 
back from a child psychiatrist within 30 minutes. So, it’s everything from ‘Oh my God, we 
need to send this kid’… ‘Can I start this kid meds? Which meds?’ And, they have a 
dedicated care coordinator who’ll do all the follow-up with the family, and the family 
agrees and gets them into services. They will arrange a one-time in-person psychiatric 
evaluation and a behavioral intake (116 Urban; Yes BH). 
Providers also spoke to how the TiPS line has supported them in becoming more 
comfortable with treatment,  
I think it made me a lot more comfortable. The fact that like there’s a TiPS Program now 
which I like. So, that if I have a question, ‘Hey, I’m doing this, this, and this, and I’m not 
really getting to where I should be. I tried changing some meds.’ I can reach out and get 
in touch with the psychiatrist and bounce some things off of them. I feel like it’s been very 
helpful and made me more comfortable too (222 Urban; No BH). 
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 Other providers shared a similar sentiment regarding TiPS being a safety net when there are 
questions,  
And, I use the TiPS line a lot. I don’t know if you know what that is – where you consult 
with the psychiatrist…I love the TiPS line even for ADHD meds or whatever. If I’m 
feeling like I don’t know where to go I’ll just call them and they have always been 
unbelievably helpful…I think just that I feel more comfortable that I have a safety net 
because we do have the TiPS line I can always call (106 Urban; Yes BH). 
Several providers spoke to how TiPS supports them in working on complicated cases, 
“we also use I think it’s called the TiPS Line where we can call and speak to a psychiatrist for a 
complicated issue where we don’t know what to do and they’ll give us advice. (105 Urban; Yes 
BH)” Another provider discussed how the TiPS line supported their ability to prescribe a 
medication that benefited two different adolescent patients,  
I mean, I think I already touched on the fact that I think that the creation of the TiPS 
phone number was a massive step forward and for me personally as a provider 
eliminating a lot of barriers. Like it’s not a horrible time to call them back to not only 
consult them, but also to give them the feedback of I just saw, you know, two teenage girls 
back to back who are doing so much better because they’re on their Zoloft. Their Zoloft 
is really helping them. You know, they’ve got their appointment set up. They’ve been on 
medication two months and thanks you guys. I couldn’t have done it without your help 
(102 Suburban; Yes BH). 
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3.7.2 Treatment challenges  
Challenges to treatment of anxiety were discussed included patient/parent level barriers, provider 
confidence in treatment techniques, medication side effects, limited behavioral health providers, 
practice level barriers, and insurance.  
3.7.2.1 Parent and patient barriers  
Several providers discussed patient and parent level barriers, negatively impacted their ability to 
treat patients. Parental acceptance of diagnosis was a major treatment barrier,  
I think the other major barrier is parental. I don't want to say compliance, but, you know, 
some parents just don't want to admit to the diagnosis or deal with the diagnosis. So then, 
getting them to buy into the treatment plans, "Hey, listen, this is what we've got to do," 
and they'll come up with the excuse, ‘I don't have transportation’, or ‘I don’t have time’, 
or they, themselves, have mental health so they can't follow through completely. So, that's 
a huge barrier for these kids (111 Rural; Yes BH).  
Other providers spoke about patients not accepting treatment plans as a barrier, 
…self-medication patients are smoking marihuana, drinking, or doing other things that 
aren’t healthy to treat their anxiety and they’re okay with that. And, don’t want to accept 
other treatments and that’s a barrier that I don’t feel well-equipped to convince them 
otherwise (220 Rural; Yes BH). 
Other providers shared that getting adolescents to go to therapy or to continue going to 
therapy was a challenge. For instance,  
Sometimes you’ll have resistance. People don’t really want to go to counseling. And, try 
to tell parents that these would be things that make the kids anxious for the rest of their 
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lives. If we could get them some, you know, help them in counseling, get them some 
coping skills so that when those things occur – they don’t just fall to pieces again (222 
Urban; No BH).  
Another provider shared that “I mean, I guess it’s just getting kids to continue seeing a therapist. 
A lot of kids don’t want to (106 Urban; Yes BH)”. 
Providers also commented that patients exhibiting anxiety are often highly scheduled 
with activities. Highly active schedules for patients was seen as a barrier to care;  
By the way, all the patients I deal with typically are in activities all year round or they 
swim four hours a day and they're like, "Well, yeah, this is important, but our practice is 
more important." So, getting them to prioritize it and potentially make sacrifices to their 
schedules, which are already jam-packed. Those are usually the patients that need the 
most help is because they are stretched so thin and have so much on their plate that 
they're really struggling with it (109 Suburban; Yes BH). 
Getting the adolescent to come to follow-up visits was also a barrier to treatment. This 
sentiment was shared by five rural providers, as well as providers from urban and suburban 
locals. For example, one provider shared,  
Well, I think big challenges are, as far as compliance, you know, when you can get to see 
the kid back. It’s kind of hard because sometimes parents think, “Well, you’re going to 
see a medical doctor or medical provider,” for something that’s behavioral health and a 
lot of times they’ll make the follow-up appointment but then they don’t come in. So, I 
think compliance is a major issue (112 Rural; No BH).  
Providers with embedded behavioral health providers believe no-show rates were higher 
when adolescents sought care outside of the primary care office,  
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Some families don’t want to come an hour to our office every week to see someone. But if 
they have a community mental health center that’s closer to where they live -- they may 
prefer to just for gas money and time may prefer to do that. So, I think our office has 
better- we’ve informally done studies showing that follow-through was much better when 
we’re referring people to a staff in our office than to people in like community (220 
Rural; Yes BH). 
Rural providers uniquely cited transportation issues are reasons for non-compliance.  
3.7.2.2 Provider barriers  
Providers discussed confidence treating anxiety as a barrier; a sentiment that was not shared by 
providers without an embedded behavioral health provider. Lack of confidence was often related 
to a lack of education,  
Well, I think it’s mostly not knowing the medications, and not having used them, not know 
the major side effects of these medications. So, more PCP education would need to be 
done before I think a lot of us would feel comfortable doing prescriptions of anti-anxiety 
medications (118 Urban; Yes BH).  
One representative quote explains different aspects of treatment that the provider 
speaking, and other providers interviewed felt untrained in,  
And then, a lot of us – myself included – I don’t have specific training on the treatment of 
anxiety. So, eight years out of residency – and when I was in residency, we really didn’t 
do this. And so, I haven’t had any training on what is the best SSRI to pick or how do you 
titrate them, or how do you wean them, or what to counsel families on and just not that 
much experience with that. And then, certainly the more if SSRIs aren’t working, the 
more exotic medicines, we’re dealing with the kids with comorbidity or with anxiety, 
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maybe ADHD – what’s the best way to navigate that? I don’t, and many of my colleagues 
just don’t have the specific training. So, we’re treating anxiety, it’s usually with an SSRI, 
and we’re shooting from the hip. We’re kind of doing our best because we’re willing, but 
as far as being the most knowledgeable, best person to treat a teen with anxiety, I think 
we’re far from that (117 Suburban; Yes BH) 
Lack of confidence was also related to not having experience in treating anxiety. For 
instance, one provider stated one reason other providers might have low comfort in medication 
prescription is due to “perhaps, just lack of exposure, lack of comfort with prescribing those 
medications (222 Urban; No BH).” Other providers spoke about lack of confidence and lack of 
education simultaneously, with one provider sharing [about other providers], “I think probably 
never having the experience of prescribing or really the education or kind of given the roadmap 
(107 Rural; No BH)”. Even with continuing education, one provider who has yet to prescribe an 
SSRI shared,  
I will say, it feels like a big leap…it still feels rather complex to me. The ADHD was easy, 
it’s Ritalin. It gives them all these versions of Ritalin. And, this is four different meds, and 
keep in mind the different side effects and you have to go off slowly and come down 
slowly. I think they’re talking about the black box…I think once I start doing it, I’ll feel 
more comfortable, but it’s hard because it’s a brand-new aspect of care (116 Urban; Yes 
BH). 
A few providers spoke about concerns related to medication safety. For example, a 
couple of providers mentioned worry about the addictive nature of benzodiazepines, “I guess 
where I get a little bit shaky is people want benzodiazepine for anxious, and I think that I get a 
little bit nervous about writing scripts for those things for like, you know, abuse potential of that 
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(114 Urban; Yes BH)”. Other providers commented on why other providers in their office might 
be uneasy prescribing certain medications due to outcome responsibility, 
…they just feel like they’re somewhat responsible if something does happen to go wrong 
especially because of the black box. I think that’s what most providers are afraid of when 
starting on medications. So, if they do happen to, unfortunately, commit suicide or try to 
hang themselves. But, they find out that responsibility also falls upon them because they 
were that person’s primary care provider (105 Urban; Yes BH). 
Another provider shared that while they did not have a high level of comfort prescribing 
medications to treat anxiety, they felt it was important to be able to do it, citing “so, you know, I 
feel like I’m probably only going to get better at this by practice, but my fear is that I’m going to 
damage somebody in the process. You know what I mean? (101 Suburban; Yes BH).” 
3.7.2.3 Limited behavioral health providers 
Several providers spoke about limited amount of behavioral health providers accessible to their 
adolescent patients. For instance, waiting times to see a behavioral health provider (off-site) were 
seen as a barrier to care, “Many people had what they felt like was a more urgent concern, and 
couldn’t be seen for four months or six months, and for someone with a behavioral health 
concern, that’s a really, really long time because a lot can happen in that (115 Suburban; Yes 
BH)”.  
Other providers spoke about limited age-appropriate behavioral health providers in their 
area. For example, one provider stated, “we don’t have- I mean, I’ve had some parents with 
concerns that are not very teen or pediatric-focused. So, parents have not wanted to take their 
kids to the locations where they said they treat addicts (107 Rural; No BH)”. Another provider 
shared a similar concern,  
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I think the biggest barrier or challenge we have is finding people comfortable dealing 
teenagers. You know, there's no doubt in my mind that there's a paucity of qualified 
mental health professionals, that I'm aware of. I'm sure they're out there, but I just don't 
know where they are. I don’t know how to get into contact with them. Nobody wants to go 
down there. That place is full with schizophrenic adults and depressed adults and it's not 
an environment conducive to a teenager who's already anxious (111 Rural; Yes BH). 
Another provider shared both wait time and communication were barriers, “getting 
people in with therapists in a timely manner, communication between therapists if it’s not within 
our practice, and, you know, that would be, I would say, those would be the biggest barriers (119 
Urban; Yes BH).” Communication with outside therapists was seen as a major barrier to 
treatment,  
The Psychological Association in Pennsylvania. We met for over a year trying to figure 
out how to improve at least a psychologist’s interaction with primary care, pediatricians 
and we didn’t get very far. I don’t know what the barrier is, but there are definitely 
barriers on communication [between provider types]. You know, there’s, just like with 
everything, there’s some people that are very good at it, but I’m saying a majority aren’t 
very good at sharing. And, I don’t know if it’s because of the patients won’t sign for the 
psychologists to share or the licensed social worker, I don’t know. But I would say that 
it’s definitely the minority of patients where we get- share information from the CBT 
sessions or whatever (113 Rural; Yes BH). 
Another provider shared their experiences with calling outside therapist to shed light on 
why they felt communication was lacking,  
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I will get a letter when one of my kids or families have been seen at an outside provider. I 
don’t think I’ve ever gotten a call, but I have called a few when there has been a concern 
or something I was worried about. And, the ones I’ve called and talked to seemed very 
surprised that their primary care was even calling. They said that. I don’t think that 
happens very often, so. (221 Suburban; Yes BH) 
3.7.2.4  Organizational- and policy-level barriers  
Only three providers discussed practice-level policies (outside of visit time) as barriers to 
treatment. One provider stated that, 
Part of my preferring it not to be our practice covers [a specific medical unit] and backs 
up [another specific medical unit]…And, so there are days when we’re called in and out 
of the office several times to run over to [larger site] to deal with things. So, if I’ve got 
someone with a more complex problem like that on my schedule -- it’s not easy for my 
colleagues to step in and take over where if they’re there for strep throat. You know, 
that’s a pretty easy thing for someone else to work into their schedule (220 Rural; Yes 
BH). 
Another provider shared that  
We need embedded mental health in a lot of pediatric practices. You have it at 
[organization]. Unfortunately, I don't, so I have to refer my families down to [location] 
and, quite honestly, they don't want to go. I'm at a real disadvantage because I don't have 
somebody yet (111 Rural; Yes BH). 
Lastly, one provider spoke adamantly about the limitations of the primary care office 
hours,  
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We’re not helping them. We’re causing them more anxiety because they have to make 
excuses on why they’re leaving again. “Why do you have to go to the doctor every week? 
What’s wrong with you?” I think that’s absurd that we do not offer evenings in the 
behavioral health model as a PCP. Now, there are a lot of community therapists who do, 
and I think that is the trend of behavioral health. You have to be accessible to make their 
life as normal as possible. And, I feel like that’s a big, big issue…and we’re doing a poor 
job as PCPs at it, and we’re supposed to be leaders of it (104 Suburban; No BH). 
Time and insurance were two barriers to treatment that a few providers discussed. For 
instance, time was seen often as a barrier to education, for example, “Time, not having enough 
education about the medications (118 Urban; Yes BH).” Several providers cited insurance and 
cost challenges for families whose child needs treatment. Providers spoke about insurance 
challenges in terms of therapy coverage, “there’s insurances don’t cover a lot of therapy, or a lot 
of therapists, and finding a child therapist, for instances, is very difficult. (118 Urban; Yes BH)” 
and costs associated with follow-up care, “the follow-ups are pretty expensive. We do follow 
these patients pretty closely just because of their risks associated with having any mental 
disorder (111 Rural; Yes BH)”. 
3.7.2.5 Telephonic Psychiatric Consultation Service Program (TiPS) 
Several challenges to using TiPS were discussed by providers. Overwhelmingly, providers 
viewed the TiPS program as extremely beneficial for identification and treatment processes. Four 
providers expressed challenges faced using TiPS. Related to time limitations, one provider 
described why they have not yet utilized the TiPS line, while acknowledging how it might be a 
useful resource, “it’s just that we are so busy in our day to day activities that it’s very hard to 
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have that as part of our practice care (118 Urban; Yes BH)”. Another provider commented on 
the hours of operation for the TiPS line,  
They’re trying to increase their accessibility to us through a program called TiPS. I don’t 
know if you will put that on there or not, but it just works okay. They’re available until 
4:00 or 4:30, so sometimes we call and it’s too late in the day (115 Suburban; Yes BH).   
This same provider also discussed a process barrier to support from TiPS,  
And sometimes, we have trouble getting our patients in to see their psychiatrist because 
they’d also like them to also see one of their therapists… And so, sometimes we use this 
phone number to ask for help and then can’t really get it because our patients aren’t 
seeing the right therapist. So, I think there’s still some roadblocks (115 Suburban; Yes 
BH). 
Lastly, one provider stated that limited ability to support patients with varying insurances was a 
barrier to using the TiPS line,  
The barrier there is they only see limited insurances, you know, which is sort of 
frustrating and I hate to say that is a cop-out -- but that always gets in the way. When you 
have a nice resource, a nice service and, oh, you can't use them for this person. It's kind 
of the price you pay for doing medicine. But, that's a huge one (111 Rural; Yes BH). 
3.8 ANXIETY SPECIFIC EDUCATION AND TRAINING 
Providers discussed types of mental health training they received throughout their formal training 
years (i.e., residency and fellowships). Only a few providers recalled having specific training on 
pediatric anxiety. For example,  
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…I think anxiety was part of it because as you can see a lot of that manifests as physical 
symptoms – so, headaches, or bellyaches, etc. My psychiatric rotation, because we only 
did inpatient, it was more major depressive disorder like these kiddos were, you know, 
suicidal…had other more significant bipolar too or things like that (108 Rural; No BH).  
For the majority of providers, formal training for pediatric anxiety in residency and 
through fellowships was limited to non-existent. For instance, one provider shared that while 
they had some specific training, there should be more of an emphasis on anxiety due to 
prevalence,  
Very little. This is something and it's sad because it’s something that was not focused on. 
I guess, it was maybe a class or two. I'm a nurse practitioner, so my pediatric rotation 
was very short and brief. So, I had it for a semester along with general pediatrics and I 
had a semester of a rotation in pediatrics. So, maybe one or two classes was focused on 
depression and anxiety, but besides that -- I'd say my education as far as formal 
education on it is very little as far as schooling goes. That's another aspect. I think needs 
to change as well. I don't think there's a lot of focus on this but it's much more common, I 
feel like than it has been before. So, I think more focus needs to be placed on it (110 
Suburban; Yes BH). 
Other providers mentioned training they received for anxiety was not specific medical 
management, “…I mean, I’m sure we had some education on ADHD and kind of the medical 
management with that. But, really not a lot of training necessarily with medical management 
anxiety for sure. Identifying the symptoms of anxiety maybe (119 Urban; Yes BH)”. 
Providers who did not receive formal education on adolescent anxiety stated,  
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(1) I know with NP, pediatrics in general was- I don’t think that we hit on adolescent 
mental health at all. I mean, aside from ADHD and oppositional defiance, that kind of 
thing…and then, mental health classes were all adult-based mental health (112 Rural; 
No BH); and, 
(2) Well, I’m old so I can tell you no. That was in the 80s, I can tell you there was- I don’t 
remember having- I think behavioral health, I think we got maybe a two to three-month 
block but 90% was ADHD and that’s pretty much all we got (113 Rural; Yes BH). 
In terms of education after residency and fellowships, only two providers stated that they 
had not received any anxiety specific continuing education. Several providers expressed that they 
have received anxiety specific training after residency and fellowship. For example, one provider 
shared, “I would say a decent amount through some workshops either namely through 
[organizations], some ADHD workshops, and then specifically managing depression, and 
anxiety, and diagnosis and management (119 Urban; Yes BH)”.  
Another provider notes multiple avenues of continuing education they received, similar to 
what other providers mentioned,  
I mean, through [organization], we’ve had a two-hour lecture back in the fall on like 
SSRI roadmap, the doctor’s luncheons. And then, I’ve gone to the TiPS conference and 
called them quite a few times. And, they give us a specific roadmap started this dose and 
then a week or two later increase. So, that has been super helpful for me. And, I don’t 
think everyone in my office or other primary care providers have had that experience. 
(107 Rural; No BH) 
A few providers spoke about education and support received from their on-site behavioral 
health provider. For example, one provider stated, “I’m lucky that I have a child psychiatrist in 
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my office. So, if I am uncomfortable with a situation where I have to guide medication therapy -- 
sometimes I will discuss it with them. (118 Urban; Yes BH)” Another provider spoke to the 
support benefits of having embedded mental health in primary care,  
I mean there’s a role out of having psychiatry and therapists within the practice. There’s 
been a lot of education. And, just within the last year, you know, there was a big medical 
meeting which really the focus of that was -- “Look how far we’ve come..” And, I think 
that’s kind of where I’ve felt, you know, a little bit more power because a lot of that 
discussion in that meeting was about taking over. Or, knowing that you have psychiatry 
back up within the office -- but taking a more active role in diagnosis…and prescribing, 
and managing medically (119 Urban; Yes BH). 
 Lastly, one provider mentioned how their practice is trying to leverage their embedded 
behavioral health specialist to provide on-going education for staff,  
We also, in our own office, are trying to get [Provider], our counselor to give us her 
own- just hearing little talks, education talks to the staff and us about what her role from 
a counseling standpoint on these specific mental health issues. So, it's kind of an ongoing 
focus we're trying to augment. But, that's kind of where we're at now with that (109 
Suburban; Yes BH). 
Almost half of the providers discussed what types of education they would like to have in 
the future specific to adolescent anxiety. Only one provider stated the opposite,  
I think we’re flooded with it now, to be honest with you. I mean, it’s a hot topic and over 
the last ten years, there have been ample opportunities to be trained on how to manage 
this, at least, in… So, I think- I don’t think we need any more (113 Rural; Yes BH). 
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For providers who discussed wanting more education, topics focused on screening, 
therapeutic treatment techniques and medication management. Providers focused on non-
medication related topics wanted to learn more about “… like the initial counseling piece. We 
certainly don’t have the time to be doing all that the therapist can do, but maybe if there were 
other pieces from a non-medication standpoint, that would be helpful. (221 Suburban; Yes BH)”. 
Other providers spoke about “talking about ways to identify it, talking about the SCARED or 
other potential screens (103 Urban; Yes BH)”. In a representative quote, one provider spoke to 
how certain educational topics could support overcoming identification barriers, 
I think certainly, as I alluded to time and reimbursement are our biggest barriers -- so, I 
think if someone can make me more efficient at how to diagnose, explain, and sell the 
idea probably most importantly sell the idea that someone is anxious to a family and then 
efficiently have the ability to explain treatments -- I would appreciate that and certainly 
these complimentary treatments like mindfulness, and relaxation techniques, and other 
things. (220 Rural; Yes BH) 
For provider who discussed wanting to learn more about medication management, topics 
focused mostly on the basics, as one provider stated, “Me, specifically, it would be on treatment. 
It would be on the basics of which medicine is the best for which kind of kid, and which side 
effects, monitoring parameters and weaning parameters (117 Suburban; Yes BH)”. Another 
provider shared more details on what educational basics are needed,  
I think the most important – most of us I believe can identify anxiety that is concerning 
enough to require therapy…But also more about the medications that are out there. 
When we would specifically use them, how we would increase their dosage, how we 
would wean them off. What labs might be needed prior to giving that certain medication 
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and would there be labs that needed to be done during medication? Things of that nature 
I think would help us be more apt to prescribe medication if necessary. (118 Urban; Yes 
BH) 
Providers also discussed how they would like to receive education. Modalities included 
modules, case studies, online PowerPoints, recordings, and lunch and learns. One provider sated 
that it might be helpful to have a lunch and learn focused on cases, 
…treatment, medicine-wise what would be not so much like an algorithm but kind of like 
if you try this and this doesn’t work then move on to this if this doesn’t work. Or, different 
medications to affect different symptoms. So, if a child is having anxiety and nightmares, 
what can we use for that versus a child that’s having anxiety and doesn’t want to eat or- 
for example. (112 Rural; No BH) 
In contrast to short training options, one provider stated, “So, education as far as 
medication goes, but I don’t think short tiny lectures. I think it would be a longer process to get 
really good at what you are doing. (115 Suburban; Yes BH)”. Another provider shared that 
while they went to half day sessions on anxiety and or depression put on by the American 
Academy of Pediatrics, the content was not specific to primary care, and therefore the provider 
found them “a little less useful (220 Rural; Yes BH)”. 
Overall, a majority of providers could not recall in-depth formal training on the 
identification and treatment of pediatric anxiety. Many providers discussed reviewing continuing 
education in the form of lectures, lunch and learns, and conferences that has specific educational 
sections regarding pediatric anxiety. Several providers shared what information they would like 
to learn more about with regards to screening, therapeutic treatment techniques and medication 
management. 
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4.0  DISCUSSION 
Understanding how different factors influence primary care provider’s capacity to both identify 
and treat adolescent anxiety is vital to understanding how future research and policy efforts can 
support improved identification and management of adolescent anxiety and support appropriate 
treatment guidelines. Specific to adolescent anxiety, this chapter discusses perceived capacity 
and responsibility primary care providers have regarding both identification (starting with ability 
to recognize signs and symptoms) and treatment. Barriers and facilitators to provider capacity are 
presented, along with recommendations based on available data. Moreover, perspectives and 
knowledge of three experts (a public health professional; a behavioral health provider; and an 
organizational expert) are presented throughout this chapter to aid in the interpretation of results 
and/or to provide a larger frame of context to the problem.  
4.1 IDENTIFICATION OF ANXIETY 
4.1.1 Signs and symptoms  
A major factor in identifying anxiety is understanding common signs and symptoms of 
adolescent anxiety. Primary care providers overwhelmingly endorsed familiarity with signs and 
symptoms of anxiety that align with literature. Approximately three fourths of providers 
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discussed somatic physical health complaints24 and all providers noted specific mental health 
complaints24,26 as flags that may indicate anxiety. It is an encouraging finding that a majority of 
providers discussed somatic symptoms as such symptoms are often a key reason anxiety is 
underdiagnosed.64,90 It is also important for primary care providers to understand physical 
manifestations of anxiety disorders as somatic symptoms are often the chief complaint sending a 
youth to the primary care office,5,9 and driving needless medical testing.5,38,41  
Providers also discussed adolescent social and scholastic habits/impairments as anxiety 
warning signs. Half of providers stated poor scholastic achievement or decreased participation in 
extracurricular activities as signs of anxiety. Such impairments are clearly presented in anxiety 
literature including decreased scholastic performance,1,5 increased missed days at school,5,9 and 
negative impairments with familial and peer relationships.1,28,29  
Interestingly, half of providers also described high-functioning adolescents (those highly 
engaged in studies or extracurriculars) as being at risk for anxiety. Often, providers linked 
aspects of daily living, including social and scholastic functioning, to physical health symptoms 
(example: headaches to bullying/issues in school) or to mental health symptoms (example: worry 
to high personal/familial expectations for performance excellence). Since a hallmark 
characterization of anxiety includes fears24,25 (e.g., daily life routines25; social situations24,25),  
and worry/negative thoughts,24,26 they may be identifying a connection between high-functioning 
youth, high-expectations, and increased worry.   
4.1.2 Sources of identification information   
Providers noted several sources of information they rely on to learn about key signs and 
symptoms of anxiety, namely patient-provider conversations, parental report, in-visit cues (e.g., 
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affect, nervousness, being withdrawn or engaged, interactions with parents, and body language), 
and a couple of providers mentioned using results of systematic screeners validated for 
depression identification. It is encouraging providers utilize multiple sources to identify anxiety 
concerns within the time constraints of a visit, however sole reliance on patient/parent report of 
anxiety as the chief complaint is cautioned as adolescent/parent may not know which feelings to 
share with providers, and less than half of parents will discuss mental health conditions with 
primary care providers.66 Furthermore, the behavioral health expert shared that youth with 
anxiety are different from those with ADHD or depression in that their symptoms are often 
“silent” and cannot always be seen on the outside; especially in time-constrained visit. 
4.1.3 Systematic screening 
Providers were all familiar with systematic screening for behavioral health conditions as all 
practices in this sample have patients’ complete substance use and depression screens prior to all 
well-child visits. None of the providers interviewed had used anxiety screens in a systematic 
way, with seven providers disclosing never using an anxiety screener. For the seven providers 
with no experience utilizing an anxiety screening tool, multiple reasons were cited including not 
knowing such screens exist, length of time it takes to complete and score, and/or a focus on 
acquiring knowledge though other sources of information. 
Providers who had used an anxiety screen (i.e., SCARED tool) reported using the tool 
only after they had an indication anxiety may be a concern. Providers used SCARED results 
mainly to support conversations with parents/patients in condition denial and/or to specify 
type/severity of anxiety. Utilizing screening results to discuss behavioral health conditions with 
patients/families may be even further supported if the screening is universal, as a non-anxiety 
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specific study by Hacker et al found providers felt the universality of screening tools supported 
the normalization of behavioral health discussions.113  
As the SCARED is more diagnostic in nature (assessing type/severity as opposed to 
general presence of an impairing condition) it seems appropriate providers use the tool to specify 
type/severity of anxiety instead of utilizing it as a mechanism to initially identify anxiety as a 
concern.  However, the diagnostic nature of the SCARED may be one reason providers are wary 
of using it in the first place. The public health professional expert shared PCPs are likely to be 
less comfortable with diagnostic screens compared to more general identification screens.  
Specifically, the organizational expert corroborated the sentiment of moving away from 
diagnostic tools in primary care for anxiety. This expert discussed how TiPs is focusing PCP 
education away from identifying types of anxiety to identifying when anxiety (of any kind) is 
causing impairments requiring intervention. If this is the case, a non-diagnostic screen would be 
more useful for primary care providers when trying to identify adolescent anxiety. 
Half of the sample believed a routine anxiety screen would be helpful, with some 
providers discussing (1) the importance of a routine anxiety screen because the routine 
depression screen does not adequately pick up on anxiety, and/or (2) anxiety is just as prevalent 
as depression and therefore should be screened for in a similar manner. To the second point 
made by providers, according to the literature, anxiety is more prevalent compared to 
depression.4 The addition of a short, routine anxiety screen was seen to be beneficial, as it would 
support PCPs in recognizing symptoms. Providers who were not in favor of a routine anxiety 
screen preferred to use anxiety screens with patients who indicated need. Again, it appears 
providers are focusing on existing anxiety screens as diagnostic tools rather than tools (or future 
tools) that can be used to identify anxiety in the first place.  
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Confusion over the purpose of a routine anxiety screen was evident. Two experts 
interviewed on this topic had slightly differing opinions regarding routine screens for anxiety. 
From the public health professional perspective, a generic, non-diagnostic behavioral health 
screen may best support mental health identification in primary care, as there could be a 
multiplicity of behavioral health concerns for any patient, including anxiety. This idea could 
support decreasing the number of behavioral health routine screens patients have to fill out and 
providers have to score. From a behavioral health provider perspective, primary care providers 
are likely to adjust to a one-page easy to score routine screen for anxiety prior to well-child 
visits. 
While there is no evidence in the literature about how systematic screening for anxiety 
may increase good clinical outcomes, the American Academy of Pediatrics Task Force on 
Mental health did find using validated mental health screeners for depression and other non-
anxiety conditions was useful.34 Even though providers know symptoms of anxiety and use 
multiple sources of information to support the identification process, anxiety (and depression) 
are  underdiagnosed 20 to 30% percent of the time.28 It may be likely a short, systematic general 
anxiety screener would support increased identification of anxiety and reduce provider reliance 
on connecting known or unknown patient risk factors112 to anxiety. 
4.1.4 Role perceptions 
A primary goal of this study was to understand provider perceptions regarding their role and 
responsibility for identifying anxiety in primary care. Overwhelming, providers perceived they 
did have a role in identification of anxiety, along with other mental health conditions. This 
finding supports data from the 59th Periodic Survey conducted by the American Academy of 
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Pediatrics, showing 80 to 90% of providers felt they had a responsibility to identify anxiety, 
depression, substance abuse, behavioral issues,  and 90% felt responsible for identifying ADHD 
and eating disorders.62 Main reasons providers gave as to why it is part of their professional role 
to identify anxiety included high prevalence rates, symptom severity, being the first point of 
contact with the medical system for patients, and being a trustworthy provider. The 
organizational expert also perceived identification of anxiety as part of a primary care providers 
role as this condition has a physical health component to it.  
Several providers shared that some PCPs viewed their role in mental health identification 
as being the first line provider who can identify a mental health concern in order to refer the 
patient out to a behavioral health provider who can provide an exact diagnosis. Interest levels, 
limited training, and visit time constraints were three reasons several providers shared as to why 
other providers may not be as comfortable identifying anxiety or may not address it as regularly 
as they themselves do. 
Several providers commented that referring adolescent patients to outside behavioral 
health specialists may not be the best route of care as adolescents may be uncomfortable with a 
new setting and or will get lost in the system. Almost half of the sample, including four of the 
five providers without embedded behavioral health providers, expressed the idea that adolescents 
were more likely to be comfortable continuing care for their condition in primary care and/or 
would actually receive the care necessary compared to if the patient was referred to an outside 
specialist. The notion of follow-up after identification was presented as a barrier to treatment by 
providers and the public health professional expert. This expert expressed similar concerns; 
referrals to outside community behavioral health providers may limit the PCPs ability to know if 
the appointment was conducted and/or receive information about ongoing treatment plans 
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through bi-directional communication. The literature highlights low communication between 
primary care and mental health providers,182 although promising models to facilitate increased 
communication are being designed and implemented.183  
4.1.5 Identification facilitators 
Providers discussed several facilitators to identifying adolescent anxiety in primary care. At the 
individual-level, providers discussed how disclosure of anxiety symptoms (or explicit disclosure 
of anxiety) from either patients or parents was helpful. A few providers also discussed the 
concept of co-learning; the idea that learning from peers with subspecialty expertise increases 
their own level of identification comfort. This interpersonal learning factor could be fostered as 
part of a practices’ “culture”; for both practices with embedded behavioral health providers and 
those without.  
At an organizational-level, providers shared three major identification facilitators. The 
presence of an embedded behavioral health provider was seen as a facilitator as PCPs reported 
increased ease of patient referral and ease of bi-directional communication compared to working 
with outside behavioral health providers. Several providers also spoke about the culture within 
their practice as being a model valuing mental health staff and how that translated into increased 
value of mental health concerns for the patient population. Providers also offered having 
embedded behavioral health providers as proof their organization values mental health care in 
primary care settings. Lastly, a few providers specifically discussed how different continuing 
education trainings (formal and non-formal) have allowed them to feel more equipped to 
recognize anxiety and utilize the SCARED screen.  
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Several providers commented on one policy-level factor, the TiPs program, as supporting 
their capacity to identify anxiety as well as other behavioral health concerns. The TiPs program 
supports any primary care provider in the state of Pennsylvania caring/providing services for 
patients with medical assistance. Providers shared TiPs supports the identification of anxiety by 
providing them with case-based recommendations for additional screening questions to ask as 
well as recommendations for next steps.  
4.1.6 Identification barriers 
Regarding barriers to identification, providers discussed organizational-level and individual-level 
barriers. At the organizational level, providers noted how time constraints within a visit was a 
barrier to identification as it impacted their ability to identify anxiety and also limited their 
ability to give anxiety the time it “deserves” due to competing health priorities.  
Providers discussed challenges with both patients and parents at times not being open and 
honest about behavioral health concerns/symptoms. Specific to anxiety, providers shared 
patients/parents sometimes have difficulty accepting anxiety and/or anxiety symptoms as a 
mental health condition. Even though primary care offices are perceived as being less 
stigmatizing compared to traditional mental health settings for receiving treatment,2,56,75,76 this 
data supports that on an individual-level, there is still stigma associated with having anxiety 
resulting in the form of patient/parent denial or non-acceptance (the adolescents feeling are 
typical).  
Parents/patients may perceive the adolescent’s symptoms as “typical” because, as our 
organizational expert shared, the adolescent may have some resiliency factor allowing them to 
function at a heightened level, while still suffering from anxiety. Increased training on how to 
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support communication between PCPs and patients/parents when introducing an anxiety 
diagnosis, or attributing somatic symptoms to anxiety is recommended. As mentioned 
previously, the presence of a universal anxiety screen may support both PCPs in identifying 
anxiety as a concern, and also support de-stigmatization of the condition when first bringing it up 
to the family/patient.  
Providers also discussed that a major barrier to the identification process was what 
happens after the adolescent is identified as having anxiety. Providers shared challenges to 
treating anxiety may negatively impact a PCPs comfort level of identifying anxiety. The idea of 
not knowing what to do after identification and or feelings of being uncomfortable with 
treatment options was also discussed by the behavioral health expert who shared primary care 
providers may not want to “open up a can of worms” during a twenty-minute visit if they are 
unclear on how to handle the next step. This expert believed this may be especially true for 
providers without an embedded mental health provider as they are not able to do a warm hand 
off at the moment anxiety is identified.  
Neither lack of clinical guidelines nor lack of efficient screening tools were mentioned 
explicitly as barriers to identification. The inclusion of clinical guidelines for identification of 
adolescent anxiety and the treatment of anxiety may support the use of validated screening tools 
as well as support providers in knowing what to recommend as next steps after anxiety is 
identified. Recommendations regarding clinical guidelines are discussed in the conclusion 
chapter as guidelines are needed for both identification and treatment of anxiety. 
Discussion around capacity for identification was relatively concise likely because 
providers overwhelming reported similar feelings of role responsibility with limited concerns 
regarding their capacity. Secondly, providers often focused on barriers to treatment after 
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identification of anxiety had occurred. Challenges thinking about next steps in the process were 
corroborated by the public health professional sharing, if a provider screens and finds something, 
they have to do something about it. Factors related to provider capacity to treat adolescent 
anxiety are presented below. 
4.2 TREATMENT OF ANXIETY  
4.2.1 Role perceptions 
While providers were inclined to view anxiety identification (and identification of other mental 
health conditions) as part of their professional role, feelings of role responsibility and comfort 
levels for the treatment of anxiety varied greatly. Providers overwhelming perceived talk therapy 
(i.e., cognitive behavioral therapy) as outside their purview as mental health providers have 
specific training to properly utilize such treatment techniques and have dedicated time in 
appointments to do so. This sentiment was not surprising as cognitive behavioral therapy is not 
commonly used in primary care settings.117 However, basic counseling, such as advice or small 
coping techniques were discussed by a few providers as something they felt they were able to 
provide to their adolescent patients.  
The majority of providers disclosed having prescribed medications for anxiety treatment 
in the past, namely SSRIs. Several providers also discussed not prescribing benzodiazepines due 
to negative associated risk factors and/or being less familiar with that medication class. 
Prescription uptake of SSRIs is an important exploratory finding as past studies often combine 
both anxiety and depression into the same category when reporting treatment types used. For 
 127 
example, a study by Ford et al., found that 50% of a sample of urban pediatricians treated 
depression and anxiety with SSRIs.75 Separating treatment decisions and comfort prescribing 
SSRIs between depression and anxiety is recommended for future studies as FDA regulations 
and side effect warnings may play different roles in PCP prescription decision making.  
As providers discussed medication treatment for anxiety, differences in role perceptions 
were highlighted. Several providers viewed their role in medication treatment as purely 
“initiative”. For example, some providers felt a responsibility to start medication treatment while 
patients wait to get an appointment with a behavioral health provider. This viewpoint may be 
critical for decreasing treatment delays as certain areas in Pennsylvania face limited availability 
of age-appropriate mental health providers,126 long wait times for mental health 
appointments,71,85,56,75 and/or may not have an embedded behavioral health provider onsite.  
A couple of providers preferred patients to first seek talk therapy (via PCP referral to a 
behavioral health provider), and if medication treatment was indicated by the other provider, that 
consultation would likely fall into the PCP purview. On the other hand, more than half of 
providers viewed their role as both starting and managing medication treatment. For providers 
with this viewpoint, many discussed if the adolescent was not responding to medication 
treatments or was a complex case, they would refer the adolescent to a behavioral health 
specialist for long-term management. The organizational expert shared that while there is not a 
national expectation that primary care providers manage anxiety treatments, focusing on 
increased education around medication prescription was a beneficial endeavor; one that is 
already occurring for many provider groups represented in this sample.  
Lastly, providers spoke about other providers whom might not be as comfortable with 
treating anxiety as they, themselves are. While insights about other providers are subjective, they 
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shed light on a population of providers who are likely different from those who agreed to 
participate in this study. Providers placed great emphasis on how low levels of confidence with 
medication treatment and or limited experience with anxiety play a major role in low comfort 
levels with treating adolescent anxiety. One provider shared a sentiment that medicine is not 
taught “perfectly evenly”, and that they believe if a provider does not have a lot of experience or 
interest in certain areas of medicine, they should not be obligated to treat that condition, be it 
physical health or mental health related.  
4.2.2 Treatment facilitators  
Providers noted several factors supporting their capacity to treat anxiety in primary care settings. 
At an individual/interpersonal-level, providers discussed co-learning as a technique to increase 
their confidence creating and implementing treatment plans. At the organizational-level, 
providers viewed having an embedded behavioral health provider within their practice as a 
tremendous asset in terms of access to therapy, bi-directional communication, and even co-
learning. From a policy-level, providers overwhelming discussed the benefits of TiPs in 
supporting them with medication initiation and management, as well as providing them with a 
“safety net” when they have case specific questions that surpass their training or comfort level. 
All facilitators for treatment were mentioned by providers as facilitators for identification; 
having similar capacity building factors may be important as centralized processes and resources 
may decrease provider burden when looking for support.  
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4.2.3 Treatment barriers 
Multiple barriers to treatment were presented by providers. At the individual-level, two main 
barriers were discussed. First, parental/patient acceptance of treatment, willingness to attend 
therapy, and ability to attend treatment appointments were presented as barriers. Willingness to 
accept treatment was tied to acceptance of an anxiety diagnosis. As discussed previously, 
supporting providers in introducing an anxiety diagnosis is critical to increasing their capacity to 
treat the condition. Secondly, transportation to and from appointments (primary care or 
behavioral health care) was cited a barrier to treatment compliance by rural providers. This 
barrier is present in the literature for healthcare in general in rural locales.132   
Three factors at the organizational-level were discussed and are limiting factors 
associated with treatment capacity. Providers discussed how not having an embedded behavioral 
health provider is or would be a barrier to providing treatment. For example, providers shared   
that no-show rates for appointments with community behavioral health providers may be higher 
compared to appointments with embedded behavioral health providers. Secondly, time was 
viewed as a barrier as providers spoke about how the length of the office visit was inadequate to 
properly educate patients/parents about treatment medications. A small number of providers also 
discussed limitations with their practice’s office hours, sharing that typical primary care office 
hours do not align with adolescent patient schedules. A couple of providers mentioned cost 
challenges families may face when it comes to treatment; specifically, in terms of coverage for 
therapy, or being able to come back for another visit.  
While only one provider discussed reimbursement for time spent on mental health as a 
barrier to care, other providers did mention limited time in well visits for discussions of mental 
health as a barrier. Moreover, this one provider discussed how they could add a “modifier” to a 
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well visit if a mental health condition was uncovered, but that code incurs the family an extra 
charge, and therefore they do not add that code onto visit. As health care systems transition to 
value-based models (instead of fee-for-service models) efforts are being made to reduce 
traditional reimbursement barriers for “behavioral health specialist consultation, care 
coordination, or physical and mental health services provided on the same day.”184 Other efforts 
are also trying to better accommodate integration of behavioral health into primary care 
including the Mental Health Parity and Addiction Equity Act, Medicaid expansion, and the 
implementation of patient-centered medical homes.184 Further, multiple recommendations have 
been put forth in a joint paper by The American Academy of Pediatrics (AAP) and the American 
Academy of Child and Adolescent Psychiatry (AACAP) that would breakdown billing barriers 
for primary care physicians.35   
From a policy-level, providers discussed two major barriers to treatment. The first being 
lack of accessible and age-appropriate mental health providers in their area. This barrier was 
shared by the behavioral health expert as well, specially focusing on how this barrier is a major 
concern for rural primary care providers, especially those without embedded behavioral health 
providers. Shortages of behavioral health providers in Pennsylvania have been reported by both 
the Health Resources and Services Administration and the American Academy of Child and 
Adolescent Psychiatry.79,86 Moreover, even when connected to an outside mental health provider, 
providers discussed communication regarding on-going treatment as limited to non-existent. 
Residency programs and organizational policy makers should focus on ways to increase the 
number of mental health professionals in this region and focus on multiple-pronged approaches 
to support the incorporation of embedded behavioral health providers in primary care practices.   
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One method of connecting PCPs to behavioral health providers is the Pennsylvania 
Department of Human Services TiPs program.87 The TiPs program has been overwhelmingly 
seen as an asset to the expansion of primary care providers capacity to treat adolescent anxiety. 
Only four providers discussed specific challenges associated with TiPs. With regards to time-
based limitations, both the hours of the TiPs operation and the limited time in PCPs schedules to 
call TiPs were seen as barriers. One provider expressed frustration with the policy that patients 
had to see the TiPs therapist in order to be scheduled with a psychiatrist; creating a roadblock for 
patients already seeing a non-TiPs therapist. Another provider shared concerns with not being 
able to utilize TiPs resources for all their patients due to insurance limitations associated with 
TiPs. As the program can be only utilized for patients with Medical Assistance (Medicaid; PA 
HealthChoices),87 expansion of insurance coverage would support the capacity of PCPs in 
treating anxiety for their entire patient population.  
A few providers commented on the safety implications of medications used to treat 
anxiety as a barrier. One provider shared that PCPs who are uncomfortable with medication 
treatment may be concerned with being responsible if an adolescent harmed themselves (e.g., 
suicide) and this specifically was referring to concerns over the FDA black box warning for 
SSRIs. The fragility of prescribing processes was further highlighted by the public health 
professional who shared that it only takes one patient with a negative reaction to an SSRI to 
make a provider feel uncomfortable with prescribing. Concerns over patient safety in relation to 
medication prescription for anxiety may be negatively impacting providers’ capacity to deliver 
medication treatment in primary care. Interestingly, a study found that over an 14-month 
(approximately) period post the 2004 black box warning, that patterns for new prescriptions for 
antidepressants (including SSRIs) for youth did not change for primary care providers.185 
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Obtaining FDA approval for medications that can be used to treat anxiety (not including 
OCD) is recommended, as appropriate guidance may support increased prescribing confidence. 
Based on the provider interviews and discussions with both the public health professional expert 
and organizational expert, it can be surmised that providers may feel more comfortable 
prescribing SSRIs for anxiety if they have proper training in residency, treatment guidelines to 
follow, and feel comfortable and empowered to manage the condition. Moreover, guidelines for 
treatment may be further necessary to provide a certain level of expectation regarding symptoms 
improvement as medication treatment efficacy increases over time, with data showing increased 
response rates at 36 weeks (82%) compared to response rates at 12 weeks (55%).186  
4.3 PROVIDER EDUCATION  
Training and knowledge were two factors affecting primary care providers’ capacity to identify 
and treat anxiety. For the majority of providers interviewed, anxiety specific training/education 
was limited during formal residencies and fellowships. During their practice years all but two 
providers said they had received anxiety specific training through various forms of continuing 
education. Providers with embedded behavioral health providers also commented on how these 
embedded providers supported their growing level of knowledge as they are able to discuss 
uncomfortable treatment cases with them.   
While the majority of providers are in a resource rich environment, including having the 
presence of embedded behavioral health providers and access to the TiPs line, almost half of the 
providers shared interest in learning more about adolescent anxiety. Topics of interest specific to 
anxiety included screening, how to converse with patients/parents regarding diagnosis and 
 133 
treatment, therapeutic treatment techniques and medication management. Specific to medication 
management, providers asked for increased education on which medications to use, when to 
use/switch medications, medication side effects, and monitoring parameters.  
Providers also discussed the formats in which they would like the education presented 
including lectures, lunch and learns, and conferences. It appears that while lectures are used 
frequently as an educational format for continuing medical education,187 it is not as effective as 
interactive/skill practicing educational formats when modifying provider practice.188 However, 
results from a systematic review found that effectiveness is greater when educational formats are 
combined (interactive and didactic formats).189 Different and frequent education formats are 
recommended to increase provider capacity for identify and treating adolescent anxiety.  
4.4 LIMITATIONS  
While results have limited generalizability due to the non-representative sample, we did achieve 
our aim of finding what factors influence primary care providers’ capacity to identify and treat 
adolescent anxiety. Self-selection bias must also be considered. Approximately 13% of eligible 
providers expressed interest in the study, with 11.6% completing the interview. It is likely that 
providers who expressed interest in the interview were somehow different from providers who 
did not (i.e., increased interest in the topic; interested in research; timing was appropriate). 
However, interviewees commented on their peers and therefore widened the perspective to 
include information about providers who did not participate. In order to obtain the largest sample 
possible, recruitment occurred through a provider-trusted research network that has routine 
contact with providers regarding various research endeavors. Anecdotally, staff conducting the 
 134 
recruitment believed the number of participants who responded to the invitations was higher than 
anticipated.  
As with any research study collecting self-report data, this study was subject to social 
desirability bias.190 As a trained interviewer, the PI sought to reduce this bias by utilizing rapport 
building techniques while also remaining professional; allowing for the facilitation of an open 
and non-judgmental environment.191 Providers were very open and honest about their beliefs 
regarding identification and treatment responsibilities. For example, some providers shared 
information regarding personal comfort levels, lack of screening tool use, and beliefs that not all 
youth with anxiety are being picked up on. Finally this study was subject to another limitation 
typically present in qualitative research, researcher bias.192 Using the qualitative principle of 
reflexivity, the PI  noted their attitudes and beliefs throughout the research process.192   
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5.0  CONCLUSION 
Limited research has been conducted specifically on adolescent anxiety in primary care settings 
despite clear evidence of the disorders’ prevalence, acute and long-term negative health effects, 
and primary care being an apt setting for both identification and treatment. This exploratory 
study adds to the existing body of mental health research in primary care by providing insight 
into primary care providers’ capacity to identify and treat adolescent anxiety. Moreover, results 
from this study begin to fill-in four evidence gaps specific to the “gold standard” criteria for 
disease screening put forth by Wilson and Junger.154-157 The overall purpose of the disease 
screening framework was to identify conditions that merit screening. Four criteria gaps for the 
screening of adolescent anxiety were identified prior to the study. Table 8 summarizes how study 
results expand the evidence base for each of the four criteria.  
Table 8. Results in Relation to Wilson and Jungers Disease Screening Framework 
1 
The condition 
sought should be 
an important health 
problem. 
Results from this study support the notion primary care providers do view 
adolescent anxiety as an important health condition. Specifically, 
providers understand the relative prevalence of anxiety as well as the negative 
health effects associated with the condition. It is unclear if providers view 
the negative consequences of anxiety as severe as those associated 
depression, as providers in this study and the experts interviewed placed great 
importance on prioritizing self-harm (associated with depression). Negative 
impairments associated with untreated anxiety should be discussed with 
primary care providers as this information may provide supporting evidence 
to increase prioritization of anxiety.  
2 
There should be an 
accepted treatment 
for patients with 
recognized disease. 
While effective pharmacological and talk therapies exist for anxiety, primary 
care providers vary regarding their role in treating anxiety and their 
capacity to provide appropriate treatment. Even though the majority of 
providers in this sample have prescribed an SSRI, they believe other providers 
see their role in treatment as identifying the concern and referring the patient 
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to a specialist. Moreover, not all providers in this sample who had prescribed 
SSRIs believe that was their responsibility to provide medication treatment for 
anxiety. Key challenges to having medication treatment be part of the 
primary care provider role included, time, limited experience/education, 
concern over medication side effects, and interest levels.  
4 




Providers in this study were aware of and had a professional responsibility 
to recognize common presentations of anxiety. Providers utilized multiple 
sources of information to support the identification process. However, 
impairment from anxiety may not be disclosed by the patient/parent and or 
may not be noticeable during a primary visit. As such, it is likely providers 
are not identifying all youth with anxiety. It is also important to note that 
the longitudinal aspect the PCP-patient relationship may allow these providers 
to have more context into the patient’s history (missing school, stomach aches, 
ect) thereby affording them the opportunity to witness early signs of anxiety.    
5 
There should be a 
suitable test or 
examination. 
The majority of providers had knowledge of specific tools available for 
screening anxiety, namely the SCARED. Providers discussed many barriers to 
utilizing the SCARED including time, form fatigue, and scoring difficulties. 
Moreover, this tool is diagnostic in nature, and was often used after a provider 
already had an indication the patient is experiencing anxiety. Research is 
needed to understand what type of screen would be most beneficial to 
primary care providers in identifying anxiety such as the GAD-7 or the 
SCARED-5.  
 
Results of this study also showcase the connection between primary care providers’ 
capacity to identify and treat adolescent anxiety. While providers overwhelmingly believe it is 
their role to identify anxiety, many were concerned with what happens after identification 
occurs. Specifically, providers in this sample had a range of perspectives as to what their 
professional role was in treating anxiety (referrals vs medication management) and their comfort 
level with various treatment options (talk therapy vs medication prescriptions). Providers 
expressed multiple barriers when referring patients to behavioral health providers, and also when 
providing medication treatment to patients. Treatment hesitancy/comfort may be linked to the 
finding that primary care providers are split when it comes to the idea of systemic screening; if 
systematic screening is instituted, providers would have the responsibility to determine a 
treatment plan for patients screening positive for anxiety. While the makeup of the treatment 
Table 8 Continued 
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plan would likely vary (referring and connecting to a specialist, providing medication 
treatment/management, or a combination of the two treatment approaches) the need for such a 
plan would be necessary.   
5.1 FUTURE RESEARCH  
Supporting providers in understanding their roles in anxiety treatment and best practices for 
identifying and treating anxiety is necessary given the prevalence of anxiety, the associated 
morbidity, and a clear lack of age-appropriate mental health specialists. Clinical guidelines 
standardizing both adolescent anxiety identification and treatment processes in primary care is 
needed to support primary care providers in feeling equipped to handle the condition and support 
consistency among providers regarding professional responsibility boundaries. As such, a larger 
evidence base is needed regarding outcomes associated with systematic screening and treatment 
best practices including FDA approval of medications for anxiety treatment. Research is also 
needed to understand how treatment for anxiety and depression differ, including when the two 
co-occur and how billing can impact treatment decisions. Lastly, a state-wide quantitative survey 
utilizing factors specifically associated with providers’ capacity to identify and treat anxiety 
should be created and deployed to expand upon the results of this study. 
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APPENDIX A CODEBOOK 
Provider Assessment of Mood (PAM): Provider describes the way they assess for behavioral 
health/mood during a visit including patient history. Includes use of SCARED or other screeners 
that are not computerized. Includes mention of not screening for anxiety or co-screening with 
depression.  
PAM – Tablet Screeners: Provider states that their office uses a tablet screener for 
depression and substance use. Includes discussions of transitions from paper to electronic 
form. 
PAM – Use of Tablet Screeners: Provider discusses how they use the tablet screen 
results during the visit. This can include discussions of how and why they do not rely on 
the screen results.  
Information Collected Without Parent (ICWP): Provider describes certain questions/topics 
that they ask/discuss with the adolescent when the parent is not present in the exam room (or 
would prefer to talk about when the parent is not present). Includes mention of limiting 
conversation topics if parent is present.  
Parent Involvement (PI): Provider mentions how the parent is involved in the adolescent’s 
health care.  
PI – Negative: Provider discusses how parental involvement is not helpful or takes away 
the adolescent’s voice.  
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PI – Information: Parents provide verbal information about the adolescent to the 
provider. Can include mention of contrasting information provided by the parent and 
adolescent. This includes information and or concerns made during the visit or outside of 
the visit (before, after, phone call)  
PI – Parent-Child Interaction: Provider uses the parent-child interaction to give them 
clues about the child’s health and wellbeing  
PI – Buy-in: Provider discusses getting parents to accept or acknowledge a MH 
condition. This includes reasons why parents may not be open to discussions related to 
MH conditions. Includes discussions about parents being resistant to medications for BH 
treatment. 
Provider Trust (PT): Provider discusses that trust in the provider from the parent is an 
important aspect of how parents respond to BH concerns or talk about BH concerns. Includes 
instances where parent will not agree to leave the visit when all other parties ask them too.  
Adolescent Openness (AO): Provider describes situations where the adolescent may or may not 
be more honest or open to talking about concerns/symptoms. 
Question 2 
Specific Patient Example (SPE): Provider tells a story about a specific patient and how they 
identified the mental health concern.  
SPE – Mental Health Reason: Provider says the reason for the visit was because the 
patient/parent had a concern about mental health specifically. 
Tipping Factors (TF): Provider discusses information sources that lead them to find out an 
adolescent had a MH concern. 
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TF – Screeners: Provider discusses how answers to the screening questions tip them off 
about mental health conditions. 
TF – Lifestyle Questions: Provider mentions they ask patient about their school, peer 
and home life; answers which can tip them off about mental health conditions.  
TF – Parent Provided Information: Provider mentions information shared by the parent 
as something that could tip them off about a mental health condition.  
TF – Physical Health Symptoms: Provider discusses physical health complaints 
(including mention of somatic symptoms or chronic complaint) such as headaches, chest 
pain, sleep issues, fatigue, appetite, heart rate, weight loss etc.  
TF – Behavioral Symptoms: Provider discusses behavioral symptoms such as trouble at 
school, flat affect, worry, nervous, pulling hair, ect. 
Prevalence (P): Provider discusses the prevalence of a mental health condition or the prevalence 
of one over another. Includes reasons for why they think the condition is prevalent.  
Co-Occurrence (CO): Provider talks about how depression and anxiety can co-occur or be the 
cause of one another. 
Coping Techniques (CT): Provider talks about recommendations they make to the patient with 
regards to the patient’s mental condition such as sleep hygiene and therapy recommendations.  
Visit Time Constraints (VTC): Provider talks about the length of a visit as a barrier to 
uncovering mental health concerns and or that it can sometime take multiple visit to figure out a 
mental health concern. 
Conflation of MH and PH (C): Provider describes patient and or parent confusing mental 




Example of a Patient with Anxiety (EXPA): Provider gives an example of a patient with 
anxiety or states they have/have had patients with anxiety.  
In-Visit Cues (IC): Provider discusses an adolescent attitude during the visit as a sign to check-
in about anxiety specific to fear, agreeableness/wanting to please. Provider discusses the 
adolescents body language in the visit as a sign to check-in about anxiety (examples: fidgeting, 
eye contact). 
Physical Health Symptoms (PHS): Provider discusses physical health symptoms (headaches, 
stomach aches, chest pains, trouble breathing, heart rate) as factors used to recognize adolescent 
anxiety.  
Typical Symptoms (TS): Provider mentions that when an adolescent is worried, trouble 
sleeping, having out of body experiences, is fearful, is anxious and or has panic attacks, these are 
factors used to recognize adolescent anxiety.  
Functioning (F): Provider discusses adolescents who are highly engaged in activities and school 
as sign to check in about anxiety (examples: perfectionists, straight As, highly engaged with 
peers/social situations). Provider discusses adolescents who are not highly engaged in activities 
and school, or with peers as factors used to recognize adolescent anxiety.  (Examples: school 
failure, shyness, selective mutism, absences from school, not interested in activities, social 
isolation)  
Patient History (PH): Provider mentions they use information from the patient’s history as a 
way to recognize anxiety. Includes discussions about past ways of self-medication/coping 
strategies used by the adolescent (ex: smoking marijuana)  
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Parent Information (PI): Provider talks about information the parent shares as a way they can 
recognize anxiety. Includes parent saying they think the child has anxiety or is the reason the 
visit was set-up. 
Screener Use (SU): Provider mentions situations in which they use the SCARED or GAD-7 
screener. Includes when provider mentions that they use a depression screener to pick up anxiety 
and or the signs they use for depression and anxiety are the same/similar. 
Normalizing Conversations (NC): Provider provides examples of how they talk to patients and 
or parents about anxiety. 
Referral (R): Provider mentions they refer adolescents to other providers. Includes mention of 
treatment options.  
Acceptance of Anxiety (AA): Provider mentions that patients and or parents not accepting or 
recognizing anxiety as a barrier.  
AA – Acceptability of Behaviors: Parents view behaviors of their child as normal and 
acceptable; includes provider mentions of parents downplaying adolescent 
habits/symptoms.  
AA – Honesty: Adolescents not being honest about their symptoms/feelings. 
AA – Physical Condition: Parents not understanding that they physical heath complaint 
is from anxiety, not a physical health issue.  
AA – Negative Perceptions: Provider mentions that patients and or parents not wanting 
to talk about mental health due to beliefs/conceptions of what it means to have mental 
health, negative views of the system and or treatment, view it as being abnormal, and 
concern/distrust in treatment. 
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Time (T): Provider mentions that time constraints during a visit as a challenge to recognizing 
anxiety. Includes when the concern is brought up during a visit and not before/during scheduling. 
Includes concerns about how to bill for a visit that includes mental health.  
Teasing Conditions Out (TCO): Provider discusses the difficulty determining if the complaint 
is physical, anxiety and or depression.  
TCO – Normal Anxiety: Provider mentions it can be challenging to determine if anxiety 
level is normal or diagnosable.  
Experience/Education (EE): Provider talks about the providers experience or education 
regarding anxiety as a barrier to recognizing the signs and symptoms of anxiety.  
Question 4 
Explanation of ID Importance (EI): Provider explains why it is important for them to ID 
anxiety. 
EI – First Line Provider: Provider described PCPs as being the first person the child 
will see. 
EI – Comfort: Provider describes that children see them frequently and that can build up 
patient history and or comfort between PCP-child. 
EI – Prevalence: Provider talks about how anxiety is common and or has increased over 
time. 
EI – Severity: Provider talks about the negative impacts’ anxiety can have on 
adolescents as a reason for why it is important to ID.  
EI – Past Experiences: Providers talk about the importance of having someone 
recognize anxiety (ex: provider as a child with no parental or PCP support). 
 144 
Role in ID Anxiety (RID): Provider explains what their role is in the identification process of 
anxiety.  
RID – Anxiety: Provider talks about how it is their role to ID anxiety. 
RID – General: Provide role to ID all conditions but it is the role of the child therapist to 
tease out what MH condition it is.  
RID – MH Provider Shortage: Providers mention that the role of ID (or to initiate 
treatment) falls to them due to the shortage of MH providers.  
RID – Referrals: Provider discusses their role after identification as referring patient to 
the MH system. Includes provider mention that it should not be the PCP role to 
manage/treat anxiety and that MH system should. 
RID – Treatment: Provider discusses their role after identification as providing coping 
skills or and initiating treatment.  
ID Facilitators (IDF): Provider talks about factors that facilitate them being able to identify 
anxiety.  
 IDF – Visit Time: Provider mentions that their practice adds time to adolescent visits.  
IDF – On-site BH: Provider discusses having a therapist in the office. 
IDF – Practice Culture: Having a practice culture that supports MH in staff and 
patients.  
IDF – Trainings: Provider talks about having specific MH training and or recent 
training.  
ID Barriers (IDB): Provider talks about barriers to being able to identify anxiety. 
IDB – Reimbursement: Provider discusses financle reimbursement, billing and patient-
costs as barriers to ID mental health in primary care.   
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IDB – Navigation of MH system: Provider mentions navigating the MH system as 
challenging for ID and or treatment for anxiety. Includes getting patient into treatment.  
IDB – Treatment Comfort: Providers discuss lack of comfort with 
management/treatment of anxiety as a barrier to identification.  Includes comments about 
education.  
IDB – Referrals to PCP: Other providers referring patients to talk to their PCP about 
physical health symptoms when another provider knows it may be MH related.  
IDB – Time: Provider discuses time as a barrier to ID anxiety. 
Question 5 
Follow-Up (FU): Providers discuss getting patients into their office for a follow-up visit as a 
challenge to ID anxiety in primary care.  
Visit Length (VL): Providers discuss reasons why the length of time allotted for visits is a 
challenge to ID anxiety in primary care. Includes discussions about how long assessment 
activities take. 
Lack of Training (LT): Provider mention lack of specific MH/anxiety training in residency or 
ever. Includes mention of lack of training for ID, treatment, and taking MH family history.  
No Screening (NS): Provider mentions not having a specific anxiety screener as a challenge to 
ID anxiety in primary care.  
Subtle Symptoms (SS): Providers mention anxiety symptoms are more subtle then other 
conditions therefore are comparatively more challenging to ID in primary care.  
Reimbursement (R): Providers mention financial reimbursement as a challenge to ID anxiety in 
primary care.  
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Mental Health Stigma (MHS): Providers talk about how stigma around mental health as a 
challenge to ID anxiety in primary care.  
MHS – Understanding: Parents not understanding physical symptoms are a symptom of 
anxiety.  
MHS – Disclosure: Parent/patient denial/disclosure regarding anxiety.  
Process After ID (PID): Providers talk about lack of knowing what to do after ID occurs or 
being uncomfortable with the process as a challenge to ID anxiety in primary care.   
PID – Prescribing: Providers talk about not being comfortable or trained to prescribe 
medications for anxiety as a barrier. 
Care Coordination: Providers talk about coordinating care with MH providers as a barrier. 
Patient Schedules: Providers discuss patient schedules as being a barrier to seeing a MH 
provider.  
Referrals: Providers discuss being able to find an appropriate MH provider to refer patients as 
barrier. This includes MH provider shortages, gender, location, and insurance.  
Continuing Education: Providers discuss training/education after residency that facilitates ID of 
anxiety in primary care.  
Visit Layout: Provider discusses being able to prioritize anxiety during a visit with competing 
priorities as a factor that facilitates ID of anxiety in primary care. 
On-site BH: Providers mention having a therapist on-site as a factor that facilitates ID of anxiety 
in primary care.  
Question 6 
SCARED (S): Provider discusses their use of the SCARED screener.  
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S – Useful: Provider explains why using the SCARED is helpful to them. Includes 
aspects of the form that are helpful or good (cohesive ect). 
S – Barriers to use: Provider explains challenges with using the SCARED including 
length of form, time to fill out the form, scoring issues, repetitive questions, ect.  
S – Length of Form: Provider talks about how the form is long, and takes a long time to 
be filled out by the patient/parent.  
S – Routine Use: Provider states that the SCARED tool would be useful to add to the 
routine iPad screeners.  
S – Automatic Scoring: Provider mentions that if the SCARED could be automatically 
scored, that would be helpful to them. 
No Anxiety Screeners (NAS): Provider states that they do not use anxiety screeners. Includes 
mention that it is not an office policy to use an anxiety screener.  
No Anxiety Routine Screen (NARS): Provider states that the SCARED tool (or any anxiety 
screener) should not be used for all patients. Includes comments about only giving it to patients 
who need it.  
Yes Anxiety Routine Screen (YARS): Provider mentions that some sort of anxiety screener 
may be a good idea to give to all patients in a routine manner. This does not include the 
SCARED (S – Routine Use code).   
Validation (V): Provider talks about how screening form results can be used to show 
parents/patients that a MH condition is real.  
Data Quality (DQ): Provider discuss concerns about the quality of data obtained from a form. 
Form Barriers (FB): Providers discuss barriers to forms in general (only co-co with S code if S 
sub codes are not applicable.) Includes form fatigue and time concerns.   
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Other BH Screeners: Provider mentions other screeners they have used including the PHQ, 
Substance Use (SBI CRAFT), Vanderbilt, GAD-7. 
 OBHS – Dislike: Provider discuses how the screening tool is not useful or inadequate.  
 OBHS – Useful: Provider discusses why the screener is useful.  
 OBHS – Anxiety: Provider states that the screener can pick up anxiety.  
Training (T): Provider talks about not being trained on scale use/identification and or the need 
for training.  
 Question 7 
Treatment Role (TR): Provider talks about their role in the treatment of anxiety. 
TR – New Role: Provider mentions that treatment of anxiety is a new addition to their 
role. 
TR – Reluctant Role: Provider mentions that they wish it was not their role but that it is 
and explains why it is in their role (ex. MH shortage, immediate need of patient ect) 
TR – Referral Role: Provider mentions that it is their role to refer to BH not to treat. 
TR – Initiate Role: Provider mentions it is their role to initiate treatment but not long-
term.  
Treatment Types: Provider talks about the types of treatment they provide to patients with 
anxiety. 
TR – Medications: Provider mentions medications as a type of treatment for anxiety 
they engage in. Includes mention of how they 1st initiate adolescents on medications. 
TR – No Mediations: Provider mentions they or other providers do not prescribe 
medications. 
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TR – Therapeutic: Provider discusses that they or other providers are comfortable with 
therapeutic techniques such as CBT ect. Provider mentions that they can provide some 
therapeutic techniques but that does not replace a BH provider and or is not the same 
quality 
TR – Referral First: Provider talks about how they refer to BH provider before med 
treatment.  
TR – No Therapeutic: Provider discusses that they or other providers are not 
comfortable with therapeutic techniques such as CBT ect.  
TR – Referral: Provider mentions that they only refer patients to BH providers, they do 
not treat.  
Low Comfort (LC): Provider mentions that they or other providers are not comfortable with a 
certain type of treatment. 
Comfort (C): Provider mentions that they or other providers are comfortable with a certain type 
of treatment. Includes mention of being uncomfortable and how they became comfortable.  
Fear of Harm (FH): Provider discuses fear of harm or doing a disservice to the adolescent if 
they treated them for anxiety versus a BH provider.  
Training (T): Provider mentions that they or other providers need more training in a certain type 
of treatment. Includes comments about having lack of experience in treatment as a barrier to 
care.  
Co-learning (CL): Provider mentions that they ask for help from others in the office about 
treatment. This does not include referral to BH providers who are onsite. Includes TiPS line.  
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On-site BH (ONBH): Providers discuss having on-site BH providers. Provider shares 
information about the flow/type of communication that occurs between them and the embedded 
BH provider.  
Off-site BH (OFFBH): Providers discuss working with off-site BH providers. Provider shares 
information about the flow/type of communication that occurs between them and the non-
embedded BH provider.  
 
Question 8 
Parents (PA): Provider mentions parents as a barrier to treatment. Includes parental denial of the 
MH condition and or that they are unable to follow treatment plans due to personal factors or 
factors outside of their control (ex. Transportation issues). 
Patients (PI): Provider mentions patients as a barrier to treatment. Incudes self-medication and 
refusal to be treated.   
Lack Training/Experience (LT): Provider mentions a barrier to treatment is a lack of training 
or experience treating adolescent anxiety. Includes things providers should be trained on 
regarding treatment.  
Lack Comfort (LC): Provider mentions a barrier to treatment is a lack of comfort in treating 
adolescent anxiety. 
Referral Role (RR): Provider mentions providers should be able to refer patients but should not 
have to treat them.  
Under-Recognition (UR): Provider mentions that a under recognition of anxiety is a barrier to 
care.   
Time (T): Provider mentions a barrier to treatment is a lack of time in the visit. 
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Limited BH Providers (LP): Provider mentions that there is a limited supply of BH providers 
that can treat adolescents (includes long wait times, accessibility, child-friendly locations)   
Insurance (I): Provider mentions that insurance is a barrier to treating adolescent anxiety.  
Practice Policy (PP): Providers mention that practice policy support the treatment of adolescent 
anxiety in primary care. This includes having an embedded BH provider at the office.  
Hours of PCPs (HPCP): providers say a barrier to treatment is not being able to treat the child 
in a way that is not noticeable to their peers or that pulls them out of school. Include hours 
worked by PCPs.  
Question 9 
Training/Education in Anxiety (TA): Provider talks about any anxiety training they have 
received. 
TA – Little training/Education: Provider talks about that while they did have some 
education, it was not a lot.  
No Anxiety Training/Education (NoTA): Provider talks about not receiving any anxiety-
specific training. 
Other BH Education (OE): Provider talks about receiving other BH training/education (do not 
specifically mention anxiety) 
BH Providers (BHP): Provider talks about BH providers.  
Need for Education (NE): Provider talks about types of training (including formats) and content 
that would be useful for them to participate in/learn about. Includes resources provider would 
like to have.  
Question 10 
Yes: Provider has additional information to add to the interview. 
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No: Provider does not have additional information to add to the interview.  
 
GLOBAL CODE (not co-coded) 
TiPS: Providers talk about the TiPS line.  
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APPENDIX B KAPPAS 
 
Question 1 Total 0.855 
Provider Assessment of Mood (PAM) Total 0.834 
PAM 0.849 
PAM – Tablet Screeners 0.885 
PAM – Use of Tablet Screeners 0.754 
Information Collected Without Parent  0.845 
Parent Involvement (PI) Total  0.915 
PI 0.801 
PI – Negative 1 
PI – Information 0.741 
PI – Parent-Child Interaction 0.791 
PI – Buy-in 0.847 
Provider Trust  0.899 
Adolescent Openness  1 
Question 2 Total  0.921 
Specific Patient Example (SPE) Total 1 
SPE 1 
SPE – Mental Health Reason 1 
Tipping Factors (TF) Total 0.889 
TF 1 
TF – Screeners 1 
TF – Lifestyle Questions 0.759 
TF – Parent Provided Information 0.441 
TF – Physical Health Symptoms 0.894 
TF – Behavioral Symptoms 0.776 
Prevalence  1 
Co-Occurrence  1 
Coping Techniques  1 
Visit Time Constraints  0.642 
Conflation of MH and PH  1 
Question 3 Total  0.906 
In-Visit Cues  0.898 
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Normalizing Conversations  0.898 
Physical Health Symptoms 0.909 
Typical Symptoms  0.866 
Functioning 1 
Patient History  0.79 
Parent Information  0.884 
Screener Use  0.912 
Referral 1 
Acceptance of Anxiety (AA) Total 8.17 
AA 0.803 
AA – Acceptability of Behaviors 1 
AA – Honesty 0.558 
AA – Physical Condition 1 
AA – Negative Perceptions 0.912 
Time 0.878 
Teasing Conditions Out (TCO) Total 0.936 
TOC 0.912 
TCO – Normal Anxiety 1 
Experience/Education  1 
Question 4 Total  0.736 
Explanation of ID Importance (EI) Total  0.888 
EI – First Line Provider 0.832 
EI – Comfort 1 
EI – Prevalence 1 
EI – Severity 0.832 
EI – Past Experiences 0.646 
Role in ID Anxiety (RID) Total  0.868 
RID – Anxiety 0.511 
RID – General 0.646 
RID – MH Provider Shortage 1 
RID – Referrals 1 
RID – Treatment 1 
ID Facilitators (IDF) Total  0.941 
IDF – Visit Time 1 
IDF – On-site BH 0.777 
IDF – Practice Culture 1 
IDF – Trainings 1 
ID Barriers (IDB) 0.732 
IDB – Reimbursement  1 
IDB – Navigation of MH system 0 
IDB – Treatment Comfort 0.617 
IDB – Referrals to PCP 1 
IBD – Time 0.646 
Question 5 Total  0.941 
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Follow-Up  1 
Visit Length  1 
Lack Training  0.78 
No Screening  0.649 
Subtle Symptoms  1 
Reimbursement 0.835 
Mental Health Stigma (MHS) Total 0.898 
MHS – Understanding 0.835 
MHS – Disclosure N/A 
MHS D 1 
Process After ID (PID) Total 1 
PID 1 
PID – Prescribing 1 
Care Coordination (CC) Total 0.96 
CC 1 
CC - Patient Schedules 1 
CC - Referrals 0.885 
Continuing Education 1 
Visit Layout 1 
On-site BH 1 
Question 6 Total  0.918 
SCARED Total 0.925 
SCARED 0.931 
S – Useful 0.76 
S – Barriers to use 1 
S – Length of Form N/A 
S – Routine Use 0.322 
S – Automatic Scoring 1 
No Anxiety Screeners  1 
No Anxiety Routine Screen  0.776 
Yes Anxiety Routine Screen  0.869 
Validation  1 
Data Quality  0 
Form Barriers  1 
Other BH Screeners (OBHS) Total 0.952 
OBHS 1 
OBHS – Dislike 0.869 
OBHS – Useful 1 
OBHS – Anxiety 0.782 
Training  1 
Question 7 Total  0.921  
Treatment Role (TR) Total  0.901 
TR – New Role 1 
TR – Reluctant Role 1 
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TR – Referral Role 1 
TR – Initiate Role 0.728 
Treatment Types (TT) Total  0.947 
TR – Medications 0.915 
TR – No Mediations 1 
TR – Therapeutic 0.877 
TR – Referral First 1 
TR – No Therapeutic 1 
TR – Referral 0.948 
Low Comfort  0.911 
Comfort 0.839 
Fear of Harm  1 
Training 0.863 
Co-learning  0.657 
On-site BH  0.948 
Off-site BH  1 
Treatment Challenges 0.85 
Question 8 Total   0.961  
Parents 1 
Patients 1 
Lack Training/Experience  1 
Lack Comfort  0.708 
Referral Role  1 
Under-Recognition  1 
Time 1 
Limited BH Providers  1 
Insurance 1 
Practice Policy  0.9 
Hours of PCPs  1 
Question 9 Total  0.972 
Training/Education in Anxiety (TA) Total 1 
TA  1 
TA – Little training/Education 1 
No Anxiety Training/Education  1 
Other BH Education  0.928 
BH Providers  0.901 
Need for Education  1 
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